• 1
    Bouchard, C., Perusse, L. (1996) Current status of the human obesity gene map. Obes Res. 4: 8190.
  • 2
    Chagnon, Y. C., Perusse, L., Bouchard, C. (1998) The human obesity gene map: the 1997 update. Obes Res. 6: 7692.
  • 3
    Chagnon, Y. C., Perusse, L., Weisnagel, J. S., Rankinen, T., Bouchard, C. (2000) The human obesity gene map: the 1999 update. Obes Res. 8: 89117.
  • 4
    Chagnon, Y. C., Rankinen, T., Snyder, E. E., Weisnagel, S. J., Perusse, L., Bouchard, C. (2003) The human obesity gene map: the 2002 update. Obes Res. 11: 313367.
  • 5
    Perusse, L., Chagnon, Y. C., Dionne, F. T., Bouchard, C. (1997) The human obesity gene map: the 1996 update. Obes Res. 5: 4961.
  • 6
    Perusse, L., Chagnon, Y. C., Weisnagel, J., Bouchard, C. (1999) The human obesity gene map: the 1998 update. Obes Res. 7: 111129.
  • 7
    Perusse, L., Chagnon, Y. C., Weisnagel, S. J., et al (2001) The human obesity gene map: the 2000 update. Obes Res. 9: 135169.
  • 8
    Rankinen, T., Perusse, L., Weisnagel, S. J., Snyder, E. E., Chagnon, Y. C., Bouchard, C. (2002) The human obesity gene map: the 2001 update. Obes Res. 10: 196243.
  • 9
    Snyder, E. E., Walts, B., Perusse, L., et al (2004) The human obesity gene map: the 2003 update. Obes Res. 12: 369439.
  • 10
    Perusse, L., Bouchard, C. (1996) Identification of genes contributing to excess body fat and fat distribution. In Angel, A Anderson H Bouchard C Lau D Leiter L Mendelson, R (eds). 7th International Congress on Obesity: Progress in Obesity Research 7 John Libbey & Company Ltd Toronto, ON.
  • 11
    Perusse, L., Rankinen, T., Zuberi, A., et al (2005) The human obesity gene map: the 2004 update. Obes Res. 13: 381490.
  • 12
    Farooqi, I. S., O'Rahilly, S. (2005) Monogenic obesity in humans. Annu Rev Med. 56: 443458.
  • 13
    Yeo, G. S., Connie, Hung CC, Rochford, J., et al (2004) A de novo mutation affecting human TrkB associated with severe obesity and developmental delay. Nat Neurosci. 7: 11871189.
  • 14
    Challis, B. G., Luan, J., Keogh, J., Wareham, N. J., Farooqi, I. S., O'Rahilly, S. (2004) Genetic variation in the corticotrophin-releasing factor receptors: identification of single-nucleotide polymorphisms and association studies with obesity in UK Caucasians. Int J Obes Relat Metab Disord. 28: 442446.
  • 15
    Gibson, W. T., Pissios, P., Trombly, D. J., et al (2004) Melanin-concentrating hormone receptor mutations and human obesity: functional analysis. Obes Res. 12: 743749.
  • 16
    Montague, C. T., Farooqi, I. S., Whitehead, J. P., et al (1997) Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387: 903908.
  • 17
    Ozata, M., Ozdemir, I. C., Licinio, J. (1999) Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J Clin Endocrinol Metab. 84: 36863695.
  • 18
    Strobel, A., Issad, T., Camoin, L., Ozata, M., Strosberg, AD. (1998) A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet. 18: 213215.
  • 19
    Farooqi, I. S., Matarese, G., Lord, G. M., et al (2002) Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest. 110: 10931103.
  • 20
    Gibson, W. T., Farooqi, I. S., Moreau, M., et al (2004) Congenital leptin deficiency due to homozygosity for the Delta133G mutation: report of another case and evaluation of response to four years of leptin therapy. J Clin Endocrinol Metab. 89: 48214826.
  • 21
    Clement, K., Vaisse, C., Lahlou, N., et al (1998) A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392: 398401.
  • 22
    Lee, Y. S., Poh, L. K., Loke, KY. (2002) A novel melanocortin 3 receptor gene (MC3R) mutation associated with severe obesity. J Clin Endocrinol Metab. 87: 14231426.
  • 23
    Rached, M., Buronfosse, A., Begeot, M., Penhoat, A. (2004) Inactivation and intracellular retention of the human I183N mutated melanocortin 3 receptor associated with obesity. Biochim Biophys Acta. 1689: 229234.
  • 24
    Tao, Y. X., Segaloff, DL. (2004) Functional characterization of melanocortin-3 receptor variants identify a loss-of-function mutation involving an amino acid critical for G protein-coupled receptor activation. J Clin Endocrinol Metab. 89: 39363942.
  • 25
    Biebermann, H., Krude, H., Elsner, A., Chubanov, V., Gudermann, T., Gruters, A. (2003) Autosomal-dominant mode of inheritance of a melanocortin-4 receptor mutation in a patient with severe early-onset obesity is due to a dominant-negative effect caused by receptor dimerization. Diabetes 52: 29842988.
  • 26
    Donohoue, P. A., Tao, Y. X., Collins, M., Yeo, G. S., O'Rahilly, S., Segaloff, DL. (2003) Deletion of codons 88–92 of the melanocortin-4 receptor gene: a novel deleterious mutation in an obese female. J Clin Endocrinol Metab. 88: 58415845.
  • 27
    Dubern, B., Clement, K., Pelloux, V., et al (2001) Mutational analysis of melanocortin-4 receptor, agouti-related protein, and alpha-melanocyte-stimulating hormone genes in severely obese children. J Pediatr. 139: 204209.
  • 28
    Farooqi, I. S., Yeo, G. S., Keogh, J. M., et al (2000) Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J Clin Invest. 106: 271279.
  • 29
    Farooqi, I. S., Keogh, J. M., Yeo, G. S., Lank, E. J., Cheetham, T., O'Rahilly, S. (2003) Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med. 348: 10851095.
  • 30
    Gu, W., Tu, Z., Kleyn, P. W., et al (1999) Identification and functional analysis of novel human melanocortin-4 receptor variants. Diabetes 48: 635639.
  • 31
    Hebebrand, J., Fichter, M., Gerber, G., et al (2002) Genetic predisposition to obesity in bulimia nervosa: a mutation screen of the melanocortin-4 receptor gene. Mol Psychiatry. 7: 647651.
  • 32
    Hinney, A., Schmidt, A., Nottebom, K., et al (1999) Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans. J Clin Endocrinol Metab. 84: 14831486.
  • 33
    Hinney, A., Hohmann, S., Geller, F., et al (2003) Melanocortin-4 receptor gene: case-control study and transmission disequilibrium test confirm that functionally relevant mutations are compatible with a major gene effect for extreme obesity. J Clin Endocrinol Metab. 88: 42584267.
  • 34
    Jacobson, P., Ukkola, O., Rankinen, T., et al (2002) Melanocortin 4 receptor sequence variations are seldom a cause of human obesity: the Swedish Obese Subjects, the HERITAGE Family Study, and a Memphis cohort. J Clin Endocrinol Metab. 87: 44424446.
  • 35
    Kobayashi, H., Ogawa, Y., Shintani, M., et al (2002) A Novel homozygous missense mutation of melanocortin-4 receptor (MC4R) in a Japanese woman with severe obesity. Diabetes 51: 243246.
  • 36
    Lubrano-Berthelier, C., Durand, E., Dubern, B., et al (2003) Intracellular retention is a common characteristic of childhood obesity-associated MC4R mutations. Hum Mol Genet. 12: 145153.
  • 37
    Lubrano-Berthelier, C., Cavazos, M., Dubern, B., et al (2003) Molecular genetics of human obesity-associated MC4R mutations. Ann N Y Acad Sci. 994: 4957.
  • 38
    Ma, L., Tataranni, P. A., Bogardus, C., Baier, LJ. (2004) Melanocortin 4 receptor gene variation is associated with severe obesity in Pima Indians. Diabetes 53: 26962699.
  • 39
    Nijenhuis, W. A., Garner, K. M., van Rozen, R. J., Adan, RA. (2003) Poor cell surface expression of human melanocortin-4 receptor mutations associated with obesity. J Biol Chem. 278: 2293922945.
  • 40
    Santini, F., Maffei, M., Ceccarini, G., et al (2004) Genetic screening for melanocortin-4 receptor mutations in a cohort of Italian obese patients: description and functional characterization of a novel mutation. J Clin Endocrinol Metab. 89: 904908.
  • 41
    Sina, M., Hinney, A., Ziegler, A., et al (1999) Phenotypes in three pedigrees with autosomal dominant obesity caused by haploinsufficiency mutations in the melanocortin-4 receptor gene. Am J Hum Genet. 65: 15011507.
  • 42
    Tao, Y. X., Segaloff, DL. (2003) Functional characterization of melanocortin-4 receptor mutations associated with childhood obesity. Endocrinology 144: 45444551.
  • 43
    Vaisse, C., Clement, K., Guy-Grand, B., Froguel, P. (1998) A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat Genet. 20: 113114.
  • 44
    Vaisse, C., Clement, K., Durand, E., Hercberg, S., Guy-Grand, B., Froguel, P. (2000) Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest. 106: 253262.
  • 45
    Valli-Jaakola, K., Lipsanen-Nyman, M., Oksanen, L., et al (2004) Identification and characterization of melanocortin-4 receptor gene mutations in morbidly obese Finnish children and adults. J Clin Endocrinol Metab. 89: 940945.
  • 46
    Yeo, G. S. H., Farooqi, I. S., Aminian, S., Halsall, D. J., Stanhope, RG. (1998) A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat Genet. 20: 111112.
  • 47
    Yeo, G. S., Lank, E. J., Farooqi, I. S., Keogh, J., Challis, B. G., O'Rahilly, S. (2003) Mutations in the human melanocortin-4 receptor gene associated with severe familial obesity disrupts receptor function through multiple molecular mechanisms. Hum Mol Genet. 12: 561574.
  • 48
    Challis, B. G., Pritchard, L. E., Creemers, J. W., et al (2002) A missense mutation disrupting a dibasic prohormone processing site in pro-opiomelanocortin (POMC) increases susceptibility to early-onset obesity through a novel molecular mechanism. Hum Mol Genet. 11: 19972004.
  • 49
    Krude, H., Biebermann, H., Luck, W., Horn, R., Brabant, G., Gruters, A. (1998) Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet. 19: 155157.
  • 50
    Jackson, R. S., Creemers, J. W. M., Ohagi, S., et al (1997) Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat Genet. 16: 303306.
  • 51
    Jackson, R. S., Creemers, J. W., Farooqi, I. S., et al (2003) Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency. J Clin Invest. 112: 15501560.
  • 52
    Faivre, L., Cormier-Daire, V., Lapierre, J. M., et al (2002) Deletion of the SIM1 gene (6q16.2) in a patient with a Prader-Willi-like phenotype. J Med Genet. 39: 594596.
  • 53
    Holder, J. L. Jr, Butte, N. F., Zinn, A. R. (2000) Profound obesity associated with a balanced translocation that disrupts the SIM1 gene. Hum Mol Genet. 9: 101108.
  • 54
    Collin, G. B., Marshall, J. D., Boerkoel, C. F., et al (1999) Alstrom syndrome: further evidence for linkage to human chromosome 2p13. Hum Genet. 105: 474479.
  • 55
    Collin, G. B., Marshall, J. D., Ikeda, A., et al (2002) Mutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alstrom syndrome. Nat Genet. 31: 7478.
  • 56
    Hearn, T., Renforth, G. L., Spalluto, C., et al (2002) Mutation of ALMS1, a large gene with a tandem repeat encoding 47 amino acids, causes Alstrom syndrome. Nat Genet. 31: 7983.
  • 57
    Macari, F., Lautier, C., Girardet, A., et al (1998) Refinement of genetic localization of the Alstrom syndrome on chromosome 2p12-13 by linkage analysis in a North African family. Hum Genet. 103: 658661.
  • 58
    Marshall, J. D., Bronson, R. T., Collin, G. B., et al (2005) New Alstrom syndrome phenotypes based on the evaluation of 182 cases. Arch Intern Med. 165: 675683.
  • 59
    Titomanlio, L., De Brasi, D., Buoninconti, A., et al (2004) Alstrom syndrome: intrafamilial phenotypic variability in sibs with a novel nonsense mutation of the ALMS1 gene. Clin Genet. 65: 156157.
  • 60
    Beales, P. L., Badano, J. L., Ross, A. J., et al (2003) Genetic interaction of BBS1 mutations with alleles at other BBS loci can result in non-Mendelian Bardet-Biedl syndrome. Am J Hum Genet. 72: 11871199.
  • 61
    Bruford, E. A., Riise, R., Teague, P. W., et al (1997) Linkage mapping in 29 Bardet-Biedl syndrome families confirms loci in chromosomal regions 11q13, 15q22.3-q23, and 16q21. Genomics 41: 9399.
  • 62
    Katsanis, N., Lewis, R. A., Stockton, D. W., et al (1999) Delineation of the critical interval of Bardet-Biedl syndrome 1 (BBS1) to a small region of 11q13, through linkage and haplotype analysis of 91 pedigrees. Am J Hum Genet. 65: 16721679.
  • 63
    Moore, S. J., Green, J. S., Fan, Y., et al (2005) Clinical and genetic epidemiology of Bardet-Biedl syndrome in Newfoundland: a 22-year prospective, population-based, cohort study. Am J Med Genet A. 132: 352360.
  • 64
    Mykytyn, K., Nishimura, D. Y., Searby, C. C., et al (2002) Identification of the gene (BBS1) most commonly involved in Bardet- Biedl syndrome, a complex human obesity syndrome. Nat Genet. 31: 435438.
  • 65
    Mykytyn, K., Nishimura, D. Y., Searby, C. C., et al (2003) Evaluation of complex inheritance involving the most common Bardet-Biedl syndrome locus (BBS1). Am J Hum Genet. 72: 429437.
  • 66
    Young, T. L., Woods, M. O., Parfrey, P. S., Green, J. S., Hefferton, D., Davidson, WS. (1999) A founder effect in the Newfoundland population reduces the Bardet-Biedl syndrome I (BBS1) interval to 1 cM. Am J Hum Genet. 65: 16801687.
  • 67
    Badano, J. L., Ansley, S. J., Leitch, C. C., Lewis, R. A., Lupski, J. R., Katsanis, N. (2003) Identification of a novel Bardet-Biedl syndrome protein, BBS7, that shares structural features with BBS1 and BBS2. Am J Hum Genet. 72: 650658.
  • 68
    Katsanis, N., Ansley, S. J., Badano, J. L., et al (2001) Triallelic inheritance in Bardet-Biedl syndrome, a Mendelian recessive disorder. Science 293: 22562259.
  • 69
    Kwitek-Black, A. E., Carmi, R., Duyk, G. M., et al (1993) Linkage of Bardet-Biedl syndrome to chromosome 16q and evidence for non-allelic genetic heterogeneity. Nat Genet. 5: 392396.
  • 70
    Nishimura, D. Y., Searby, C. C., Carmi, R., et al (2001) Positional cloning of a novel gene on chromosome 16q causing Bardet-Biedl syndrome (BBS2). Hum Mol Genet. 10: 865874.
  • 71
    Beales, P. L., Katsanis, N., Lewis, R. A., et al (2001) Genetic and mutational analyses of a large multiethnic Bardet-Biedl cohort reveal a minor involvement of BBS6 and delineate the critical intervals of other loci. Am J Hum Genet. 68: 606616.
  • 72
    Chiang, A. P., Nishimura, D., Searby, C., et al (2004) Comparative genomic analysis identifies an ADP-ribosylation factor-like gene as the cause of Bardet-Biedl syndrome (BBS3). Am J Hum Genet. 75: 475484.
  • 73
    Fan, Y., Esmail, M. A., Ansley, S. J., et al (2004) Mutations in a member of the Ras superfamily of small GTP-binding proteins causes Bardet-Biedl syndrome. Nat Genet. 36: 989993.
  • 74
    Sheffield, V. C., Carmi, R., Kwitek-Black, A., et al (1994) Identification of a Bardet-Biedl syndrome locus on chromosome 3 and evaluation of an efficient approach to homozygosity mapping. Hum Mol Genet. 3: 13311335.
  • 75
    Young, T. L., Woods, M. O., Parfrey, P. S., et al (1998) Canadian Bardet-Biedl syndrome family reduces the critical region of BBS3 (3p) and presents with a variable phenotype. Am J Med Genet. 78: 461467.
  • 76
    Carmi, R., Rokhlina, T., Kwitek-Black, A. E., et al (1995) Use of a DNA pooling strategy to identify a human obesity syndrome locus on chromosome 15. Hum Mol Genet. 4: 913.
  • 77
    Gorman, S., Haider, N., Grieshammer, U., et al (1999) The cloning and developmental expression of unconventional myosin IXA (MYO9A) a gene in the Bardet-Biedl syndrome (BBS4) region at chromosome 15q22–q23. Genomics 59: 150160.
  • 78
    Katsanis, N., Eichers, E. R., Ansley, S. J., et al (2002) BBS4 is a minor contributor to Bardet-Biedl syndrome and may also participate in triallelic inheritance. Am J Hum Genet. 71: 2229.
  • 79
    Kim, J. C., Badano, J. L., Sibold, S., et al (2004) The Bardet-Biedl protein BBS4 targets cargo to the pericentriolar region and is required for microtubule anchoring and cell cycle progression. Nat Genet. 36: 462470.
  • 80
    Mykytyn, K., Braun, T., Carmi, R., et al (2001) Identification of the gene that, when mutated, causes the human obesity syndrome BBS4. Nat Genet. 28: 188191.
  • 81
    Mykytyn, K., Mullins, R. F., Andrews, M., et al (2004) Bardet-Biedl syndrome type 4 (BBS4)-null mice implicate Bbs4 in flagella formation but not global cilia assembly. Proc Natl Acad Sci U S A. 101: 86648669.
  • 82
    Li, J. B., Gerdes, J. M., Haycraft, C. J., et al (2004) Comparative genomics identifies a flagellar and basal body proteome that includes the BBS5 human disease gene. Cell 117: 541552.
  • 83
    Woods, M., Young, T., Parfrey, P., Hefferton, D., Green, J., Davidson, W. (1999) Genetic heterogeneity of Bardet-Biedl syndrome in a distinct Canadian population: evidence for a fifth locus. Genomics 55: 29.
  • 84
    Young, T. L., Penney, L., Woods, M. O., et al (1999) A fifth locus for Bardet-Biedl syndrome maps to chromosome 2q31. Am J Hum Genet. 64: 900904.
  • 85
    Katsanis, N., Beales, P. L., Woods, M. O., et al (2000) Mutations in MKKS cause obesity, retinal dystrophy and renal malformations associated with Bardet-Biedl syndrome. Nat Genet. 26: 6770.
  • 86
    Slavotinek, A. M., Stone, E. M., Mykytyn, K., et al (2000) Mutations in MKKS cause Bardet-Biedl syndrome. Nat Genet. 26: 1516.
  • 87
    Slavotinek, A. M., Searby, C., Al-Gazali, L., et al (2002) Mutation analysis of the MKKS gene in McKusick-Kaufman syndrome and selected Bardet-Biedl syndrome patients. Hum Genet. 110: 561567.
  • 88
    Stone, D. L., Slavotinek, A., Bouffard, G. G., et al (2000) Mutation of a gene encoding a putative chaperonin causes McKusick-Kaufman syndrome. Nat Genet. 25: 7982.
  • 89
    Blacque, O. E., Reardon, M. J., Li, C., et al (2004) Loss of C. elegans BBS-7 and BBS-8 protein function results in cilia defects and compromised intraflagellar transport. Genes Dev. 18: 16301642.
  • 90
    Ansley, S. J., Badano, J. L., Blacque, O. E., et al (2003) Basal body dysfunction is a likely cause of pleiotropic Bardet-Biedl syndrome. Nature 425: 628633.
  • 91
    Agarwal, A. K., Arioglu, E., De Almeida, S., et al (2002) AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. Nat Genet. 31: 2123.
  • 92
    Agarwal, A. K., Simha, V., Oral, E. A., et al (2003) Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy. J Clin Endocrinol Metab. 88: 48404847.
  • 93
    Garg, A., Wilson, R., Barnes, R., et al (1999) A gene for congenital generalized lipodystrophy maps to human chromosome 9q34. J Clin Endocrinol Metab. 84: 33903394.
  • 94
    Gomes, K. B., Fernandes, A. P., Ferreira, A. C., et al (2004) Mutations in the seipin and AGPAT2 genes clustering in consanguineous families with Berardinelli-Seip congenital lipodystrophy from two separate geographical regions of Brazil. J Clin Endocrinol Metab. 89: 357361.
  • 95
    Magre, J., Delepine, M., Van Maldergem, L., et al (2003) Prevalence of mutations in AGPAT2 among human lipodystrophies. Diabetes 52: 15731578.
  • 96
    Heathcote, K., Rajab, A., Magre, J., et al (2002) Molecular analysis of Berardinelli-Seip congenital lipodystrophy in Oman: evidence for multiple loci. Diabetes 51: 12911293.
  • 97
    Magre, J., Delepine, M., Khallouf, E., et al (2001) Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nat Genet. 28: 365370.
  • 98
    Rajab, A., Heathcote, K., Joshi, S., Jeffery, S., Patton, M. (2002) Heterogeneity for congenital generalized lipodystrophy in seventeen patients from Oman. Am J Med Genet. 110: 219225.
  • 99
    Matthijs, G., Schollen, E., Pardon, E., et al (1997) Mutations in PMMM2, a phosphomannomutase gene on chromosome 16p13, in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome). Nat Genet. 16: 8892.[Published erratum in Nat Genet. 1997;16:316].
  • 100
    Falk, M. J., Feiler, H. S., Neilson, D. E., et al (2004) Cohen syndrome in the Ohio Amish. Am J Med Genet. 128A: 2328.
  • 101
    Hennies, H. C., Rauch, A., Seifert, W., et al (2004) Allelic heterogeneity in the COH1 gene explains clinical variability in Cohen syndrome. Am J Hum Genet. 75: 138145.
  • 102
    Kivitie-Kallio, S., Norio, R. (2001) Cohen syndrome: essential features, natural history, and heterogeneity. Am J Med Genet. 102: 125135.
  • 103
    Kolehmainen, J., Black, G. C., Saarinen, A., et al (2003) Cohen syndrome is caused by mutations in a novel gene, COH1, encoding a transmembrane protein with a presumed role in vesicle-mediated sorting and intracellular protein transport. Am J Hum Genet. 72: 13591369.
  • 104
    Kolehmainen, J., Wilkinson, R., Lehesjoki, A. E., et al (2004) Delineation of Cohen syndrome following a large-scale genotype-phenotype screen. Am J Hum Genet. 75: 122127.
  • 105
    Tahvanainen, E., Norio, R., Karila, E., et al (1994) Cohen syndrome gene assigned to the long arm of chromosome 8 by linkage analysis. Nat Genet. 7: 201204.
  • 106
    Arroyo, A., Pernasetti, F., Vasilyev, V. V., Amato, P., Yen, S. S., Mellon, PL. (2002) A unique case of combined pituitary hormone deficiency caused by a PROP1 gene mutation (R120C) associated with normal height and absent puberty. Clin Endocrinol (Oxf). 57: 283291.
  • 107
    Mendonca, B. B., Osorio, M. G., Latronico, A. C., Estefan, V., Lo, L. S., Arnhold, IJ. (1999) Longitudinal hormonal and pituitary imaging changes in two females with combined pituitary hormone deficiency due to deletion of A301, G302 in the PROP1 gene. J Clin Endocrinol Metab. 84: 942945.
  • 108
    Rosenbloom, A. L., Almonte, A. S., Brown, M. R., Fisher, D. A., Baumbach, L., Parks, JS. (1999) Clinical and biochemical phenotype of familial anterior hypopituitarism from mutation of the PROP1 gene. J Clin Endocrinol Metab. 84: 5057.
  • 109
    Akagi, M., Inui, K., Nakajima, S., et al (2000) Mutation analysis of two Japanese patients with Fanconi-Bickel syndrome. J Hum Genet. 45: 6062.
  • 110
    Burwinkel, B., Sanjad, S. A., Al-Sabban, E., Al-Abbad, A., Kilimann, MW. (1999) A mutation in GLUT2, not in phosphorylase kinase subunits, in hepato-renal glycogenosis with Fanconi syndrome and low phosphorylase kinase activity. Hum Genet. 105: 240243.
  • 111
    Matsuura, T., Tamura, T., Chinen, Y., Ohta, T. (2002) A novel mutation (N32K) of GLUT2 gene in a Japanese patient with Fanconi-Bickel syndrome. Clin Genet. 62: 255256.
  • 112
    Odievre, M. H., Lombes, A., Dessemme, P., et al (2002) A secondary respiratory chain defect in a patient with Fanconi-Bickel syndrome. J Inherit Metab Dis. 25: 379384.
  • 113
    Sakamoto, O., Ogawa, E., Ohura, T., et al (2000) Mutation analysis of the GLUT2 gene in patients with Fanconi-Bickel syndrome. Pediatr Res. 48: 586589.
  • 114
    Santer, R., Schneppenheim, R., Dombrowski, A., Gotze, H., Steinmann, B., Schaub, J. (1997) Mutations in GLUT2, the gene for the liver-type glucose transporter, in patients with Fanconi-Bickel syndrome. Nat Genet. 17: 324326.[Published erratum in Nat Genet. 1998;18:298].
  • 115
    Santer, R., Groth, S., Kinner, M., et al (2002) The mutation spectrum of the facilitative glucose transporter gene SLC2A2 (GLUT2) in patients with Fanconi-Bickel syndrome. Hum Genet. 110: 2129.
  • 116
    Tsuda, M., Kitasawa, E., Ida, H., Eto, Y., Owada, M. (2000) A newly recognized missense mutation in the GLUT2 gene in a patient with Fanconi-Bickel syndrome. Eur J Pediatr. 159: 867
  • 117
    Yoo, H. W., Shin, Y. L., Seo, E. J., Kim, GH. (2002) Identification of a novel mutation in the GLUT2 gene in a patient with Fanconi-Bickel syndrome presenting with neonatal diabetes mellitus and galactosemia. Eur J Pediatr. 161: 351353.
  • 118
    Barreto-Filho, J. A., Alcantara, M. R., Salvatori, R., et al (2002) Familial isolated growth hormone deficiency is associated with increased systolic blood pressure, central obesity, and dyslipidemia. J Clin Endocrinol Metab. 87: 20182023.
  • 119
    Salvatori, R., Hayashida, C. Y., Aguiar-Oliveira, M. H., et al (1999) Familial dwarfism due to a novel mutation of the growth hormone-releasing hormone receptor gene. J Clin Endocrinol Metab. 84: 917923.
  • 120
    Wajnrajch, M. P., Gertner, J. M., Harbison, M. D., Chua, S. C., Leibel, RL. (1996) Nonsense mutation in the human growth hormone-releasing hormone receptor causes growth failure analogous to the little (lit) mouse. Nat Genet. 12: 8890.
  • 121
    Draper, N., Walker, E. A., Bujalska, I. J., et al (2003) Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency. Nat Genet. 34: 434439.
  • 122
    Jamieson, A., Wallace, A. M., Andrew, R., et al (1999) Apparent cortisone reductase deficiency: a functional defect in 11beta-hydroxysteroid dehydrogenase type 1. J Clin Endocrinol Metab. 84: 35703574.
  • 123
    Savage, D. B., Agostini, M., Barroso, I., et al (2002) Digenic inheritance of severe insulin resistance in a human pedigree. Nat Genet. 31: 379384.
  • 124
    Bellus, G. A., Hefferon, T. W., de Luna, R. I. Ortiz, et al (1995) Achondroplasia is defined by recurrent G380R mutations of FGFR3. Am J Hum Genet. 56: 368373.
  • 125
    Rousseau, F., Bonaventure, J., Legeai-Mallet, L., et al (1994) Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 371: 252254.
  • 126
    Shiang, R., Thompson, L. M., Zhu, Y. Z., et al (1994) Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 78: 335342.
  • 127
    Superti-Furga, A., Eich, G., Bucher, H. U., et al (1995) A glycine 375-to-cysteine substitution in the transmembrane domain of the fibroblast growth factor receptor-3 in a newborn with achondroplasia. Eur J Pediatr. 154: 215219.
  • 128
    Ahmed, S. F., Dixon, P. H., Bonthron, D. T., et al (1998) GNAS1 mutational analysis in pseudohypoparathyroidism. Clin Endocrinol (Oxf). 49: 525531.
  • 129
    Ahrens, W., Hiort, O., Staedt, P., Kirschner, T., Marschke, C., Kruse, K. (2001) Analysis of the GNAS1 gene in Albright's hereditary osteodystrophy. J Clin Endocrinol Metab. 86: 46304634.
  • 130
    Aldred, M. A., Trembath, RC. (2000) Activating and inactivating mutations in the human GNAS1 gene. Hum Mutat. 16: 183189.
  • 131
    De Sanctis, L., Romagnolo, D., Olivero, M., et al (2003) Molecular analysis of the GNAS1 gene for the correct diagnosis of Albright hereditary osteodystrophy and pseudohypoparathyroidism. Pediatr Res. 53: 749755.
  • 132
    Farfel, Z., Iiri, T., Shapira, H., Roitman, A., Mouallem, M., Bourne, HR. (1996) Pseudohypoparathyroidism, a novel mutation in the beta gamma-contact region of Gs alpha impairs receptor stimulation. J Biol Chem. 271: 1965319655.
  • 133
    Fischer, J. A., Egert, F., Werder, E., Born, W. (1998) An inherited mutation associated with functional deficiency of the alpha-subunit of the guanine nucleotide-binding protein Gs in pseudo- and pseudopseudohypoparathyroidism. J Clin Endocrinol Metab. 83: 935938.
  • 134
    Iiri, T., Herzmark, P., Nakamoto, J. M., van Dop, C., Bourne, HR. (1994) Rapid GDP release from Gs alpha in patients with gain and loss of endocrine function. Nature 371: 164168.
  • 135
    Ishikawa, Y., Tajima, T., Nakae, J., et al (2001) Two mutations of the Gsalpha gene in two Japanese patients with sporadic pseudohypoparathyroidism type Ia. J Hum Genet. 46: 426430.
  • 136
    Lim, S. H., Poh, L. K., Cowell, C. T., Tey, B. H., Loke, KY. (2002) Mutational analysis of the GNAS1 exons encoding the stimulatory G protein in five patients with pseudohypoparathyroidism type 1a. J Pediatr Endocrinol Metab. 15: 259268.
  • 137
    Linglart, A., Carel, J. C., Garabedian, M., Le, T., Mallet, E., Kottler, ML. (2002) GNAS1 lesions in pseudohypoparathyroidism Ia and Ic: genotype phenotype relationship and evidence of the maternal transmission of the hormonal resistance. J Clin Endocrinol Metab. 87: 189197.
  • 138
    Mantovani, G., Romoli, R., Weber, G., et al (2000) Mutational analysis of GNAS1 in patients with pseudohypoparathyroidism: identification of two novel mutations. J Clin Endocrinol Metab. 85: 42434248.
  • 139
    Patten, J. L., Johns, D. R., Valle, D., et al (1990) Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright's hereditary osteodystrophy. N Engl J Med. 322: 14121419.
  • 140
    Rickard, S. J., Wilson, LC. (2003) Analysis of GNAS1 and overlapping transcripts identifies the parental origin of mutations in patients with sporadic Albright hereditary osteodystrophy and reveals a model system in which to observe the effects of splicing mutations on translated and untranslated messenger RNA. Am J Hum Genet. 72: 961974.
  • 141
    Schwindinger, W. F., Miric, A., Zimmerman, D., Levine, MA. (1994) A novel Gs alpha mutant in a patient with Albright hereditary osteodystrophy uncouples cell surface receptors from adenylyl cyclase. J Biol Chem. 269: 2538725391.
  • 142
    Warner, D. R., Gejman, P. V., Collins, R. M., Weinstein, LS. (1997) A novel mutation adjacent to the switch III domain of G(S alpha) in a patient with pseudohypoparathyroidism. Mol Endocrinol. 11: 17181727.
  • 143
    Warner, D. R., Weng, G., Yu, S., Matalon, R., Weinstein, LS. (1998) A novel mutation in the switch 3 region of Gsalpha in a patient with Albright hereditary osteodystrophy impairs GDP binding and receptor activation. J Biol Chem. 273: 2397623983.
  • 144
    Weinstein, L. S., Gejman, P. V., Friedman, E., et al (1990) Mutations of the Gs alpha-subunit gene in Albright hereditary osteodystrophy detected by denaturing gradient gel electrophoresis. Proc Natl Acad Sci U S A. 87: 82878290.
  • 145
    Weinstein, L. S., Gejman, P. V., de Mazancourt, P., American, N., Spiegel, AM. (1992) A heterozygous 4-bp deletion mutation in the Gs alpha gene (GNAS1) in a patient with Albright hereditary osteodystrophy. Genomics 13: 13191321.
  • 146
    Wilson, L. C., Oude, Luttikhuis ME, Clayton, P. T., Fraser, W. D., Trembath, RC. (1994) Parental origin of Gs alpha gene mutations in Albright's hereditary osteodystrophy. J Med Genet. 31: 835839.
  • 147
    Yu, D., Yu, S., Schuster, V., Kruse, K., Clericuzio, C., Weinstein, L. (1999) Identification of two novel deletion mutations within the G(s)alpha gene (GNAS1) in Albright hereditary osteodystrophy. J Clin Endocrinol Metab. 84: 32543259.
  • 148
    Hedeland, H., Berntorp, K., Arheden, K., Kristoffersson, U. (1992) Pseudohypoparathyroidism type I and Albright's hereditary osteodystrophy with a proximal 15q chromosomal deletion in mother and daughter. Clin Genet. 42: 129134.
  • 149
    Chassaing, N., De Mas, P., Tauber, M., et al (2004) Molecular characterization of a cryptic 2q37 deletion in a patient with Albright hereditary osteodystrophy-like phenotype. Am J Med Genet A. 128: 410413.
  • 150
    Davids, M. S., Crawford, E., Weremowicz, S., et al (2001) STK25 is a candidate gene for pseudopseudohypoparathyroidism. Genomics 77: 24.
  • 151
    Giardino, D., Finelli, P., Gottardi, G., et al (2003) Narrowing the candidate region of Albright hereditary osteodystrophy-like syndrome by deletion mapping in a patient with an unbalanced cryptic translocation t(2;6)(q37.3;q26). Am J Med Genet. 122A: 261265.
  • 152
    Phelan, M. C., Rogers, R. C., Clarkson, K. B., et al (1995) Albright hereditary osteodystrophy and del(2) (q37.3) in four unrelated individuals. Am J Med Genet. 58: 17.
  • 153
    Polityko, A., Maltseva, O., Rumyantseva, N., et al (2004) Two further AHO-like syndrome patients with deletion of glypican 1 gene region in 2q37.2-q37.3. Int J Mol Med. 14: 977979.
  • 154
    Shrimpton, A. E., Braddock, B. R., Thomson, L. L., Stein, C. K., Hoo, JJ. (2004) Molecular delineation of deletions on 2q37.3 in three cases with an Albright hereditary osteodystrophy-like phenotype. Clin Genet. 66: 537544.
  • 155
    Wilson, L. C., Leverton, K., Oude Luttikhuis M. E., et al (1995) Brachydactyly and mental retardation: an Albright hereditary osteodystrophy-like syndrome localized to 2q37. Am J Hum Genet. 56: 400407.
  • 156
    Gillessen-Kaesbach, G., Demuth, S., Thiele, H., Theile, U., Lich, C., Horsthemke, B. (1999) A previously unrecognised phenotype characterised by obesity, muscular hypotonia, and ability to speak in patients with Angelman syndrome caused by an imprinting defect. Eur J Hum Genet. 7: 638644.
  • 157
    Stratakis, C. A., Lafferty, A., Taymans, S. E., Gafni, R. I., Meck, J. M., Blancato, J. (2000) Anisomastia associated with interstitial duplication of chromosome 16, mental retardation, obesity, dysmorphic facies, and digital anomalies: molecular mapping of a new syndrome by fluorescent in situ hybridization and microsatellites to 16q13 (D16S419–D16S503). J Clin Endocrinol Metab. 85: 33963401.
  • 158
    Casey, M., Mah, C., Merliss, A. D., et al (1998) Identification of a novel genetic locus for familial cardiac myxomas and Carney complex. Circulation 98: 25602566.
  • 159
    Casey, M., Vaughan, C. J., He, J., et al (2000) Mutations in the protein kinase A R1alpha regulatory subunit cause familial cardiac myxomas and Carney complex. J Clin Invest. 106: R31R38.
  • 160
    Groussin, L., Jullian, E., Perlemoine, K., et al (2002) Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease. J Clin Endocrinol Metab. 87: 43244329.
  • 161
    Kirschner, L. S., Carney, J. A., Pack, S. D., et al (2000) Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat Genet. 26: 8992.
  • 162
    Kirschner, L. S., Sandrini, F., Monbo, J., Lin, J. P., Carney, J. A., Stratakis, CA. (2000) Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the carney complex. Hum Mol Genet. 9: 30373046.
  • 163
    Stratakis, CA. (2001) Clinical genetics of multiple endocrine neoplasias, Carney complex and related syndromes. J Endocrinol Invest. 24: 370383.
  • 164
    Stratakis, C. A., Kirschner, L. S., Carney, JA. (2001) Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J Clin Endocrinol Metab. 86: 40414046.
  • 165
    Stratakis, C. A., Carney, J. A., Lin, J. P., et al (1996) Carney complex, a familial multiple neoplasia and lentiginosis syndrome: analysis of 11 kindreds and linkage to the short arm of chromosome 2. J Clin Invest. 97: 699705.
  • 166
    Agarwal, A. K., Garg, A. (2002) A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy. J Clin Endocrinol Metab. 87: 408411.
  • 167
    Al-Shali, K., Cao, H., Knoers, N., Hermus, A. R., Tack, C. J., Hegele, RA. (2004) A single-base mutation in the peroxisome proliferator-activated receptor gamma4 promoter associated with altered in vitro expression and partial lipodystrophy. J Clin Endocrinol Metab. 89: 56555660.
  • 168
    Hegele, R. A., Cao, H., Frankowski, C., Mathews, S. T., Leff, T. (2002) PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy. Diabetes 51: 35863590.
  • 169
    Savage, D. B., Tan, G. D., Acerini, C. L., et al (2003) Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma. Diabetes 52: 910917.
  • 170
    Anderson, J., Khan, M., David, W., et al (1999) Confirmation of linkage of hereditary partial lipodystrophy to chromosome 1q21–22. Am J Med Genet. 82: 161165.
  • 171
    Cao, H., Hegele, RA. (2000) Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum Mol Genet. 9: 109112.
  • 172
    Caux, F., Dubosclard, E., Lascols, O., et al (2003) A new clinical condition linked to a novel mutation in lamins A and C with generalized lipoatrophy, insulin-resistant diabetes, disseminated leukomelanodermic papules, liver steatosis, and cardiomyopathy. J Clin Endocrinol Metab. 88: 10061013.
  • 173
    Garg, A., Vinaitheerthan, M., Weatherall, P. T., Bowcock, AM. (2001) Phenotypic heterogeneity in patients with familial partial lipodystrophy (Dunnigan variety) related to the site of missense mutations in lamin a/c gene. J Clin Endocrinol Metab. 86: 5965.
  • 174
    Garg, A., Speckman, R. A., Bowcock, AM. (2002) Multisystem dystrophy syndrome due to novel missense mutations in the amino-terminal head and alpha-helical rod domains of the lamin A/C gene. Am J Med. 112: 549555.
  • 175
    Peters, J., Barnes, R., Bennett, L., Gitomer, W., Bowcock, A., Garg, A. (1998) Localization of the gene for familial partial lipodystrophy (Dunnigan variety) to chromosome 1q21-22. Nat Genet. 18: 292295.
  • 176
    Savage, D. B., Soos, M. A., Powlson, A., et al (2004) Familial partial lipodystrophy associated with compound heterozygosity for novel mutations in the LMNA gene. Diabetologia 47: 753756.
  • 177
    Schmidt, H. H., Genschel, J., Baier, P., et al (2001) Dyslipemia in familial partial lipodystrophy caused by an R482W mutation in the LMNA gene. J Clin Endocrinol Metab. 86: 22892295.
  • 178
    Shackleton, S., Lloyd, D. J., Jackson, S. N., et al (2000) LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nat Genet. 24: 153156.
  • 179
    Speckman, R. A., Garg, A., Du, F., et al (2000) Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C. Am J Hum Genet. 66: 11921198.
  • 180
    van der Kooi, A. J., Bonne, G., Eymard, B., et al (2002) Lamin A/C mutations with lipodystrophy, cardiac abnormalities, and muscular dystrophy. Neurology 59: 620623.
  • 181
    Cama, A., de la Luz, Sierra M, Ottini, L., et al (1991) A mutation in the tyrosine kinase domain of the insulin receptor associated with insulin resistance in an obese woman. J Clin Endocrinol Metab. 73: 894901.
  • 182
    Globerman, H., Karnieli, E. (1998) Analysis of the insulin receptor gene tyrosine kinase domain in obese patients with hyperandrogenism, insulin resistance and acanthosis nigricans (type C insulin resistance). Int J Obes Relat Metab Disord. 22: 349353.
  • 183
    Kim, H., Kadowaki, H., Sakura, H., et al (1992) Detection of mutations in the insulin receptor gene in patients with insulin resistance by analysis of single-stranded conformational polymorphisms. Diabetologia 35: 261266.
  • 184
    Krook, A., Kumar, S., Laing, I., Boulton, A. J., Wass, J. A., O'Rahilly, S. (1994) Molecular scanning of the insulin receptor gene in syndromes of insulin resistance. Diabetes 43: 357368.
  • 185
    Moller, D. E., Cohen, O., Yamaguchi, Y., et al (1994) Prevalence of mutations in the insulin receptor gene in subjects with features of the type A syndrome of insulin resistance. Diabetes 43: 247255.
  • 186
    Shimada, F., Taira, M., Suzuki, Y., et al (1990) Insulin-resistant diabetes associated with partial deletion of insulin- receptor gene. Lancet 335: 11791181.
  • 187
    Shimada, F., Suzuki, Y., Taira, M., et al (1992) Abnormal messenger ribonucleic acid (mRNA) transcribed from a mutant insulin receptor gene in a patient with type A insulin resistance. Diabetologia 35: 639644.
  • 188
    Wertheimer, E., Litvin, Y., Ebstein, R. P., et al (1994) Deletion of exon 3 of the insulin receptor gene in a kindred with a familial form of insulin resistance. J Clin Endocrinol Metab. 78: 11531158.
  • 189
    Binder, G., Keller, E., Mix, M., et al (2001) Isolated GH deficiency with dominant inheritance: new mutations, new insights. J Clin Endocrinol Metab. 86: 38773881.
  • 190
    Bassett, J. H., Forbes, S. A., Pannett, A. A., et al (1998) Characterization of mutations in patients with multiple endocrine neoplasia type 1. Am J Hum Genet. 62: 232244.
  • 191
    Gaitan, D., Loosen, P. T., Orth, DN. (1993) Two patients with Cushing's disease in a kindred with multiple endocrine neoplasia type I. J Clin Endocrinol Metab. 76: 15801582.
  • 192
    Langer, P., Cupisti, K., Bartsch, D. K., et al (2002) Adrenal involvement in multiple endocrine neoplasia type 1. World J Surg. 26: 891896.
  • 193
    Matsuzaki, L. N., Canto-Costa, M. H., Hauache, OM. (2004) Cushing's disease as the first clinical manifestation of multiple endocrine neoplasia type 1 (MEN1) associated with an R460X mutation of the MEN1 gene. Clin Endocrinol (Oxf). 60: 142143.
  • 194
    Vasen, H. F., Lamers, C. B., Lips, CJ. (1989) Screening for the multiple endocrine neoplasia syndrome type I: a study of 11 kindreds in The Netherlands. Arch Intern Med. 149: 27172722.
  • 195
    Verges, B., Boureille, F., Goudet, P., et al (2002) Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study. J Clin Endocrinol Metab. 87: 457465.
  • 196
    Rix, M., Hertel, N. T., Nielsen, F. C., et al (2004) Cushing's disease in childhood as the first manifestation of multiple endocrine neoplasia syndrome type 1. Eur J Endocrinol. 151: 709715.
  • 197
    Biswas, S., Munier, F. L., Yardley, J., et al (2001) Missense mutations in COL8A2, the gene encoding the alpha2 chain of type VIII collagen, cause two forms of corneal endothelial dystrophy. Hum Mol Genet. 10: 24152423.
  • 198
    Heon, E., Mathers, W. D., Alward, W. L., et al (1995) Linkage of posterior polymorphous corneal dystrophy to 20q11. Hum Mol Genet. 4: 485488.
  • 199
    Heon, E., Greenberg, A., Kopp, K. K., et al (2002) VSX1: a gene for posterior polymorphous dystrophy and keratoconus. Hum Mol Genet. 11: 10291036.
  • 200
    Boccaccio, I., Glatt-Deeley, H., Watrin, F., Roeckel, N., Lalande, M., Muscatelli, F. (1999) The human MAGEL2 gene and its mouse homologue are paternally expressed and mapped to the Prader-Willi region. Hum Mol Genet. 8: 24972505.
  • 201
    Gallagher, R. C., Pils, B., Albalwi, M., Francke, U. (2002) Evidence for the role of PWCR1/HBII-85 C/D box small nucleolar RNAs in Prader-Willi syndrome. Am J Hum Genet. 71: 669678.
  • 202
    Gilhuis, H. J., van Ravenswaaij, C. M., Hamel, B. J., Gabreels, FJ. (2000) Interstitial 6q deletion with a Prader-Willi-like phenotype: a new case and review of the literature. Eur J Paediatr Neurol. 4: 3943.
  • 203
    Gole, L., Crolla, J. A., Thomas, S. N., Jacobs, P. A., Dennis, NR. (2004) Characterization of breakpoints in the GABRG3 and TSPY genes in a family with a t(Y;15)(p11.2;q12). Am J Med Genet. 125A: 177180.
  • 204
    Hordijk, R., Wierenga, H., Scheffer, H., Leegte, B., Hofstra, R. M., Stolte-Dijkstra, I. (1999) Maternal uniparental disomy for chromosome 14 in a boy with a normal karyotype. J Med Genet. 36: 782785.
  • 205
    Jay, P., Rougeulle, C., Massacrier, A., et al (1997) The human necdin gene NDN, is maternally imprinted and located in the Prader-Willi syndrome chromosomal region. Nat Genet. 17: 357361.
  • 206
    Jong, M. T., Gray, T. A., Ji, Y., et al (1999) A novel imprinted gene, encoding a RING zinc-finger protein, and overlapping antisense transcript in the Prader-Willi syndrome critical region. Hum Mol Genet. 8: 783793.
  • 207
    Kuslich, C. D., Kobori, J. A., Mohapatra, G., Gregorio-King, C., Donlon, TA. (1999) Prader-Willi syndrome is caused by disruption of the SNRPN gene. Am J Hum Genet. 64: 7076.
  • 208
    Lee, S., Kozlov, S., Hernandez, L., et al (2000) Expression and imprinting of MAGEL2 suggest a role in Prader-Willi syndrome and the homologous murine imprinting phenotype. Hum Mol Genet. 9: 18131819.
  • 209
    Meguro, M., Mitsuya, K., Nomura, N., et al (2001) Large-scale evaluation of imprinting status in the Prader-Willi syndrome region: an imprinted direct repeat cluster resembling small nucleolar RNA genes. Hum Mol Genet. 10: 383394.
  • 210
    Ming, J. E., Blagowidow, N., Knoll, J. H., et al (2000) Submicroscopic deletion in cousins with Prader-Willi syndrome causes a grandmatrilineal inheritance pattern: effects of imprinting. Am J Med Genet. 92: 1924.
  • 211
    Ohta, T., Gray, T. A., Rogan, P. K., et al (1999) Imprinting-mutation mechanisms in Prader-Willi syndrome. Am J Hum Genet. 64: 397413.
  • 212
    Robinson, W. P., Bottani, A., Xie, Y. G., et al (1991) Molecular, cytogenetic, and clinical investigations of Prader-Willi syndrome patients. Am J Hum Genet. 49: 12191234.
  • 213
    Stein, C. K., Stred, S. E., Thomson, L. L., Smith, F. C., Hoo, JJ. (1996) Interstitial 6q deletion and Prader-Willi-like phenotype. Clin Genet. 49: 306310.
  • 214
    Turleau, C., Demay, G., Cabanis, M. O., Lenoir, G., de Grouchy, J. (1988) 6q1 monosomy: a distinctive syndrome. Clin Genet. 34: 3842.
  • 215
    Villa, A., Urioste, M., Bofarull, J. M., Martinez-Frias, ML. (1995) De novo interstitial deletion q16.2q21 on chromosome 6. Am J Med Genet. 55: 379383.
  • 216
    Wevrick, R., Kerns, J. A., Francke, U. (1994) Identification of a novel paternally expressed gene in the Prader-Willi syndrome region. Hum Mol Genet. 3: 18771882.
  • 217
    Wirth, J., Back, E., Huttenhofer, A., et al (2001) A translocation breakpoint cluster disrupts the newly defined 3′ end of the SNURF-SNRPN transcription unit on chromosome 15. Hum Mol Genet. 10: 201210.
  • 218
    de los Santos, T., Schweizer, J., Rees, C. A., Francke, U. (2000) Small evolutionarily conserved RNA, resembling C/D box small nucleolar RNA, is transcribed from PWCR1, a novel imprinted gene in the Prader-Willi deletion region, which Is highly expressed in brain. Am J Hum Genet. 67: 10671082.
  • 219
    Roland, B., Lowry, R. B., Cox, D. M., Ferreira, P., Lin, CC. (1993) Familial complex chromosomal rearrangement resulting in duplication/deletion of 6q14 to 6q16. Clin Genet. 43: 117121.
  • 220
    Smith, A. (1999) The diagnosis of Prader-Willi syndrome. J Paediatr Child Health 35: 335337.
  • 221
    Behr, M., Ramsden, D. B., Loos, U. (1997) Deoxyribonucleic acid binding and transcriptional silencing by a truncated c-erbAB1 thyroid hormone receptor identified in a severely retarded patient with resistance to thyroid hormone. J Clin Endocrinol Metab. 82: 10811087.
  • 222
    Bamshad, M., Lin, R. C., Law, D. J., et al (1997) Mutations in human TBX3 alter limb, apocrine and genital development in ulnar-mammary syndrome. Nat Genet. 16: 311315.
  • 223
    Bamshad, M., Le, T., Watkins, W. S., et al (1999) The spectrum of mutations in TBX3: Genotype/Phenotype relationship in ulnar-mammary syndrome. Am J Hum Genet. 64: 15501562.
  • 224
    Sasaki, G., Ogata, T., Ishii, T., Hasegawa, T., Sato, S., Matsuo, N. (2002) Novel mutation of TBX3 in a Japanese family with ulnar-mammary syndrome: implication for impaired sex development. Am J Med Genet. 110: 365369.
  • 225
    Wollnik, B., Kayserili, H., Uyguner, O., Tukel, T., Yuksel-Apak, M. (2002) Haploinsufficiency of TBX3 causes ulnar-mammary syndrome in a large Turkish family. Ann Genet. 45: 213217.
  • 226
    Amor, DJ. (2002) Morbid obesity and hyperphagia in the WAGR syndrome. Clin Dysmorphol. 11: 7374.
  • 227
    Bremond-Gignac, D., Crolla, J. A., Copin, H., et al (2005) Combination of WAGR and Potocki-Shaffer contiguous deletion syndromes in a patient with an 11p11.2-p14 deletion. Eur J Hum Genet. 13: 409413.
  • 228
    Chao, L. Y., Mishra, R., Strong, L. C., Saunders, GF. (2003) Missense mutations in the DNA-binding region and termination codon in PAX6. Hum Mutat. 21: 138145.
  • 229
    Fischbach, B. V., Trout, K. L., Lewis, J., Luis, C. A., Sika, M. (2005) WAGR syndrome: a clinical review of 54 cases. Pediatrics 116: 984988.
  • 230
    Gul, D., Ogur, G., Tunca, Y., Ozcan, O. (2002) Third case of WAGR syndrome with severe obesity and constitutional deletion of chromosome (11)(p12p14). Am J Med Genet. 107: 7071.
  • 231
    Marlin, S., Couet, D., Lacombe, D., Cessans, C., Bonneau, D. (1994) Obesity: a new feature of WAGR (del 11p) syndrome. Clin Dysmorphol. 3: 255257.
  • 232
    Tiberio, G., Digilio, M. C., Giannotti, A. (2000) Obesity and WAGR syndrome. Clin Dysmorphol. 9: 6364.
  • 233
    Crawford, J., Lower, K. M., Hennekam, R. C., et al (2006) Mutation screening in Borjeson-Forssman-Lehmann Syndrome (BFLS): identification of a novel, de novo PHF6 mutation in a female patient. J Med Genet. 43: 238243.
  • 234
    Baumstark, A., Lower, K. M., Sinkus, A., et al (2003) Novel PHF6 mutation p.D333del causes Borjeson-Forssman-Lehmann syndrome. J Med Genet. 40: e50
  • 235
    Gecz, J., Baker, E., Donnelly, A., et al (1999) Fibroblast growth factor homologous factor 2 (FHF2): gene structure, expression and mapping to the Borjeson-Forssman-Lehmann syndrome region in Xq26 delineated by a duplication breakpoint in a BFLS-like patient. Hum Genet. 104: 5663.
  • 236
    Kubota, T., Oga, S., Ohashi, H., Iwamoto, Y., Fukushima, Y. (1999) Borjeson-Forssman-Lehmann syndrome in a woman with skewed X-chromosome inactivation. Am J Med Genet. 87: 258261.
  • 237
    Lower, K. M., Turner, G., Kerr, B. A., et al (2002) Mutations in PHF6 are associated with Borjeson-Forssman-Lehmann syndrome. Nat Genet. 32: 661665.
  • 238
    Lower, K. M., Solders, G., Bondeson, M. L., et al (2004) 1024C> T (R342X) is a recurrent PHF6 mutation also found in the original Borjeson-Forssman-Lehmann syndrome family. Eur J Hum Genet. 12: 787789.
  • 239
    Vallee, D., Chevrier, E., Graham, G. E., et al (2004) A novel PHF6 mutation results in enhanced exon skipping and mild Borjeson-Forssman-Lehmann syndrome. J Med Genet. 41: 778783.
  • 240
    Visootsak, J., Rosner, B., Dykens, E., et al (2004) Clinical and behavioral features of patients with Borjeson-Forssman-Lehmann syndrome with mutations in PHF6. J Pediatr. 145: 819825.
  • 241
    Merry, D. E., Lesko, J. G., Sosnoski, D. M., et al (1989) Choroideremia and deafness with stapes fixation: a contiguous gene deletion syndrome in Xq21. Am J Hum Genet. 45: 530540.
  • 242
    Schwartz, M., Yang, H. M., Niebuhr, E., Rosenberg, T., Page, DC. (1988) Regional localization of polymorphic DNA loci on the proximal long arm of the X chromosome using deletions associated with choroideremia. Hum Genet. 78: 156160.
  • 243
    Fryns, J. P., Haspeslagh, M., Dereymaeker, A. M., Volcke, P., Van den Berghe, H. (1987) A peculiar subphenotype in the fra(X) syndrome: extreme obesity-short stature-stubby hands and feet-diffuse hyperpigmentation: further evidence of disturbed hypothalamic function in the fra(X) syndrome? Clin Genet. 32: 388392.
  • 244
    Quan, F., Zonana, J., Gunter, K., Peterson, K. L., Magenis, R. E., Popovich, BW. (1995) An atypical case of fragile X syndrome caused by a deletion that includes the FMR1 gene. Am J Hum Genet. 56: 10421051.
  • 245
    Schrander-Stumpel, C., Gerver, W. J., Meyer, H., Engelen, J., Mulder, H., Fryns, JP. (1994) Prader-Willi-like phenotype in fragile X syndrome. Clin Genet. 45: 175180.
  • 246
    de Vries, B. B., Fryns, J. P., Butler, M. G., et al (1993) Clinical and molecular studies in fragile X patients with a Prader-Willi-like phenotype. J Med Genet. 30: 761766.
  • 247
    DeLozier-Blanchet, C. D., Haenggeli, C. A., Bottani, A. (1999) MEHMO, a novel syndrome: assignment of disease locus to Xp21.1-p22.13: mental retardation, epileptic seizures, hypogonadism and genitalism, microcephaly, obesity. Eur J Hum Genet. 7: 621622.
  • 248
    Leshinsky-Silver, E., Zinger, A., Bibi, C. N., et al (2002) MEHMO (mental retardation, epileptic seizures, hypogenitalism, microcephaly, obesity): a new X-linked mitochondrial disorder. Eur J Hum Genet. 10: 226230.
  • 249
    Steinmuller, R., Steinberger, D., Muller, U. (1998) MEHMO (mental retardation, epileptic seizures, hypogonadism and -genitalism, microcephaly, obesity), a novel syndrome: assignment of disease locus to Xp21.1-p22.13. Eur J Hum Genet. 6: 201206.
  • 250
    Ahmad, W., De Fusco, M., ul Haque, M. F., et al (1999) Linkage mapping of a new syndromic form of X-linked mental retardation, MRXS7, associated with obesity. Eur J Hum Genet. 7: 828832.
  • 251
    Couvert, P., Bienvenu, T., Aquaviva, C., et al (2001) MECP2 is highly mutated in X-linked mental retardation. Hum Mol Genet. 10: 941946.
  • 252
    Kleefstra, T., Yntema, H. G., Oudakker, A. R., et al (2002) De novo MECP2 frameshift mutation in a boy with moderate mental retardation, obesity and gynaecomastia. Clin Genet. 61: 359362.
  • 253
    Castro, N. H., dos Santos, R. C., Nelson, R., et al (2003) Shashi XLMR syndrome: report of a second family. Am J Med Genet. 118A: 4951.
  • 254
    Shashi, V., Berry, M. N., Shoaf, S., Sciote, J. J., Goldstein, D., Hart, TC. (2000) A unique form of mental retardation with a distinctive phenotype maps to Xq26–q27. Am J Hum Genet. 66: 469479.[Published erratum in Am J Hum Genet. 2000;66:1472].
  • 255
    Monaghan, K. G., Van Dyke, D. L., Feldman, GL. (1998) Prader-Willi-like syndrome in a patient with an Xq23q25 duplication. Am J Med Genet. 80: 227231.
  • 256
    Hughes-Benzie, R. M., Pilia, G., Xuan, J. Y., et al (1996) Simpson-Golabi-Behmel syndrome: genotype/phenotype analysis of 18 affected males from 7 unrelated families. Am J Med Genet. 66: 227234.
  • 257
    Lindsay, S., Ireland, M., O'Brien, O., et al (1997) Large scale deletions in the GPC3 gene may account for a minority of cases of Simpson-Golabi-Behmel syndrome. J Med Genet. 34: 480483.
  • 258
    Mariani, S., Iughetti, L., Bertorelli, R., et al (2003) Genotype/phenotype correlations of males affected by Simpson-Golabi-Behmel syndrome with GPC3 gene mutations: patient report and review of the literature. J Pediatr Endocrinol Metab. 16: 225232.
  • 259
    Neri, G., Gurrieri, F., Zanni, G., Lin, A. (1998) Clinical and molecular aspects of the Simpson-Golabi-Behmel syndrome. Am J Med Genet. 79: 279283.
  • 260
    Okamoto, N., Yagi, M., Imura, K., Wada, Y. (1999) A clinical and molecular study of a patient with Simpson-Golabi-Behmel syndrome. J Hum Genet. 44: 327329.
  • 261
    Pilia, G., Hughes-Benzie, R. M., MacKenzie, A., et al (1996) Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nat Genet. 12: 241247.
  • 262
    Veugelers, M., Vermeesch, J., Watanabe, K., Yamaguchi, Y., Marynen, P., David, G. (1998) GPC4, the gene for human K-glypican, flanks GPC3 on xq26: deletion of the GPC3-GPC4 gene cluster in one family with Simpson-Golabi-Behmel syndrome. Genomics 53: 111.
  • 263
    Veugelers, M., Cat, B. D., Muyldermans, S. Y., et al (2000) Mutational analysis of the GPC3/GPC4 glypican gene cluster on Xq26 in patients with Simpson-Golabi-Behmel syndrome: identification of loss-of-function mutations in the GPC3 gene. Hum Mol Genet. 9: 13211328.
  • 264
    Xuan, J. Y., Hughes-Benzie, R. M., MacKenzie, AE. (1999) A small interstitial deletion in the GPC3 gene causes Simpson-Golabi-Behmel syndrome in a Dutch-Canadian family. J Med Genet. 36: 5758.
  • 265
    Brzustowicz, L. M., Farrell, S., Khan, M. B., Weksberg, R. (1999) Mapping of a new SGBS locus to chromosome Xp22 in a family with a severe form of Simpson-Golabi-Behmel syndrome. Am J Hum Genet. 65: 779783.
  • 266
    Gedeon, A., Mulley, J., Turner, G. (1996) Gene localisation for Wilson-Turner syndrome (WTS:MIM 309585). Am J Med Genet. 64: 8081.
  • 267
    Wilson, M., Mulley, J., Gedeon, A., Robinson, H., Turner, G. (1991) New X-linked syndrome of mental retardation, gynecomastia, and obesity is linked to DXS255. Am J Med Genet. 40: 406413.
  • 268
    Mynatt, R. L., Stephens, JM. (2003) Regulation of PPARgamma and obesity by agouti/melanocortin signaling in adipocytes. Ann N Y Acad Sci. 994: 141146.
  • 269
    Mynatt, R. L., Miltenberger, R. J., Klebig, M. L., et al (1997) Combined effects of insulin treatment and adipose tissue-specific agouti expression on the development of obesity. Proc Natl Acad Sci U S A. 94: 919922.
  • 270
    Klebig, M. L., Wilkinson, J. E., Geisler, J. G., Woychik, RP. (1995) Ectopic expression of the agouti gene in transgenic mice causes obesity, features of type II diabetes, and yellow fur. Proc Natl Acad Sci U S A. 92: 47284732.
  • 271
    Kim, W. S., Fitzgerald, M. L., Kang, K., et al (2005) Abca7 null mice retain normal macrophage phosphatidylcholine and cholesterol efflux activity despite alterations in adipose mass and serum cholesterol levels. J Biol Chem. 280: 39893995.
  • 272
    Oh, W., Abu-Elheiga, L., Kordari, P., et al (2005) Glucose and fat metabolism in adipose tissue of acetyl-CoA carboxylase 2 knockout mice. Proc Natl Acad Sci U S A. 102: 13841389.
  • 273
    Abu-Elheiga, L., Matzuk, M. M., Abo-Hashema, K. A., Wakil, SJ. (2001) Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science 291: 26132616.
  • 274
    Cox, K. B., Hamm, D. A., Millington, D. S., et al (2001) Gestational, pathologic and biochemical differences between very long-chain acyl-CoA dehydrogenase deficiency and long-chain acyl-CoA dehydrogenase deficiency in the mouse. Hum Mol Genet. 10: 20692077.
  • 275
    Exil, V. J., Roberts, R. L., Sims, H., et al (2003) Very-long-chain acyl-coenzyme a dehydrogenase deficiency in mice. Circ Res. 93: 448455.
  • 276
    Masaki, M., Kurisaki, T., Shirakawa, K., Sehara-Fujisawa, A. (2005) Role of meltrin [alpha] (ADAM12) in obesity induced by high- fat diet. Endocrinology 146: 17521763.
  • 277
    Shindo, T., Kurihara, H., Kuno, K., et al (2000) ADAMTS-1: a metalloproteinase-disintegrin essential for normal growth, fertility, and organ morphology and function. J Clin Invest. 105: 13451352.
  • 278
    Gray, S. L., Cummings, K. J., Jirik, F. R., Sherwood, NM. (2001) Targeted disruption of the pituitary adenylate cyclase-activating polypeptide gene results in early postnatal death associated with dysfunction of lipid and carbohydrate metabolism. Mol Endocrinol. 15: 17391747.
  • 279
    Burcelin, R., Uldry, M., Foretz, M., et al (2004) Impaired glucose homeostasis in mice lacking the alpha1b-adrenergic receptor subtype. J Biol Chem. 279: 11081115.
  • 280
    Valet, P., Grujic, D., Wade, J., et al (2000) Expression of human alpha 2-adrenergic receptors in adipose tissue of beta 3-adrenergic receptor-deficient mice promotes diet-induced obesity. J Biol Chem. 275: 3479734802.
  • 281
    Bachman, E. S., Dhillon, H., Zhang, C. Y., et al (2002) betaAR signaling required for diet-induced thermogenesis and obesity resistance. Science 297: 843845.
  • 282
    Soloveva, V., Graves, R. A., Rasenick, M. M., Spiegelman, B. M., Ross, SR. (1997) Transgenic mice overexpressing the beta 1-adrenergic receptor in adipose tissue are resistant to obesity. Mol Endocrinol. 11: 2738.
  • 283
    Susulic, V. S., Frederich, R. C., Lawitts, J., et al (1995) Targeted disruption of the beta 3-adrenergic receptor gene. J Biol Chem. 270: 2948329492.
  • 284
    Revelli, J. P., Preitner, F., Samec, S., et al (1997) Targeted gene disruption reveals a leptin-independent role for the mouse beta3-adrenoceptor in the regulation of body composition. J Clin Invest. 100: 10981106.
  • 285
    Zhang, L., Reidy, S. P., Nicholson, T. E., et al (2005) The role of AEBP1 in sex-specific diet-induced obesity. Mol Med. epub ahead of print.
  • 286
    Wortley, K. E., Anderson, K. D., Yasenchak, J., et al (2005) Agouti-related protein-deficient mice display an age-related lean phenotype. Cell Metab. 2: 421427.
  • 287
    Ollmann, M. M., Wilson, B. D., Yang, Y. K., et al (1997) Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 278: 135138.
  • 288
    Bewick, G. A., Gardiner, J. V., Dhillo, W. S., et al (2005) Post-embryonic ablation of AgRP neurons in mice leads to a lean, hypophagic phenotype. FASEB J. 19: 16801682.
  • 289
    Kouyama, R., Suganami, T., Nishida, J., et al (2005) Attenuation of diet-induced weight gain and adiposity through increased energy expenditure in mice lacking angiotensin II type 1a receptor. Endocrinology 146: 34813489.
  • 290
    Yvan-Charvet, L., Even, P., Bloch-Faure, M., et al (2005) Deletion of the angiotensin type 2 receptor (AT2R) reduces adipose cell size and protects from diet-induced obesity and insulin resistance. Diabetes 54: 991999.
  • 291
    Mathews, S. T., Singh, G. P., Ranalletta, M., et al (2002) Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene. Diabetes 51: 24502458.
  • 292
    Narisawa, S., Huang, L., Iwasaki, A., Hasegawa, H., Alpers, D. H., Millan, JL. (2003) Accelerated fat absorption in intestinal alkaline phosphatase knockout mice. Mol Cell Biol. 23: 75257530.
  • 293
    Lai, K. M., Gonzalez, M., Poueymirou, W. T., et al (2004) Conditional activation of akt in adult skeletal muscle induces rapid hypertrophy. Mol Cell Biol. 24: 92959304.
  • 294
    Garofalo, R. S., Orena, S. J., Rafidi, K., et al (2003) Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta. J Clin Invest. 112: 197208.
  • 295
    Collin, G. B., Cyr, E., Bronson, R., et al (2005) Alms1-disrupted mice recapitulate human Alstrom syndrome. Hum Mol Genet. 14: 23232333.
  • 296
    Savolainen, K., Kotti, T. J., Schmitz, W., et al (2004) A mouse model for alpha-methylacyl-CoA racemase deficiency: adjustment of bile acid synthesis and intolerance to dietary methyl-branched lipids. Hum Mol Genet. 13: 955965.
  • 297
    Backhed, F., Ding, H., Wang, T., et al (2004) The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA. 101: 1571815723.
  • 298
    Oike, Y., Akao, M., Yasunaga, K., et al (2005) Angiopoietin-related growth factor antagonizes obesity and insulin resistance. Nat Med. 11: 400408.
  • 299
    Jong, M. C., Voshol, P. J., Muurling, M., et al (2001) Protection from obesity and insulin resistance in mice overexpressing human apolipoprotein C1. Diabetes 50: 27792785.
  • 300
    Jong, M. C., Rensen, P. C., Dahlmans, V. E., van der Boom, H., van Berkel, T. J., Havekes, LM. (2001) Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice. J Lipid Res. 42: 15781585.
  • 301
    Duivenvoorden, I., Teusink, B., Rensen, P. C., Romijn, J. A., Havekes, L. M., Voshol, PJ. (2005) Apolipoprotein C3 deficiency results in diet-induced obesity and aggravated insulin resistance in mice. Diabetes. 54: 664671.
  • 302
    Hara-Chikuma, M., Sohara, E., Rai, T., et al (2005) Progressive adipocyte hypertrophy in aquaporin-7-deficient mice: adipocyte glycerol permeability as a novel regulator of fat accumulation. J Biol Chem. 280: 1549315496.
  • 303
    Hibuse, T., Maeda, N., Funahashi, T., et al (2005) Aquaporin 7 deficiency is associated with development of obesity through activation of adipose glycerol kinase. Proc Natl Acad Sci USA. 102: 1099310998.
  • 304
    Fan, W., Yanase, T., Nomura, M., et al (2005) Androgen receptor null male mice develop late-onset obesity caused by decreased energy expenditure and lipolytic activity but show normal insulin sensitivity with high adiponectin secretion. Diabetes 54: 10001008.
  • 305
    Matsumoto, T., Takeyama, K., Sato, T., Kato, S. (2003) Androgen receptor functions from reverse genetic models. J Steroid Biochem Mol Biol. 85: 9599.
  • 306
    Whitson, R. H., Tsark, W., Huang, T. H., Itakura, K. (2003) Neonatal mortality and leanness in mice lacking the ARID transcription factor Mrf-2. Biochem Biophys Res Commun. 312: 9971004.
  • 307
    Surendran, S., Matalon, K. M., Szucs, S., Tyring, S. K., Matalon, R. (2003) Metabolic changes in the knockout mouse for Canavan's disease: implications for patients with Canavan's disease. J Child Neurol. 18: 611615.
  • 308
    Meneton, P., Schultheis, P. J., Greeb, J., et al (1998) Increased sensitivity to K+ deprivation in colonic H,K-ATPase-deficient mice. J Clin Invest. 101: 536542.
  • 309
    Pawlikowska, L., Groen, A., Eppens, E. F., et al (2004) A mouse genetic model for familial cholestasis caused by ATP8B1 mutations reveals perturbed bile salt homeostasis but no impairment in bile secretion. Hum Mol Genet. 13: 881892.
  • 310
    Moitra, J., Mason, M. M., Olive, M., et al (1998) Life without white fat: a transgenic mouse. Genes Dev. 12: 31683181.
  • 311
    Kulaga, H. M., Leitch, C. C., Eichers, E. R., et al (2004) Loss of BBS proteins causes anosmia in humans and defects in olfactory cilia structure and function in the mouse. Nat Genet. 36: 994998.
  • 312
    Nishimura, D. Y., Fath, M., Mullins, R. F., et al (2004) Bbs2-null mice have neurosensory deficits, a defect in social dominance, and retinopathy associated with mislocalization of rhodopsin. Proc Natl Acad Sci USA. 101: 1658816593.
  • 313
    Coppola, V., Tessarollo, L. (2004) Control of hyperphagia prevents obesity in BDNF heterozygous mice. Neuroreport. 15: 26652668.
  • 314
    Fox, E. A., Byerly, MS. (2004) A mechanism underlying mature-onset obesity: evidence from the hyperphagic phenotype of brain-derived neurotrophic factor mutants. Am J Physiol Regul Integr Comp Physiol. 286: R994R1004.
  • 315
    Ohki-Hamazaki, H., Watase, K., Yamamoto, K., et al (1997) Mice lacking bombesin receptor subtype-3 develop metabolic defects and obesity. Nature 390: 165169.
  • 316
    Baker, D. J., Jeganathan, K. B., Cameron, J. D., et al (2004) BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nat Genet. 36: 744749.
  • 317
    Murray, I., Havel, P. J., Sniderman, A. D., Cianflone, K. (2000) Reduced body weight, adipose tissue, and leptin levels despite increased energy intake in female mice lacking acylation-stimulating protein. Endocrinology 141: 10411049.
  • 318
    Xia, Z., Stanhope, K. L., Digitale, E., et al (2004) Acylation-stimulating protein (ASP)/complement C3adesArg deficiency results in increased energy expenditure in mice. J Biol Chem. 279: 40514057.
  • 319
    Asnicar, M. A., Smith, D. P., Yang, D. D., et al (2001) Absence of cocaine- and amphetamine-regulated transcript results in obesity in mice fed a high caloric diet. Endocrinology 142: 43944400.
  • 320
    Elefteriou, F., Ahn, J. D., Takeda, S., et al (2005) Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434: 514520.
  • 321
    Razani, B., Combs, T. P., Wang, X. B., et al (2002) Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities. J Biol Chem. 277: 86358647.
  • 322
    Capozza, F., Combs, T. P., Cohen, A. W., et al (2005) Caveolin-3 knockout mice show increased adiposity and whole body insulin resistance, with ligand-induced insulin receptor instability in skeletal muscle. Am J Physiol Cell Physiol. 288: C1317C1331.
  • 323
    Molero, J. C., Jensen, T. E., Withers, P. C., et al (2004) c-Cbl-deficient mice have reduced adiposity, higher energy expenditure, and improved peripheral insulin action. J Clin Invest. 114: 13261333.
  • 324
    Raghavan, V. V., Rao, HV. (1976) On the absence of trehalose in the earwig Euborellia annulipes (Lupas). Indian J Exp Biol. 14: 194196.
  • 325
    Hopken, U. E., Achtman, A. H., Kruger, K., Lipp, M. (2004) Distinct and overlapping roles of CXCR5 and CCR7 in B-1 cell homing and early immunity against bacterial pathogens. J Leukoc Biol. 76: 709718.
  • 326
    Nomoto, S., Ohta, M., Kanai, S., et al (2004) Absence of the cholecystokinin-A receptor deteriorates homeostasis of body temperature in response to changes in ambient temperature. Am J Physiol Regul Integr Comp Physiol. 287: R556R561.
  • 327
    Sarruf, D. A., Iankova, I., Abella, A., Assou, S., Miard, S., Fajas, L. (2005) Cyclin D3 promotes adipogenesis through activation of peroxisome proliferator-activated receptor gamma. Mol Cell Biol. 25: 99859995.
  • 328
    Hajri, T., Han, X. X., Bonen, A., Abumrad, NA. (2002) Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice. J Clin Invest. 109: 13811389.
  • 329
    Castro, C. H., Shin, C. S., Stains, J. P., et al (2004) Targeted expression of a dominant-negative N-cadherin in vivo delays peak bone mass and increases adipogenesis. J Cell Sci. 117: 28532864.
  • 330
    Naaz, A., Holsberger, D. R., Iwamoto, G. A., Nelson, A., Kiyokawa, H., Cooke, PS. (2004) Loss of cyclin-dependent kinase inhibitors produces adipocyte hyperplasia and obesity. FASEB J. 18: 19251927.
  • 331
    Wang, N. D., Finegold, M. J., Bradley, A., et al (1995) Impaired energy homeostasis in C/EBP alpha knockout mice. Science. 269: 11081112.
  • 332
    Chiu, C. H., Lin, W. D., Huang, S. Y., Lee, YH. (2004) Effect of a C/EBP gene replacement on mitochondrial biogenesis in fat cells. Genes Dev. 18: 19701975.
  • 333
    Wang, L., Shao, J., Muhlenkamp, P., et al (2000) Increased insulin receptor substrate-1 and enhanced skeletal muscle insulin sensitivity in mice lacking CCAAT/enhancer-binding protein beta. J Biol Chem. 275: 1417314181.
  • 334
    Tanaka, T., Yoshida, N., Kishimoto, T., Akira, S. (1997) Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene. Embo J. 16: 74327443.
  • 335
    Yamada, M., Miyakawa, T., Duttaroy, A., et al (2001) Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean. Nature 410: 207212.
  • 336
    Zhou, Z., Yon, Toh S, Chen, Z., et al (2003) Cidea-deficient mice have lean phenotype and are resistant to obesity. Nat Genet. 35: 4956.
  • 337
    Turek, F. W., Joshu, C., Kohsaka, A., et al (2005) Obesity and metabolic syndrome in circadian Clock mutant mice. Science 308: 10431045.
  • 338
    Cota, D., Marsicano, G., Tschop, M., et al (2003) The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest. 112: 423431.
  • 339
    Ravinet Trillou C., Delgorge, C., Menet, C., Arnone, M., Soubrie, P. (2004) CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity. Int J Obes Relat Metab Disord. 28: 640648.
  • 340
    Chan, J. C., Knudson, O., Wu, F., Morser, J., Dole, W. P., Wu, Q. (2005) Hypertension in mice lacking the proatrial natriuretic peptide convertase corin. Proc Natl Acad Sci USA. 102: 785790.
  • 341
    Cawley, N. X., Zhou, J., Hill, J. M., et al (2004) The carboxypeptidase E knockout mouse exhibits endocrinological and behavioral deficits. Endocrinology 145: 58075819.
  • 342
    Nyman, L. R., Cox, K. B., Hoppel, C. L., et al (2005) Homozygous carnitine palmitoyltransferase 1a (liver isoform) deficiency is lethal in the mouse. Mol Genet Metab. 86: 179187.
  • 343
    Stenzel-Poore, M. P., Cameron, V. A., Vaughan, J., Sawchenko, P. E., Vale, W. (1992) Development of Cushing's syndrome in corticotropin-releasing factor transgenic mice. Endocrinology 130: 33783386.
  • 344
    Bale, T. L., Anderson, K. R., Roberts, A. J., Lee, K. F., Nagy, T. R., Vale, WW. (2003) Corticotropin-releasing factor receptor-2-deficient mice display abnormal homeostatic responses to challenges of increased dietary fat and cold. Endocrinology 144: 25802587.
  • 345
    Xie, J., Zhu, H., Larade, K., et al (2004) Absence of a reductase, NCB5OR, causes insulin-deficient diabetes. Proc Natl Acad Sci USA. 101: 1075010755.
  • 346
    Misso, M. L., Hewitt, K. N., Boon, W. C., Murata, Y., Jones, M. E., Simpson, ER. (2005) Cholesterol feeding prevents adiposity in the obese female aromatase knockout (ArKO) mouse. Horm Metab Res. 37: 2631.
  • 347
    Jones, M. E., Thorburn, A. W., Britt, K. L., et al (2000) Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci USA. 97: 1273512740.
  • 348
    Szczypka, M. S., Rainey, M. A., Palmiter, RD. (2000) Dopamine is required for hyperphagia in Lep(ob/ob) mice. Nat Genet. 25: 102104.
  • 349
    Zhou, Q. Y., Palmiter, RD. (1995) Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic. Cell 83: 11971209.
  • 350
    Walz, K., Caratini-Rivera, S., Bi, W., et al (2003) Modeling del(17)(p11.2p11.2) and dup(17)(p11.2p11.2) contiguous gene syndromes by chromosome engineering in mice: phenotypic consequences of gene dosage imbalance. Mol Cell Biol. 23: 36463655.
  • 351
    Smith, S. J., Cases, S., Jensen, D. R., et al (2000) Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat. Nat Genet. 25: 8790.
  • 352
    Chen, N., Liu, L., Zhang, Y., Ginsberg, H. N., Yu, YH. (2005) Whole-body Insulin Resistance in the Absence of Obesity in FVB Mice With Overexpression of Dgat1 in Adipose Tissue. Diabetes. 54: 33793386.
  • 353
    Yamazaki, T., Sasaki, E., Kakinuma, C., Yano, T., Miura, S., Ezaki, O. (2005) Increased very low density lipoprotein secretion and gonadal fat mass in mice overexpressing liver DGAT1. J Biol Chem. 280: 2150621514.
  • 354
    Wechsler, A., Brafman, A., Shafir, M., et al (2003) Generation of viable cholesterol-free mice. Science 302: 2087
  • 355
    Lee, K., Villena, J. A., Moon, Y. S., et al (2003) Inhibition of adipogenesis and development of glucose intolerance by soluble preadipocyte factor-1 (Pref-1). J Clin Invest. 111: 453461.
  • 356
    Ladiges, W. C., Knoblaugh, S. E., Morton, J. F., et al (2005) Pancreatic beta-cell failure and diabetes in mice with a deletion mutation of the endoplasmic reticulum molecular chaperone gene P58IPK. Diabetes 54: 10741081.
  • 357
    Takeda, U., Utani, A., Wu, J., et al (2002) Targeted disruption of dermatopontin causes abnormal collagen fibrillogenesis. J Invest Dermatol. 119: 678683.
  • 358
    McQuade, J. A., Benoit, S. C., Xu, M., Woods, S. C., Seeley, RJ. (2004) High-fat diet induced adiposity in mice with targeted disruption of the dopamine-3 receptor gene. Behav Brain Res. 151: 313319.
  • 359
    Tsukiyama-Kohara, K., Poulin, F., Kohara, M., et al (2001) Adipose tissue reduction in mice lacking the translational inhibitor 4E- BP1. Nat Med. 7: 11281132.
  • 360
    Lee, D., Pearsall, R. S., Das, S., Dey, S. K., Godfrey, V. L., Threadgill, DW. (2004) Epiregulin is not essential for development of intestinal tumors but is required for protection from intestinal damage. Mol Cell Biol. 24: 89078916.
  • 361
    Carrier, J. C., Deblois, G., Champigny, C., Levy, E., Giguere, V. (2004) Estrogen-related receptor alpha (ERRalpha) is a transcriptional regulator of apolipoprotein A-IV and controls lipid handling in the intestine. J Biol Chem. 279: 5205252058.
  • 362
    Luo, J., Sladek, R., Carrier, J., Bader, J. A., Richard, D., Giguere, V. (2003) Reduced fat mass in mice lacking orphan nuclear receptor estrogen-related receptor alpha. Mol Cell Biol. 23: 79477956.
  • 363
    Hotamisligil, G. S., Johnson, R. S., Distel, R. J., Ellis, R., Papaioannou, V. E., Spiegelman, BM. (1996) Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 274: 13771379.
  • 364
    Maeda, K., Uysal, K. T., Makowski, L., et al (2003) Role of the fatty acid binding protein mal1 in obesity and insulin resistance. Diabetes 52: 300307.
  • 365
    Maeda, K., Cao, H., Kono, K., et al (2005) Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes. Cell Metab. 1: 107119.
  • 366
    Kharitonenkov, A., Shiyanova, T. L., Koester, A., et al (2005) FGF-21 as a novel metabolic regulator. J Clin Invest. 115: 16271635.
  • 367
    Heglind, M., Cederberg, A., Aquino, J., Lucas, G., Ernfors, P., Enerback, S. (2005) Lack of the central nervous system- and neural crest-expressed forkhead gene Foxs1 affects motor function and body weight. Mol Cell Biol. 25: 56165625.
  • 368
    Sabatakos, G., Sims, N. A., Chen, J., et al (2000) Overexpression of DeltaFosB transcription factor(s) increases bone formation and inhibits adipogenesis. Nat Med. 6: 985990.
  • 369
    Kveiborg, M., Sabatakos, G., Chiusaroli, R., et al (2004) DeltaFosB induces osteosclerosis and decreases adipogenesis by two independent cell-autonomous mechanisms. Mol Cell Biol. 24: 28202830.
  • 370
    Wolfrum, C., Shih, D. Q., Kuwajima, S., Norris, A. W., Kahn, C. R., Stoffel, M. (2003) Role of Foxa-2 in adipocyte metabolism and differentiation. J Clin Invest. 112: 345356.
  • 371
    Kim, J. K., Kim, H. J., Park, S. Y., et al (2005) Adipocyte-specific overexpression of FOXC2 prevents diet-induced increases in intramuscular fatty acyl CoA and insulin resistance. Diabetes 54: 16571663.
  • 372
    Cederberg, A., Gronning, L. M., Ahren, B., Tasken, K., Carlsson, P., Enerback, S. (2001) FOXC2 is a winged helix gene that counteracts obesity, hypertriglyceridemia, and diet-induced insulin resistance. Cell 106: 563573.
  • 373
    Danilovich, N., Babu, P. S., Xing, W., Gerdes, M., Krishnamurthy, H., Sairam, MR. (2000) Estrogen deficiency, obesity, and skeletal abnormalities in follicle- stimulating hormone receptor knockout (FORKO) female mice. Endocrinology 141: 42954308.
  • 374
    Aizman, R., Asher, C., Fuzesi, M., et al (2002) Generation and phenotypic analysis of CHIF knockout mice. Am J Physiol Renal Physiol. 283: F569F577.
  • 375
    Hohmann, J. G., Teklemichael, D. N., Weinshenker, D., Wynick, D., Clifton, D. K., Steiner, RA. (2004) Obesity and endocrine dysfunction in mice with deletions of both neuropeptide Y and galanin. Mol Cell Biol. 24: 29782985.
  • 376
    Schmidt, A., Marescau, B., Boehm, E. A., et al (2004) Severely altered guanidino compound levels, disturbed body weight homeostasis and impaired fertility in a mouse model of guanidinoacetate N-methyltransferase (GAMT) deficiency. Hum Mol Genet. 13: 905921.
  • 377
    Maquoi, E., Voros, G., Carmeliet, P., Collen, D., Lijnen, HR. (2005) Role of Gas-6 in adipogenesis and nutritionally induced adipose tissue development in mice. Arterioscler Thromb Vasc Biol. 25: 10021007.
  • 378
    Cowey, S. L., Quast, M., Belalcazar, L. M., et al (2005) Abdominal obesity, insulin resistance, and colon carcinogenesis are increased in mutant mice lacking gastrin gene expression. Cancer 103: 26432653.
  • 379
    Gelling, R. W., Du, X. Q., Dichmann, D. S., et al (2003) Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice. Proc Natl Acad Sci USA. 100: 14381443.
  • 380
    Otaegui, P. J., Ferre, T., Riu, E., Bosch, F. (2003) Prevention of obesity and insulin resistance by glucokinase expression in skeletal muscle of transgenic mice. FASEB J. 17: 20972099.
  • 381
    Ferre, T., Riu, E., Franckhauser, S., Agudo, J., Bosch, F. (2003) Long-term overexpression of glucokinase in the liver of transgenic mice leads to insulin resistance. Diabetologia 46: 16621668.
  • 382
    Wang, W., Yang, Y., Meng, Y., Shi, Y. (2004) GDF-3 is an adipogenic cytokine under high fat dietary condition. Biochem Biophys Res Commun. 321: 10241031.
  • 383
    McPherron, A. C., Lee, SJ. (2002) Suppression of body fat accumulation in myostatin-deficient mice. J Clin Invest. 109: 595601.
  • 384
    Lin, J., Arnold, H. B., Della-Fera, M. A., Azain, M. J., Hartzell, D. L., Baile, CA. (2002) Myostatin knockout in mice increases myogenesis and decreases adipogenesis. Biochem Biophys Res Commun. 291: 701706.
  • 385
    Zhao, B., Wall, R. J., Yang, J. (2005) Transgenic expression of myostatin propeptide prevents diet-induced obesity and insulin resistance. Biochem Biophys Res Commun. 337: 248255.
  • 386
    McClain, D. A., Hazel, M., Parker, G., Cooksey, RC. (2005) Adipocytes with increased hexosamine flux exhibit insulin resistance, increased glucose uptake, and increased synthesis and storage of lipid. Am J Physiol Endocrinol Metab. 288: E973E979.
  • 387
    Rossi, J., Herzig, K. H., Voikar, V., Hiltunen, P. H., Segerstrale, M., Airaksinen, MS. (2003) Alimentary tract innervation deficits and dysfunction in mice lacking GDNF family receptor alpha2. J Clin Invest. 112: 707716.
  • 388
    Olsson, B., Bohlooly, Y. M., Fitzgerald, S. M., et al (2005) Bovine growth hormone transgenic mice are resistant to diet-induced obesity but develop hyperphagia, dyslipidemia, and diabetes on a high-fat diet. Endocrinology 146: 920930.
  • 389
    Bohlooly, Y. M., Olsson, B., Bruder, C. E., et al (2005) Growth hormone overexpression in the central nervous system results in hyperphagia-induced obesity associated with insulin resistance and dyslipidemia. Diabetes 54: 5162.
  • 390
    Rowland, J. E., Lichanska, A. M., Kerr, L. M., et al (2005) In vivo analysis of growth hormone receptor signaling domains and their associated transcripts. Mol Cell Biol. 25: 6677.
  • 391
    Cai, A., Hyde, JF. (1999) The human growth hormone-releasing hormone transgenic mouse as a model of modest obesity: differential changes in leptin receptor (OBR) gene expression in the anterior pituitary and hypothalamus after fasting and OBR localization in somatotrophs. Endocrinology 140: 36093614.
  • 392
    Wortley, K. E., Anderson, K. D., Garcia, K., et al (2004) Genetic deletion of ghrelin does not decrease food intake but influences metabolic fuel preference. Proc Natl Acad Sci USA. 101: 82278232.
  • 393
    Sun, Y., Wang, P., Zheng, H., Smith, RG. (2004) Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc Natl Acad Sci USA. 101: 46794684.
  • 394
    Lall, S., Balthasar, N., Carmignac, D., et al (2004) Physiological studies of transgenic mice overexpressing growth hormone (GH) secretagogue receptor 1A in GH-releasing hormone neurons. Endocrinology 145: 16021611.
  • 395
    Xie, D., Cheng, H., Hamrick, M., et al (2005) Glucose-dependent insulinotropic polypeptide receptor knockout mice have altered bone turnover. Bone 37: 759769.
  • 396
    Zhou, H., Yamada, Y., Tsukiyama, K., et al (2005) Gastric inhibitory polypeptide modulates adiposity and fat oxidation under diminished insulin action. Biochem Biophys Res Commun. 335: 937942.
  • 397
    Miyawaki, K., Yamada, Y., Ban, N., et al (2002) Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat Med. 8: 738742.
  • 398
    Chen, M., Gavrilova, O., Liu, J., et al (2005) Alternative Gnas gene products have opposite effects on glucose and lipid metabolism. Proc Natl Acad Sci USA. 102: 73867391.
  • 399
    Yu, S., Gavrilova, O., Chen, H., et al (2000) Paternal versus maternal transmission of a stimulatory G-protein alpha subunit knockout produces opposite effects on energy metabolism. J Clin Invest. 105: 615623.
  • 400
    Germain-Lee, E. L., Schwindinger, W., Crane, J. L., et al (2005) A mouse model of Albright hereditary osteodystrophy generated by targeted disruption of exon 1 of the Gnas gene. Endocrinology 146: 46974709.
  • 401
    Schwindinger, W. F., Giger, K. E., Betz, K. S., et al (2004) Mice with deficiency of G protein gamma3 are lean and have seizures. Mol Cell Biol. 24: 77587768.
  • 402
    Hammond, L. E., Gallagher, P. A., Wang, S., et al (2002) Mitochondrial glycerol-3-phosphate acyltransferase-deficient mice have reduced weight and liver triacylglycerol content and altered glycerolipid fatty acid composition. Mol Cell Biol. 22: 82048214.
  • 403
    Brown, L. J., Koza, R. A., Everett, C., et al (2002) Normal thyroid thermogenesis but reduced viability and adiposity in mice lacking the mitochondrial glycerol phosphate dehydrogenase. J Biol Chem. 277: 3289232898.
  • 404
    Alfadda, A., DosSantos, R. A., Stepanyan, Z., Marrif, H., Silva, JE. (2004) Mice with deletion of the mitochondrial glycerol-3-phosphate dehydrogenase gene exhibit a thrifty phenotype: effect of gender. Am J Physiol Regul Integr Comp Physiol. 287: R147R156.
  • 405
    Macdonald, L. E., Wortley, K. E., Gowen, L. C., et al (2005) Resistance to diet-induced obesity in mice globally overexpressing OGH/GPB5. Proc Natl Acad Sci USA. 102: 24962501.
  • 406
    Gu, W., Geddes, B. J., Zhang, C., Foley, K. P., Stricker-Krongrad, A. (2004) The prolactin-releasing peptide receptor (GPR10) regulates body weight homeostasis in mice. J Mol Neurosci. 22: 93103.
  • 407
    Tunaru, S., Kero, J., Schaub, A., et al (2003) PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect. Nat Med. 9: 352355.
  • 408
    Marsh, D. J., Weingarth, D. T., Novi, D. E., et al (2002) Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism. Proc Natl Acad Sci USA. 99: 32403245.
  • 409
    Steneberg, P., Rubins, N., Bartoov-Shifman, R., Walker, M. D., Edlund, H. (2005) The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse. Cell Metab. 1: 245258.
  • 410
    Ishii, M., Fei, H., Friedman, JM. (2003) Targeted disruption of GPR7, the endogenous receptor for neuropeptides B and W, leads to metabolic defects and adult-onset obesity. Proc Natl Acad Sci USA. 100: 1054010545.
  • 411
    Lei, X. G., Cheng, WH. (2005) New roles for an old selenoenzyme: evidence from glutathione peroxidase-1 null and overexpressing mice. J Nutr. 135: 22952298.
  • 412
    McClung, J. P., Roneker, C. A., Mu, W., et al (2004) Development of insulin resistance and obesity in mice overexpressing cellular glutathione peroxidase. Proc Natl Acad Sci USA. 101: 88528857.
  • 413
    Bradbury, M. J., Campbell, U., Giracello, D., et al (2005) Metabotropic glutamate receptor mGlu5 is a mediator of appetite and energy balance in rats and mice. J Pharmacol Exp Ther. 313: 395402.
  • 414
    Duvoisin, R. M., Zhang, C., Pfankuch, T. F., et al (2005) Increased measures of anxiety and weight gain in mice lacking the group III metabotropic glutamate receptor mGluR8. Eur J Neurosci. 22: 425436.
  • 415
    Pearce, N. J., Arch, J. R., Clapham, J. C., et al (2004) Development of glucose intolerance in male transgenic mice overexpressing human glycogen synthase kinase-3beta on a muscle-specific promoter. Metabolism 53: 13221330.
  • 416
    Campbell, P. K., Waymire, K. G., Heier, R. L., et al (2002) Mutation of a novel gene results in abnormal development of spermatid flagella, loss of intermale aggression and reduced body fat in mice. Genetics 162: 307320.
  • 417
    Hara, J., Beuckmann, C. T., Nambu, T., et al (2001) Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron. 30: 345354.
  • 418
    Hara, J., Yanagisawa, M., Sakurai, T. (2005) Difference in obesity phenotype between orexin-knockout mice and orexin neuron-deficient mice with same genetic background and environmental conditions. Neurosci Lett. 380: 239242.
  • 419
    Fulop, A. K., Foldes, A., Buzas, E., et al (2003) Hyperleptinemia, visceral adiposity, and decreased glucose tolerance in mice with a targeted disruption of the histidine decarboxylase gene. Endocrinology 144: 43064314.
  • 420
    Fain, J. N., Del Mar, N. A., Meade, C. A., Reiner, A., Goldowitz, D. (2001) Abnormalities in the functioning of adipocytes from R6/2 mice that are transgenic for the Huntington's disease mutation. Hum Mol Genet. 10: 145152.
  • 421
    Yamaguchi, A., Katsuyama, K., Nagahama, K., Takai, T., Aoki, I., Yamanaka, S. (2004) Possible role of autoantibodies in the pathophysiology of GM2 gangliosidoses. J Clin Invest. 113: 200208.
  • 422
    Anand, A., Chada, K. (2000) In vivo modulation of Hmgic reduces obesity. Nat Genet. 24: 377380.
  • 423
    Masaki, T., Chiba, S., Yasuda, T., et al (2004) Involvement of hypothalamic histamine H1 receptor in the regulation of feeding rhythm and obesity. Diabetes 53: 22502260.
  • 424
    Takahashi, K., Suwa, H., Ishikawa, T., Kotani, H. (2002) Targeted disruption of H3 receptors results in changes in brain histamine tone leading to an obese phenotype. J Clin Invest. 110: 17911799.
  • 425
    Morton, N. M., Paterson, J. M., Masuzaki, H., et al (2004) Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes 53: 931938.
  • 426
    Masuzaki, H., Paterson, J., Shinyama, H., et al (2001) A transgenic model of visceral obesity and the metabolic syndrome. Science 294: 21662170.
  • 427
    Kershaw, E. E., Morton, N. M., Dhillon, H., Ramage, L., Seckl, J. R., Flier, JS. (2005) Adipocyte-specific glucocorticoid inactivation protects against diet-induced obesity. Diabetes 54: 10231031.
  • 428
    Nonogaki, K., Abdallah, L., Goulding, E. H., Bonasera, S. J., Tecott, LH. (2003) Hyperactivity and reduced energy cost of physical activity in serotonin 5-HT(2C) receptor mutant mice. Diabetes 52: 315320.
  • 429
    Dong, Z. M., Gutierrez-Ramos, J. C., Coxon, A., Mayadas, T. N., Wagner, DD. (1997) A new class of obesity genes encodes leukocyte adhesion receptors. Proc Natl Acad Sci USA. 94: 75267530.
  • 430
    Gregoire, F. M., Zhang, Q., Smith, S. J., et al (2002) Diet-induced obesity and hepatic gene expression alterations in C57BL/6J and ICAM-1-deficient mice. Am J Physiol Endocrinol Metab. 282: E703E713.
  • 431
    Wang, H. W., Babic, A. M., Mitchell, H. A., Liu, K., Wagner, DD. (2005) Elevated soluble ICAM-1 levels induce immune deficiency and increase adiposity in mice. FASEB J. 19: 10181020.
  • 432
    Koh, H. J., Lee, S. M., Son, B. G., et al (2004) Cytosolic NADP+-dependent isocitrate dehydrogenase plays a key role in lipid metabolism. J Biol Chem. 279: 3996839974.
  • 433
    Wang, Y., Iordanov, H., Swietlicki, E. A., et al (2005) Targeted intestinal overexpression of the immediate early gene tis7 in transgenic mice increases triglyceride absorption and adiposity. J Biol Chem. 280: 3476434775.
  • 434
    Bienvenu, G., Seurin, D., Le Bouc, Y., Even, P., Babajko, S., Magnan, C. (2005) Dysregulation of energy homeostasis in mice overexpressing insulin-like growth factor-binding protein 6 in the brain. Diabetologia 48: 11891197.
  • 435
    Hirsch, E., Irikura, V. M., Paul, S. M., Hirsh, D. (1996) Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice. Proc Natl Acad Sci USA. 93: 1100811013.
  • 436
    Matsuki, T., Horai, R., Sudo, K., Iwakura, Y. (2003) IL-1 plays an important role in lipid metabolism by regulating insulin levels under physiological conditions. J Exp Med. 198: 877888.
  • 437
    Wallenius, V., Wallenius, K., Ahren, B., et al (2002) Interleukin-6-deficient mice develop mature-onset obesity. Nat Med. 8: 7579.
  • 438
    Di Gregorio, G. B., Hensley, L., Lu, T., Ranganathan, G., Kern, PA. (2004) Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: absence of development of age-related obesity. Am J Physiol Endocrinol Metab. 287: E182E187.
  • 439
    Sleeman, M. W., Wortley, K. E., Lai, K. M., et al (2005) Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity. Nat Med. 11: 199205.
  • 440
    Cariou, B., Postic, C., Boudou, P., et al (2004) Cellular and molecular mechanisms of adipose tissue plasticity in muscle insulin receptor knockout mice. Endocrinology 145: 19261932.
  • 441
    Lin, X., Taguchi, A., Park, S., et al (2004) Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes. J Clin Invest. 114: 908916.
  • 442
    Kubota, N., Terauchi, Y., Tobe, K., et al (2004) Insulin receptor substrate 2 plays a crucial role in beta cells and the hypothalamus. J Clin Invest. 114: 917927.
  • 443
    Xu, J., Koni, P. A., Wang, P., et al (2003) The voltage-gated potassium channel Kv1.3 regulates energy homeostasis and body weight. Hum Mol Genet. 12: 551559.
  • 444
    Kanezaki, Y., Obata, T., Matsushima, R., et al (2004) K(ATP) channel knockout mice crossbred with transgenic mice expressing a dominant-negative form of human insulin receptor have glucose intolerance but not diabetes. Endocr J. 51: 133144.
  • 445
    Oishi, Y., Manabe, I., Tobe, K., et al (2005) Kruppel-like transcription factor KLF5 is a key regulator of adipocyte differentiation. Cell Metab. 1: 2739.
  • 446
    Elefteriou, F., Takeda, S., Ebihara, K., et al (2004) Serum leptin level is a regulator of bone mass. Proc Natl Acad Sci USA. 101: 32583263.
  • 447
    Ogawa, Y., Masuzaki, H., Hosoda, K., et al (1999) Increased glucose metabolism and insulin sensitivity in transgenic skinny mice overexpressing leptin. Diabetes 48: 18221829.
  • 448
    Bates, S. H., Stearns, W. H., Dundon, T. A., et al (2003) STAT3 signalling is required for leptin regulation of energy balance but not reproduction. Nature 421: 856859.
  • 449
    McMinn, J. E., Liu, S. M., Liu, H., et al (2005) Neuronal deletion of Lepr elicits diabesity in mice without affecting cold tolerance or fertility. Am J Physiol Endocrinol Metab. 289: E403E411.
  • 450
    Cohen, P., Zhao, C., Cai, X., et al (2001) Selective deletion of leptin receptor in neurons leads to obesity. J Clin Invest. 108: 11131121.
  • 451
    Reichart, U., Renner-Muller, I., Hoflich, A., et al (2000) Contrasting obesity phenotypes uncovered by partial leptin receptor gene deletion in transgenic mice. Biochem Biophys Res Commun. 269: 502507.
  • 452
    de Luca, C., Kowalski, T. J., Zhang, Y., et al (2005) Complete rescue of obesity, diabetes, and infertility in db/db mice by neuron-specific LEPR-B transgenes. J Clin Invest. 115: 34843493.
  • 453
    Kero, J. T., Savontaus, E., Mikola, M., et al (2003) Obesity in transgenic female mice with constitutively elevated luteinizing hormone secretion. Am J Physiol Endocrinol Metab. 285: E812E818.
  • 454
    Du, H., Heur, M., Duanmu, M., et al (2001) Lysosomal acid lipase-deficient mice: depletion of white and brown fat, severe hepatosplenomegaly, and shortened life span. J Lipid Res. 42: 489500.
  • 455
    Du, H., Dardzinski, B. J., O'Brien, K. J., Donnelly, LF. (2005) MRI of fat distribution in a mouse model of lysosomal acid lipase deficiency. AJR Am J Roentgenol. 184: 658662.
  • 456
    Farahani, P., Fisler, J. S., Wong, H., Diament, A. L., Yi, N., Warden, CH. (2004) Reciprocal hemizygosity analysis of mouse hepatic lipase reveals influence on obesity. Obes Res. 12: 292305.
  • 457
    Harada, K., Shen, W. J., Patel, S., et al (2003) Resistance to high-fat diet-induced obesity and altered expression of adipose-specific genes in HSL-deficient mice. Am J Physiol Endocrinol Metab. 285: E1182E1195.
  • 458
    Wang, S. P., Laurin, N., Himms-Hagen, J., et al (2001) The adipose tissue phenotype of hormone-sensitive lipase deficiency in mice. Obes Res. 9: 119128.
  • 459
    Fortier, M., Soni, K., Laurin, N., et al (2005) Human hormone-sensitive lipase (HSL): expression in white fat corrects the white adipose phenotype of HSL-deficient mice. J Lipid Res. 46: 18601867.
  • 460
    Phan, J., Peterfy, M., Reue, K. (2004) Lipin expression preceding peroxisome proliferator-activated receptor-gamma is critical for adipogenesis in vivo and in vitro. J Biol Chem. 279: 2955829564.
  • 461
    Phan, J., Reue, K. (2005) Lipin, a lipodystrophy and obesity gene. Cell Metab. 1: 7383.
  • 462
    Bost, F., Aouadi, M., Caron, L., et al (2005) The extracellular signal-regulated kinase isoform ERK1 is specifically required for in vitro and in vivo adipogenesis. Diabetes 54: 402411.
  • 463
    Hirosumi, J., Tuncman, G., Chang, L., et al (2002) A central role for JNK in obesity and insulin resistance. Nature 420: 333336.
  • 464
    Jaeschke, A., Czech, M. P., Davis, RJ. (2004) An essential role of the JIP1 scaffold protein for JNK activation in adipose tissue. Genes Dev. 18: 19761980.
  • 465
    Butler, A. A., Kesterson, R. A., Khong, K., et al (2000) A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 141: 35183521.
  • 466
    Chen, A. S., Marsh, D. J., Trumbauer, M. E., et al (2000) Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat Genet. 26: 97102.
  • 467
    Huszar, D., Lynch, C. A., Fairchild-Huntress, V., et al (1997) Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88: 131141.
  • 468
    Balthasar, N., Dalgaard, L. T., Lee, C. E., et al (2005) Divergence of melanocortin pathways in the control of food intake and energy expenditure. Cell 123: 493505.
  • 469
    Takahashi, M., Kamei, Y., Ezaki, O. (2005) Mest/Peg1 imprinted gene enlarges adipocytes and is a marker of adipocyte size. Am J Physiol Endocrinol Metab. 288: E117E124.
  • 470
    Fath, M. A., Mullins, R. F., Searby, C., et al (2005) Mkks-null mice have a phenotype resembling Bardet-Biedl syndrome. Hum Mol Genet. 14: 11091118.
  • 471
    Iizuka, K., Bruick, R. K., Liang, G., Horton, J. D., Uyeda, K. (2004) Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis. Proc Natl Acad Sci USA. 101: 72817286.
  • 472
    Andarawewa, K. L., Motrescu, E. R., Chenard, M. P., et al (2005) Stromelysin-3 is a potent negative regulator of adipogenesis participating to cancer cell-adipocyte interaction/crosstalk at the tumor invasive front. Cancer Res. 65: 1086210871.
  • 473
    Pendas, A. M., Folgueras, A. R., Llano, E., et al (2004) Diet-induced obesity and reduced skin cancer susceptibility in matrix metalloproteinase 19-deficient mice. Mol Cell Biol. 24: 53045313.
  • 474
    Beattie, J. H., Wood, A. M., Newman, A. M., et al (1998) Obesity and hyperleptinemia in metallothionein (-I and -II) null mice. Proc Natl Acad Sci USA. 95: 358363.
  • 475
    Michalska, A. E., Choo, KH. (1993) Targeting and germ-line transmission of a null mutation at the metallothionein I and II loci in mouse. Proc Natl Acad Sci USA. 90: 80888092.
  • 476
    Riu, E., Ferre, T., Hidalgo, A., et al (2003) Overexpression of c-myc in the liver prevents obesity and insulin resistance. FASEB J. 17: 17151717.
  • 477
    Good, D. J., Porter, F. D., Mahon, K. A., Parlow, A. F., Westphal, H., Kirsch, IR. (1997) Hypogonadism and obesity in mice with a targeted deletion of the Nhlh2 gene. Nat Genet. 15: 397401.
  • 478
    Hanada, R., Teranishi, H., Pearson, J. T., et al (2004) Neuromedin U has a novel anorexigenic effect independent of the leptin signaling pathway. Nat Med. 10: 10671073.
  • 479
    Kowalski, T. J., Spar, B. D., Markowitz, L., et al (2005) Transgenic overexpression of neuromedin U promotes leanness and hypophagia in mice. J Endocrinol. 185: 151164.
  • 480
    Gomez-Ambrosi, J., Becerril, S., Oroz, P., et al (2004) Reduced adipose tissue mass and hypoleptinemia in iNOS deficient mice: effect of LPS on plasma leptin and adiponectin concentrations. FEBS Lett. 577: 351356.
  • 481
    Kelly, M. A., Beuckmann, C. T., Williams, S. C., et al (2005) Neuropeptide B-deficient mice demonstrate hyperalgesia in response to inflammatory pain. Proc Natl Acad Sci USA. 102: 99429947.
  • 482
    Kushi, A., Sasai, H., Koizumi, H., Takeda, N., Yokoyama, M., Nakamura, M. (1998) Obesity and mild hyperinsulinemia found in neuropeptide Y-Y1 receptor-deficient mice. Proc Natl Acad Sci USA. 95: 1565915664.
  • 483
    Marsh, D. J., Hollopeter, G., Kafer, K. E., Palmiter, RD. (1998) Role of the Y5 neuropeptide Y receptor in feeding and obesity. Nat Med. 4: 718721.
  • 484
    Gerin, I., Dolinsky, V. W., Shackman, J. G., et al (2005) LXRbeta is required for adipocyte growth, glucose homeostasis, and beta cell function. J Biol Chem. 280: 2302423031.
  • 485
    Maglich, J. M., Stoltz, C. M., Goodwin, B., Hawkins-Brown, D., Moore, J. T., Kliewer, SA. (2002) Nuclear pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. Mol Pharmacol. 62: 638646.
  • 486
    Kellendonk, C., Eiden, S., Kretz, O., et al (2002) Inactivation of the GR in the nervous system affects energy accumulation. Endocrinology 143: 23332340.
  • 487
    Remaury, A., Vita, N., Gendreau, S., et al (2002) Targeted inactivation of the neurotensin type 1 receptor reveals its role in body temperature control and feeding behavior but not in analgesia. Brain Res. 953: 6372.
  • 488
    Tabarin, A., Chaves, Y. D., Carmona, Mdel C, et al (2005) Resistance to diet-induced obesity in [micro]-opioid receptor-deficient mice: evidence for a “thrifty gene.”. Diabetes 54: 35103516.
  • 489
    Wang, Z. Q., Stingl, L., Morrison, C., et al (1997) PARP is important for genomic stability but dispensable in apoptosis. Genes Dev. 11: 23472358.
  • 490
    Wang, Z. Q., Auer, B., Stingl, L., et al (1995) Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease. Genes Dev. 9: 509520.
  • 491
    Zhu, X., Zhou, A., Dey, A., et al (2002) Disruption of PC1/3 expression in mice causes dwarfism and multiple neuroendocrine peptide processing defects. Proc Natl Acad Sci USA. 99: 1029310298.
  • 492
    Wei, S., Feng, Y., Che, F. Y., et al (2004) Obesity and diabetes in transgenic mice expressing proSAAS. J Endocrinol. 180: 357368.
  • 493
    Curley, J. P., Pinnock, S. B., Dickson, S. L., et al (2005) Increased body fat in mice with a targeted mutation of the paternally expressed imprinted gene Peg3. FASEB J. 19: 13021304.
  • 494
    Noga, A. A., Vance, DE. (2003) A gender-specific role for phosphatidylethanolamine N-methyltransferase-derived phosphatidylcholine in the regulation of plasma high density and very low density lipoproteins in mice. J Biol Chem. 278: 2185121859.
  • 495
    Li, Z., Agellon, L. B., Vance, DE. (2005) Phosphatidylcholine homeostasis and liver failure. J Biol Chem. 280: 3779837802.
  • 496
    Chen, D., Mauvais-Jarvis, F., Bluher, M., et al (2004) p50alpha/p55alpha phosphoinositide 3-kinase knockout mice exhibit enhanced insulin sensitivity. Mol Cell Biol. 24: 320329.
  • 497
    Lamia, K. A., Peroni, O. D., Kim, Y. B., Rameh, L. E., Kahn, B. B., Cantley, LC. (2004) Increased insulin sensitivity and reduced adiposity in phosphatidylinositol 5-phosphate 4-kinase beta−/− mice. Mol Cell Biol. 24: 50805087.
  • 498
    Huggins, K. W., Boileau, A. C., Hui, DY. (2002) Protection against diet-induced obesity and obesity- related insulin resistance in group 1B PLA2-deficient mice. Am J Physiol Endocrinol Metab. 283: E994E1001.
  • 499
    Tansey, J. T., Sztalryd, C., Gruia-Gray, J., et al (2001) Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity. Proc Natl Acad Sci USA. 98: 64946499.
  • 500
    Zhou, Q., Zhao, J., Wiedmer, T., Sims, PJ. (2002) Normal hemostasis but defective hematopoietic response to growth factors in mice deficient in phospholipid scramblase 1. Blood 99: 40304038.
  • 501
    Wiedmer, T., Zhao, J., Li, L., et al (2004) Adiposity, dyslipidemia, and insulin resistance in mice with targeted deletion of phospholipid scramblase 3 (PLSCR3). Proc Natl Acad Sci USA. 101: 1329613301.
  • 502
    Kokkotou, E., Jeon, J. Y., Wang, X., et al (2005) Mice with MCH ablation resist diet-induced obesity through strain-specific mechanisms. Am J Physiol Regul Integr Comp Physiol. 289: R117R124.
  • 503
    Shimada, M., Tritos, N. A., Lowell, B. B., Flier, J. S., Maratos-Flier, E. (1998) Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature 396: 670674.
  • 504
    Challis, B. G., Coll, A. P., Yeo, G. S., et al (2004) Mice lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY(3–36). Proc Natl Acad Sci USA. 101: 46954700.
  • 505
    Yaswen, L., Diehl, N., Brennan, M. B., Hochgeschwender, U. (1999) Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat Med. 5: 10661070.
  • 506
    Gu, J., Weng, Y., Zhang, Q. Y., et al (2003) Liver-specific deletion of the NADPH-cytochrome P450 reductase gene: impact on plasma cholesterol homeostasis and the function and regulation of microsomal cytochrome P450 and heme oxygenase. J Biol Chem. 278: 2589525901.
  • 507
    Henderson, C. J., Otto, D. M., Carrie, D., et al (2003) Inactivation of the hepatic cytochrome P450 system by conditional deletion of hepatic cytochrome P450 reductase. J Biol Chem. 278: 1348013486.
  • 508
    Miyazaki, M., Dobrzyn, A., Sampath, H., et al (2004) Reduced adiposity and liver steatosis by stearoyl-CoA desaturase deficiency are independent of peroxisome proliferator-activated receptor-alpha. J Biol Chem. 279: 3501735024.
  • 509
    Finck, B. N., Bernal-Mizrachi, C., Han, D. H., et al (2005) A potential link between muscle peroxisome proliferator- activated receptor-alpha signaling and obesity-related diabetes. Cell Metab. 1: 133144.
  • 510
    Wang, Y. X., Lee, C. H., Tiep, S., et al (2003) Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell 113: 159170.
  • 511
    Luquet, S., Lopez-Soriano, J., Holst, D., et al (2003) Peroxisome proliferator-activated receptor delta controls muscle development and oxidative capability. FASEB J. 17: 22992301.
  • 512
    Akiyama, T. E., Lambert, G., Nicol, C. J., et al (2004) Peroxisome proliferator-activated receptor beta/delta regulates very low density lipoprotein production and catabolism in mice on a Western diet. J Biol Chem. 279: 2087420881.
  • 513
    Jones, J. R., Barrick, C., Kim, K. A., et al (2005) Deletion of PPARgamma in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance. Proc Natl Acad Sci USA. 102: 62076212.
  • 514
    He, W., Barak, Y., Hevener, A., et al (2003) Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle. Proc Natl Acad Sci USA. 100: 1571215717.
  • 515
    Norris, A. W., Chen, L., Fisher, S. J., et al (2003) Muscle-specific PPARgamma-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones. J Clin Invest. 112: 608618.
  • 516
    Rosen, E. D., Kulkarni, R. N., Sarraf, P., et al (2003) Targeted elimination of peroxisome proliferator-activated receptor gamma in beta cells leads to abnormalities in islet mass without compromising glucose homeostasis. Mol Cell Biol. 23: 72227229.
  • 517
    Zhang, J., Fu, M., Cui, T., et al (2004) Selective disruption of PPARgamma 2 impairs the development of adipose tissue and insulin sensitivity. Proc Natl Acad Sci USA. 101: 1070310708.
  • 518
    Freedman, B. D., Lee, E. J., Park, Y., Jameson, JL. (2005) A dominant negative peroxisome proliferator-activated receptor-gamma knock-in mouse exhibits features of the metabolic syndrome. J Biol Chem. 280: 1711817125.
  • 519
    Lin, J., Wu, P. H., Tarr, P. T., et al (2004) Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell 119: 121135.
  • 520
    Leone, T. C., Lehman, J. J., Finck, B. N., et al (2005) PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol. 3: e101
  • 521
    Kamei, Y., Ohizumi, H., Fujitani, Y., et al (2003) PPARgamma coactivator 1beta/ERR ligand 1 is an ERR protein ligand, whose expression induces a high-energy expenditure and antagonizes obesity. Proc Natl Acad Sci USA. 100: 1237812383.
  • 522
    Delibegovic, M., Armstrong, C. G., Dobbie, L., Watt, P. W., Smith, A. J., Cohen, PT. (2003) Disruption of the striated muscle glycogen targeting subunit PPP1R3A of protein phosphatase 1 leads to increased weight gain, fat deposition, and development of insulin resistance. Diabetes 52: 596604.
  • 523
    Crosson, S. M., Khan, A., Printen, J., Pessin, J. E., Saltiel, AR. (2003) PTG gene deletion causes impaired glycogen synthesis and developmental insulin resistance. J Clin Invest. 111: 14231432.
  • 524
    Ueno, N., Inui, A., Iwamoto, M., et al (1999) Decreased food intake and body weight in pancreatic polypeptide- overexpressing mice. Gastroenterology 117: 14271432.
  • 525
    Asakawa, A., Inui, A., Yuzuriha, H., et al (2003) Characterization of the effects of pancreatic polypeptide in the regulation of energy balance. Gastroenterology 124: 13251336.
  • 526
    Villena, J. A., Viollet, B., Andreelli, F., Kahn, A., Vaulont, S., Sul, HS. (2004) Induced adiposity and adipocyte hypertrophy in mice lacking the AMP-activated protein kinase-alpha2 subunit. Diabetes 53: 22422249.
  • 527
    Barnes, B. R., Marklund, S., Steiler, T. L., et al (2004) The 5′-AMP-activated protein kinase gamma3 isoform has a key role in carbohydrate and lipid metabolism in glycolytic skeletal muscle. J Biol Chem. 279: 3844138447.
  • 528
    Newhall, K. J., Cummings, D. E., Nolan, M. A., McKnight, GS. (2005) Deletion of the RIIbeta-subunit of protein kinase A decreases body weight and increases energy expenditure in the obese, leptin-deficient ob/ob mouse. Mol Endocrinol. 19: 982991.
  • 529
    Cummings, D. E., Brandon, E. P., Planas, J. V., Motamed, K., Idzerda, R. L., McKnight, GS. (1996) Genetically lean mice result from targeted disruption of the RII beta subunit of protein kinase A. Nature 382: 622626.
  • 530
    Serra, C., Federici, M., Buongiorno, A., et al (2003) Transgenic mice with dominant negative PKC-theta in skeletal muscle: a new model of insulin resistance and obesity. J Cell Physiol. 196: 8997.
  • 531
    Harvey, N. L., Srinivasan, R. S., Dillard, M. E., et al (2005) Lymphatic vascular defects promoted by Prox1 haploinsufficiency cause adult-onset obesity. Nat Genet. 37: 10721081.
  • 532
    Elchebly, M., Payette, P., Michaliszyn, E., et al (1999) Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283: 15441548.
  • 533
    Klaman, L. D., Boss, O., Peroni, O. D., et al (2000) Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol Cell Biol. 20: 54795489.
  • 534
    Zhang, E. E., Chapeau, E., Hagihara, K., Feng, GS. (2004) Neuronal Shp2 tyrosine phosphatase controls energy balance and metabolism. Proc Natl Acad Sci USA. 101: 1606416069.
  • 535
    Yamao, T., Noguchi, T., Takeuchi, O., et al (2002) Negative regulation of platelet clearance and of the macrophage phagocytic response by the transmembrane glycoprotein SHPS-1. J Biol Chem. 277: 3983339839.
  • 536
    Wang, Z., Moro, E., Kovacs, K., Yu, R., Melmed, S. (2003) Pituitary tumor transforming gene-null male mice exhibit impaired pancreatic beta cell proliferation and diabetes. Proc Natl Acad Sci USA. 100: 34283432.
  • 537
    Bi, W., Ohyama, T., Nakamura, H., et al (2005) Inactivation of Rai1 in mice recapitulates phenotypes observed in chromosome engineered mouse models for Smith-Magenis syndrome. Hum Mol Genet. 14: 983995.
  • 538
    de Mora, J. Font, Esteban, L. M., Burks, D. J., et al (2003) Ras-GRF1 signaling is required for normal beta-cell development and glucose homeostasis. Embo J. 22: 30393049.
  • 539
    Uehara, S., Tsuchida, M., Kanno, T., Sasaki, M., Nishikibe, M., Fukamizu, A. (2003) Late-onset obesity in mice transgenic for the human renin gene. Int J Mol Med. 11: 723727.
  • 540
    Kim, K. H., Zhao, L., Moon, Y., Kang, C., Sul, HS. (2004) Dominant inhibitory adipocyte-specific secretory factor (ADSF)/resistin enhances adipogenesis and improves insulin sensitivity. Proc Natl Acad Sci USA. 101: 67806785.
  • 541
    Kushiyama, A., Shojima, N., Ogihara, T., et al (2005) Resistin-like molecule beta activates MAPKs, suppresses insulin signaling in hepatocytes, and induces diabetes, hyperlipidemia, and fatty liver in transgenic mice on a high fat diet. J Biol Chem. 280: 4201642025.
  • 542
    El-Haschimi, K., Dufresne, S. D., Hirshman, M. F., Flier, J. S., Goodyear, L. J., Bjorbaek, C. (2003) Insulin resistance and lipodystrophy in mice lacking ribosomal S6 kinase 2. Diabetes 52: 13401346.
  • 543
    Um, S. H., Frigerio, F., Watanabe, M., et al (2004) Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 431: 200205.
  • 544
    Osswald, C., Baumgarten, K., Stumpel, F., et al (2005) Mice without the regulator gene Rsc1A1 exhibit increased Na+-d-glucose cotransport in small intestine and develop obesity. Mol Cell Biol. 25: 7887.
  • 545
    Haugen, B. R., Jensen, D. R., Sharma, V., et al (2004) Retinoid X receptor gamma-deficient mice have increased skeletal muscle lipoprotein lipase activity and less weight gain when fed a high-fat diet. Endocrinology 145: 36793685.
  • 546
    Ntambi, J. M., Miyazaki, M., Stoehr, J. P., et al (2002) Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc Natl Acad Sci USA. 99: 1148211486.
  • 547
    Reizes, O., Lincecum, J., Wang, Z., et al (2001) Transgenic expression of syndecan-1 uncovers a physiological control of feeding behavior by syndecan-3. Cell 106: 105116.
  • 548
    Strader, A. D., Reizes, O., Woods, S. C., Benoit, S. C., Seeley, RJ. (2004) Mice lacking the syndecan-3 gene are resistant to diet-induced obesity. J Clin Invest. 114: 13541360.
  • 549
    Ma, L. J., Mao, S. L., Taylor, K. L., et al (2004) Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1. Diabetes 53: 336346.
  • 550
    Lijnen, HR. (2005) Effect of plasminogen activator inhibitor-1 deficiency on nutritionally-induced obesity in mice. Thromb Haemost. 93: 816819.
  • 551
    Lijnen, H. R., Alessi, M. C., Van Hoef, B., Collen, D., Juhan-Vague, I. (2005) On the role of plasminogen activator inhibitor-1 in adipose tissue development and insulin resistance in mice. J Thromb Haemost. 3: 11741179.
  • 552
    Lijnen, H. R., Van Hoef, B., Umans, K., Collen, D. (2004) Neointima formation and thrombosis after vascular injury in transgenic mice overexpressing plasminogen activator inhibitor-1 (PAI-1). J Thromb Haemost. 2: 1622.
  • 553
    Bodine, P. V., Zhao, W., Kharode, Y. P., et al (2004) The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice. Mol Endocrinol. 18: 12221237.
  • 554
    Ren, D., Li, M., Duan, C., Rui, L. (2005) Identification of SH2-B as a key regulator of leptin sensitivity, energy balance, and body weight in mice. Cell Metab. 2: 95104.
  • 555
    Holder, J. L., Jr, Zhang, L., Kublaoui, B. M., et al (2004) Sim1 gene dosage modulates the homeostatic feeding response to increased dietary fat in mice. Am J Physiol Endocrinol Metab. 287: E105E113.
  • 556
    Michaud, J. L., Boucher, F., Melnyk, A., et al (2001) Sim1 haploinsufficiency causes hyperphagia, obesity and reduction of the paraventricular nucleus of the hypothalamus. Hum Mol Genet. 10: 14651473.
  • 557
    Katz, E. B., Stenbit, A. E., Hatton, K., DePinho, R., Charron, MJ. (1995) Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4. Nature 377: 151155.
  • 558
    Carvalho, E., Kotani, K., Peroni, O. D., Kahn, BB. (2005) Adipose-specific overexpression of GLUT4 reverses insulin resistance and diabetes in mice lacking GLUT4 selectively in muscle. Am J Physiol Endocrinol Metab. 289: E551E561.
  • 559
    Ma, Y. H., Hu, J. H., Zhou, X. G., et al (2000) Transgenic mice overexpressing gamma-aminobutyric acid transporter subtype I develop obesity. Cell Res. 10: 303310.
  • 560
    Buhman, K. K., Accad, M., Novak, S., et al (2000) Resistance to diet-induced hypercholesterolemia and gallstone formation in ACAT2-deficient mice. Nat Med. 6: 13411347.
  • 561
    Mori, H., Hanada, R., Hanada, T., et al (2004) Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity. Nat Med. 10: 739743.
  • 562
    Sock, E., Schmidt, K., Hermanns-Borgmeyer, I., Bosl, M. R., Wegner, M. (2001) Idiopathic weight reduction in mice deficient in the high-mobility-group transcription factor Sox8. Mol Cell Biol. 21: 69516959.
  • 563
    Bradshaw, A. D., Graves, D. C., Motamed, K., Sage, EH. (2003) SPARC-null mice exhibit increased adiposity without significant differences in overall body weight. Proc Natl Acad Sci USA. 100: 60456050.
  • 564
    Shimomura, I., Hammer, R. E., Richardson, J. A., et al (1998) Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev. 12: 31823194.
  • 565
    Horton, J. D., Shimomura, I., Ikemoto, S., Bashmakov, Y., Hammer, RE. (2003) Overexpression of sterol regulatory element-binding protein-1a in mouse adipose tissue produces adipocyte hypertrophy, increased fatty acid secretion, and fatty liver. J Biol Chem. 278: 3665236660.
  • 566
    Cui, Y., Huang, L., Elefteriou, F., et al (2004) Essential role of STAT3 in body weight and glucose homeostasis. Mol Cell Biol. 24: 258269.
  • 567
    Gao, Q., Wolfgang, M. J., Neschen, S., et al (2004) Disruption of neural signal transducer and activator of transcription 3 causes obesity, diabetes, infertility, and thermal dysregulation. Proc Natl Acad Sci USA. 101: 46614666.
  • 568
    Udy, G. B., Towers, R. P., Snell, R. G., et al (1997) Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci USA. 94: 72397244.
  • 569
    Clouthier, D. E., Comerford, S. A., Hammer, RE. (1997) Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice. J Clin Invest. 100: 26972713.
  • 570
    Liu, Y. Y., Schultz, J. J., Brent, GA. (2003) A thyroid hormone receptor alpha gene mutation (P398H) is associated with visceral adiposity and impaired catecholamine-stimulated lipolysis in mice. J Biol Chem. 278: 3891338920.
  • 571
    Xu, Z. P., Wawrousek, E. F., Piatigorsky, J. (2002) Transketolase haploinsufficiency reduces adipose tissue and female fertility in mice. Mol Cell Biol. 22: 61426147.
  • 572
    Ventre, J., Doebber, T., Wu, M., et al (1997) Targeted disruption of the tumor necrosis factor-alpha gene: metabolic consequences in obese and nonobese mice. Diabetes. 46: 15261531.
  • 573
    Voros, G., Maquoi, E., Collen, D., Lijnen, HR. (2004) Influence of membrane-bound tumor necrosis factor (TNF)-alpha on obesity and glucose metabolism. J Thromb Haemost. 2: 507513.
  • 574
    Stubdal, H., Lynch, C. A., Moriarty, A., et al (2000) Targeted deletion of the tub mouse obesity gene reveals that tubby is a loss-of-function mutation. Mol Cell Biol. 20: 878882.
  • 575
    Sheth, S. S., Castellani, L. W., Chari, S., et al (2005) Thioredoxin-interacting protein deficiency disrupts the fasting-feeding metabolic transition. J Lipid Res. 46: 123134.
  • 576
    Kwon, Y. T., Xia, Z., Davydov, I. V., Lecker, S. H., Varshavsky, A. (2001) Construction and analysis of mouse strains lacking the ubiquitin ligase UBR1 (E3alpha) of the N-end rule pathway. Mol Cell Biol. 21: 80078021.
  • 577
    Liu, X., Rossmeisl, M., McClaine, J., Riachi, M., Harper, M. E., Kozak, LP. (2003) Paradoxical resistance to diet-induced obesity in UCP1-deficient mice. J Clin Invest. 111: 399407.
  • 578
    Couplan, E., Gelly, C., Goubern, M., et al (2002) High level of uncoupling protein 1 expression in muscle of transgenic mice selectively affects muscles at rest and decreases their IIb fiber content. J Biol Chem. 277: 4307943088.
  • 579
    Lowell, B. B., S-Susulic, V., Hamann, A., et al (1993) Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature 366: 740742.
  • 580
    Ortmann, S., Prinzler, J., Klaus, S. (2003) Self-selected macronutrient diet affects energy and glucose metabolism in brown fat-ablated mice. Obes Res. 11: 15361544.
  • 581
    Horvath, T. L., Diano, S., Miyamoto, S., et al (2003) Uncoupling proteins-2 and 3 influence obesity and inflammation in transgenic mice. Int J Obes Relat Metab Disord. 27: 433442.
  • 582
    Son, C., Hosoda, K., Ishihara, K., et al (2004) Reduction of diet-induced obesity in transgenic mice overexpressing uncoupling protein 3 in skeletal muscle. Diabetologia 47: 4754.
  • 583
    Choi, Y. S., Hong, S. B., Jeon, H. K., et al (2003) Insertional mutation in the intron 1 of Unc5h3 gene induces ataxic, lean and hyperactive phenotype in mice. Exp Anim. 52: 273283.
  • 584
    Hahm, S., Mizuno, T. M., Wu, T. J., et al (1999) Targeted deletion of the Vgf gene indicates that the encoded secretory peptide precursor plays a novel role in the regulation of energy balance. Neuron. 23: 537548.
  • 585
    Frykman, P. K., Brown, M. S., Yamamoto, T., Goldstein, J. L., Herz, J. (1995) Normal plasma lipoproteins and fertility in gene-targeted mice homozygous for a disruption in the gene encoding very low density lipoprotein receptor. Proc Natl Acad Sci USA. 92: 84538457.
  • 586
    Kang, S., Bajnok, L., Longo, K. A., et al (2005) Effects of Wnt signaling on brown adipocyte differentiation and metabolism mediated by PGC-1alpha. Mol Cell Biol. 25: 12721282.
  • 587
    Longo, K. A., Wright, W. S., Kang, S., et al (2004) Wnt10b inhibits development of white and brown adipose tissues. J Biol Chem. 279: 3550335509.
  • 588
    Vertino, A. M., Taylor-Jones, J. M., Longo, K. A., et al (2005) Wnt10b deficiency promotes coexpression of myogenic and adipogenic programs in myoblasts. Mol Biol Cell. 16: 20392048.
  • 589
    Taylor, G. A., Carballo, E., Lee, D. M., et al (1996) A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 4: 445454.
  • 590
    MacNeil, M. D., Grosz, MD. (2002) Genome-wide scans for QTL affecting carcass traits in Hereford x composite double backcross populations. J Anim Sci. 80: 23162324.
  • 591
    Ikeobi, C. O., Woolliams, J. A., Morrice, D. R., et al (2002) Quantitative trait loci affecting fatness in the chicken. Anim Genet. 33: 428435.
  • 592
    Tuiskula-Haavisto, M., Honkatukia, M., Vilkki, J., de Koning, D. J., Schulman, N. F., Maki-Tanila, A. (2002) Mapping of quantitative trait loci affecting quality and production traits in egg layers. Poult Sci. 81: 919927.
  • 593
    Sasaki, O., Odawara, S., Takahashi, H., et al (2004) Genetic mapping of quantitative trait loci affecting body weight, egg character and egg production in F2 intercross chickens. Anim Genet. 35: 188194.
  • 594
    Jennen, D. G., Vereijken, A. L., Bovenhuis, H., Crooijmans, R. M., van der Poel, J. J., Groenen, MA. (2005) Confirmation of quantitative trait loci affecting fatness in chickens. Genet Sel Evol. 37: 215228.
  • 595
    Jennen, D. G., Vereijken, A. L., Bovenhuis, H., et al (2004) Detection and localization of quantitative trait loci affecting fatness in broilers. Poult Sci. 83: 295301.
  • 596
    Hansen, C., Yi, N., Zhang, Y. M., Xu, S., Gavora, J., Cheng, HH. (2005) Identification of QTL for production traits in chickens. Anim Biotechnol. 16: 6779.
  • 597
    Yi, N., Diament, A., Chiu, S., et al (2004) Characterization of epistasis influencing complex spontaneous obesity in the BSB model. Genetics 167: 399409.
  • 598
    Harper, J. M., Galecki, A. T., Burke, D. T., Pinkosky, S. L., Miller, RA. (2003) Quantitative trait loci for insulin-like growth factor I, leptin, thyroxine, and corticosterone in genetically heterogeneous mice. Physiol Genomics 15: 4451.
  • 599
    Dragani, T. A., Zeng, Z. B., Canzian, F., et al (1995) Mapping of body weight loci on mouse chromosome X. Mamm Genome. 6: 778781.
  • 600
    Diament, A. L., Farahani, P., Chiu, S., Fisler, J., Warden, CH. (2004) A novel mouse Chromosome 2 congenic strain with obesity phenotypes. Mamm Genome. 15: 452459.
  • 601
    Yi, N., Chiu, S., Allison, D. B., Fisler, J. S., Warden, CH. (2004) Epistatic interaction between two nonstructural loci on chromosomes 7 and 3 influences hepatic lipase activity in BSB mice. J Lipid Res. 45: 20632070.
  • 602
    Warden, C. H., Fisler, J. S., Pace, M. J., Svenson, K. L., Lusis, AJ. (1993) Coincidence of genetic loci for plasma cholesterol levels and obesity in a multifactorial mouse model. J Clin Invest. 92: 773779.
  • 603
    Warden, C. H., Fisler, J. S., Shoemaker, S. M., et al (1995) Identification of four chromosomal loci determining obesity in a multifactorial mouse model. J Clin Invest. 95: 15451552.
  • 604
    Liu, X., Oliver, F., Brown, S. D., Denny, P., Keightley, PD. (2001) High-resolution quantitative trait locus mapping for body weight in mice by recombinant progeny testing. Genet Res. 77: 191197.
  • 605
    Liu, X., Bunger, L., Keightley, PD. (2001) Characterization of a major X-linked quantitative trait locus influencing body weight of mice. J Hered. 92: 355357.
  • 606
    Oliver, F., Christians, J. K., Liu, X., et al (2005) Regulatory variation at glypican-3 underlies a major growth QTL in mice. PLoS Biol. 3: e135
  • 607
    Ishikawa, A., Matsuda, Y., Namikawa, T. (2000) Detection of quantitative trait loci for body weight at 10 weeks from Philippine wild mice. Mamm Genome. 11: 824830.
  • 608
    Ishikawa, A., Namikawa, T. (2004) Mapping major quantitative trait loci for postnatal growth in an intersubspecific backcross between C57BL/6J and Philippine wild mice by using principal component analysis. Genes Genet Syst. 79: 2739.
  • 609
    Ishikawa, A., Hatada, S., Nagamine, Y., Namikawa, T. (2005) Further mapping of quantitative trait loci for postnatal growth in an inter-sub-specific backcross of wild Mus musculus castaneus and C57BL/6J mice. Genet Res. 85: 127137.
  • 610
    Collins, A. C., Martin, I. C. A., Kirkpatrick, BW. (1993) Growth quantitative trait loci (QTL) on mouse Chromosome 10 in a Quackenbush-Swiss × C57BL/6J backcross. Mamm Genome. 4: 454458.
  • 611
    Reed, D. R., Li, X., McDaniel, A. H., et al (2003) Loci on chromosomes 2, 4, 9, and 16 for body weight, body length, and adiposity identified in a genome scan of an F2 intercross between the 129P3/J and C57BL/6ByJ mouse strains. Mamm Genome. 14: 302313.
  • 612
    Taylor, B. A., Phillips, SJ. (1996) Detection of obesity QTLs on mouse chromosomes 1 and 7 by selective DNA pooling. Genomics 34: 389398.
  • 613
    Taylor, B. A., Phillips, SJ. (1997) Obesity QTLs on mouse chromosome 2 and 17. Genomics 43: 249257.
  • 614
    West, D. B., Waguespack, J., York, B., Goudey-Lebevre, J., Price, RA. (1994) Genetics of dietary obesity in AKR/J × SWR/J mice: segregation of the trait and identification of a linked locus on chromosome 4. Mamm Genome. 5: 546552.
  • 615
    West, D. B., Goudey-Lefevre, J., York, B., Truett, GE. (1994) Dietary obesity linked to genetic loci on chromosomes 9 and 15 in a polygenic mouse model. J Clin Invest. 94: 14101416.
  • 616
    Ewart-Toland, A., Mounzih, K., Qiu, J., Chehab, FF. (1999) Effect of the genetic background on the reproduction of leptin-deficient obese mice. Endocrinology 140: 732738.
  • 617
    Warden, C. H., Stone, S., Chiu, S., et al (2004) Identification of a congenic mouse line with obesity and body length phenotypes. Mamm Genome. 15: 460471.
  • 618
    Hirayama, I., Yi, Z., Izumi, S., et al (1999) Genetic analysis of obese diabetes in the TSOD mouse. Diabetes. 48: 11831191.
  • 619
    Stoehr, J. P., Byers, J. E., Clee, S. M., et al (2004) Identification of major quantitative trait loci controlling body weight variation in ob/ob mice. Diabetes 53: 245249.
  • 620
    Ueda, H., Ikegami, H., Kawaguchi, Y., et al (1999) Genetic analysis of late-onset type 2 diabetes in a mouse model of human complex trait. Diabetes 48: 11681174.
  • 621
    Almind, K., Kulkarni, R. N., Lannon, S. M., Kahn, CR. (2003) Identification of interactive loci linked to insulin and leptin in mice with genetic insulin resistance. Diabetes 52: 15351543.
  • 622
    Ishimori, N., Li, R., Kelmenson, P. M., et al (2004) Quantitative trait loci that determine plasma lipids and obesity in C57BL/6J and 129S1/SvImJ inbred mice. J Lipid Res. 45: 16241632.
  • 623
    Almind, K., Kahn, CR. (2004) Genetic determinants of energy expenditure and insulin resistance in diet-induced obesity in mice. Diabetes 53: 32743285.
  • 624
    Zhang, S., Gershenfeld, HK. (2003) Genetic contributions to body weight in mice: relationship of exploratory behavior to weight. Obes Res. 11: 828838.
  • 625
    Singer, J. B., Hill, A. E., Burrage, L. C., et al (2004) Genetic dissection of complex traits with chromosome substitution strains of mice. Science 304: 445448.
  • 626
    Mehrabian, M., Wen, P., Fisler, J., Davis, R., Lusis, A. (1998) Genetic loci controlling body fat, lipoprotein metabolism, and insulin levels in a multifactorial mouse model. J Clin Invest. 101: 24852496.
  • 627
    Estrada-Smith, D., Castellani, L. W., Wong, H., et al (2004) Dissection of multigenic obesity traits in congenic mouse strains. Mamm Genome. 15: 1422.
  • 628
    Smith Richards B. K., Belton, B. N., Poole, A. C., et al (2002) QTL analysis of self-selected macronutrient diet intake: fat, carbohydrate, and total kilocalories. Physiol Genomics. 11: 205217.
  • 629
    Keightley, P. D., Hardge, T., May, L., Bulfield, G. (1996) A genetic map of quantitative trait loci for body weight in the mouse. Genetics 142: 227235.
  • 630
    Keightley, P. D., Morris, K. H., Ishikawa, A., Falconer, V. M., Oliver, F. (1998) Test of candidate gene-quantitative trait locus association applied to fatness in mice. Heredity 81: 630637.
  • 631
    Suto, J., Matsuura, S., Imamura, K., Yamanaka, H., Sekikawa, K. (1998) Genetics of obesity in KK mouse and effects of A(y) allele on quantitative regulation. Mamm Genome. 9: 506510.
  • 632
    Suto, J., Sekikawa, K. (2004) Confirmation and characterization of murine body weight QTLs, Bwq1 and Bwq2, identified in C57BL/6J × KK-Ay/a F2-Ay/a mice. J Vet Med Sci. 66: 10391045.
  • 633
    Taylor, B. A., Tarantino, L. M., Phillips, SJ. (1999) Gender-influenced obesity QTLs identified in a cross involving the KK type II diabetes-prone mouse strain. Mamm Genome. 10: 963968.
  • 634
    Nezer, C., Moreau, L., Brouwers, B., et al (1999) An imprinted QTL with major effect on muscle mass and fat deposition maps to the IGF2 locus in pigs. Nat Genet. 21: 155156.
  • 635
    Corva, P. M., Horvat, S., Medrano, JF. (2001) Quantitative trait loci affecting growth in high growth (hg) mice. Mamm Genome. 12: 284290.
  • 636
    Wu, R., Ma, C. X., Hou, W., Corva, P., Medrano, JF. (2005) Functional mapping of quantitative trait loci that interact with the hg mutation to regulate growth trajectories in mice. Genetics 171: 239249.
  • 637
    Collin, G. B., Maddatu, T. P., Sen, S., Naggert, JK. (2005) Genetic modifiers interact with Cpefat to affect body weight, adiposity, and hyperglycemia. Physiol Genomics 22: 182190.
  • 638
    York, B., Lei, K., West, DB. (1996) Sensitivity to dietary obesity linked to a locus on chromosome 15 in a CAST/Ei × C57B1/6J F2 intercross. Mamm Genome. 7: 677681.
  • 639
    Rance, K. A., Hill, W. G., Keightley, PD. (1997) Mapping quantitative trait loci for body weight on the X chromosome in mice: I. Analysis of a reciprocal F2 population. Genet Res. 70: 117124.
  • 640
    Mantey, C., Brockmann, G. A., Kalm, E., Reinsch, N. (2005) Mapping and exclusion mapping of genomic imprinting effects in mouse F2 families. J Hered. 96: 329338.
  • 641
    Carlborg, O., Brockmann, G. A., Haley, CS. (2005) Simultaneous mapping of epistatic QTL in DU6i × DBA/2 mice. Mamm Genome. 16: 481494.
  • 642
    Brockmann, G. A., Kratzsch, J., Haley, C. S., Renne, U., Schwerin, M., Karle, S. (2000) Single QTL effects, epistasis, and pleiotropy account for two-thirds of the phenotypic F(2) variance of growth and obesity in DU6i × DBA/2 mice. Genome Res. 10: 19411957.
  • 643
    Brockmann, G. A., Haley, C. S., Renne, U., Knott, S. A., Schwerin, M. (1998) Quantitative trait loci affecting body weight and fatness from a mouse line selected for extreme high growth. Genetics. 150: 369381.
  • 644
    Horvat, S., Bunger, L., Falconer, V. M., et al (2000) Mapping of obesity QTLs in a cross between mouse lines divergently selected on fat content. Mamm Genome. 11: 27.
  • 645
    Stylianou, I. M., Christians, J. K., Keightley, P. D., et al (2004) Genetic complexity of an obesity QTL (Fob3) revealed by detailed genetic mapping. Mamm Genome. 15: 472481.
  • 646
    Stylianou, I. M., Clinton, M., Keightley, P. D., et al (2005) Microarray gene expression analysis of the Fob3b obesity QTL identifies positional candidate gene Sqle and perturbed cholesterol and glycolysis pathways. Physiol Genomics. 20: 224232.
  • 647
    Allan, M. F., Eisen, E. J., Pomp, D. (2005) Genomic mapping of direct and correlated responses to long-term selection for rapid growth rate in mice. Genetics. 170: 18631877.
  • 648
    Bennett, B., Carosone-Link, P. J., Lu, L., Chesler, E. J., Johnson, TE. (2005) Genetics of body weight in the LXS recombinant inbred mouse strains. Mamm Genome. 16: 764774.
  • 649
    Shike, T., Hirose, S., Kobayashi, M., Funabiki, K., Shirai, T., Tomino, Y. (2001) Susceptibility and negative epistatic loci contributing to type 2 diabetes and related phenotypes in a KK/Ta mouse model. Diabetes. 50: 19431948.
  • 650
    Gohda, T., Makita, Y., Shike, T., et al (2003) Identification of epistatic interaction involved in obesity using the KK/Ta mouse as a type 2 diabetes model: is Zn-alpha2 glycoprotein-1 a candidate gene for obesity? Diabetes. 52: 21752181.
  • 651
    Vaughn, T. T., Pletscher, L. S., Peripato, A., et al (1999) Mapping quantitative trait loci for murine growth: a closer look at genetic architecture. Genet Res. 74: 313322.
  • 652
    Cheverud, J. M., Routman, E. J., Duarte, F. A., van Swinderen, B., Cothran, K., Perel, C. (1996) Quantitative trait loci for murine growth. Genetics. 142: 13051319.
  • 653
    Cheverud, J. M., Vaughn, T. T., Pletscher, L. S., et al (2001) Genetic architecture of adiposity in the cross of LG/J and SM/J inbred mice. Mamm Genome. 12: 312.
  • 654
    Cheverud, J. M., Ehrich, T. H., Hrbek, T., Kenney, J. P., Pletscher, L. S., Semenkovich, CF. (2004) Quantitative trait loci for obesity- and diabetes-related traits and their dietary responses to high-fat feeding in LGXSM recombinant inbred mouse strains. Diabetes 53: 33283336.
  • 655
    Rocha, J. L., Eisen, E. J., Van Vleck, L. D., Pomp, D. (2004) A large-sample QTL study in mice: II. Body composition. Mamm Genome. 15: 100113.
  • 656
    Jerez-Timaure, N. C., Kearney, F., Simpson, E. B., Eisen, E. J., Pomp, D. (2004) Characterization of QTL with major effects on fatness and growth on mouse chromosome 2. Obes Res. 12: 14081420.
  • 657
    Jerez-Timaure, N. C., Eisen, E. J., Pomp, D. (2005) Fine mapping of a QTL region with large effects on growth and fatness on mouse chromosome 2. Physiol Genomics 21: 411422.
  • 658
    Rocha, J. L., Eisen, E. J., Van Vleck, L. D., Pomp, D. (2004) A large-sample QTL study in mice: I. Growth. Mamm Genome. 15: 8399.
  • 659
    Moody, D. E., Pomp, D., Nielsen, M. K., Van Vleck, LD. (1999) Identification of quantitative trait loci influencing traits related to energy balance in selection and inbred lines of mice. Genetics 152: 699711.
  • 660
    Rance, K. A., Fustin, J. M., Dalgleish, G., Hambly, C., Bunger, L., Speakman, J.R. (2005) A paternally imprinted QTL for mature body mass on mouse chromosome 8. Mamm Genome. 16: 567577.
  • 661
    Reifsnyder, P. C., Churchill, G., Leiter, EH. (2000) Maternal environment and genotype interact to establish diabesity in mice. Genome Res. 10: 15681578.
  • 662
    Lembertas, A. V., Perusse, L., Chagnon, Y. C., et al (1997) Identification of an obesity quantitative trait locus on mouse chromosome 2 and evidence of linkage to body fat and insulin on the human homologous region 20q. J Clin Invest. 100: 12401247.
  • 663
    Kluge, R., Giesen, K., Bahrenberg, G., Plum, L., Ortlepp, J. R., Joost, HG. (2000) Quantitative trait loci for obesity and insulin resistance (Nob1, Nob2) and their interaction with the leptin receptor allele (LeprA720T/T1044I) in New Zealand obese mice. Diabetologia 43: 15651572.
  • 664
    Plum, L., Giesen, K., Kluge, R., et al (2002) Characterisation of the mouse diabetes susceptibility locus Nidd/SJL: islet cell destruction, interaction with the obesity QTL Nob1, and effect of dietary fat. Diabetologia 45: 823830.
  • 665
    Giesen, K., Plum, L., Kluge, R., Ortlepp, J., Joost, HG. (2003) Diet-dependent obesity and hypercholesterolemia in the New Zealand obese mouse: identification of a quantitative trait locus for elevated serum cholesterol on the distal mouse chromosome 5. Biochem Biophys Res Commun. 304: 812817.
  • 666
    Anunciado, R. V., Nishimura, M., Mori, M., et al (2001) Quantitative trait loci for body weight in the intercross between SM/J and A/J mice. Exp Anim. 50: 319324.
  • 667
    Taylor, B. A., Wnek, C., Schroeder, D., Phillips, SJ. (2001) Multiple obesity QTLs identified in an intercross between the NZO (New Zealand obese) and the SM (small) mouse strains. Mamm Genome. 12: 95103.
  • 668
    Kim, J. H., Sen, S., Avery, C. S., et al (2001) Genetic analysis of a new mouse model for non-insulin-dependent diabetes. Genomics 74: 273286.
  • 669
    Kim, K. S., Thomsen, H., Bastiaansen, J., et al (2004) Investigation of obesity candidate genes on porcine fat deposition quantitative trait loci regions. Obes Res. 12: 19811994.
  • 670
    Johnson, P. L., McEwan, J. C., Dodds, K. G., Purchas, R. W., Blair, HT. (2005) A directed search in the region of GDF8 for quantitative trait loci affecting carcass traits in Texel sheep. J Anim Sci. 83: 19882000.
  • 671
    Watanabe, T., Okuno, S., Oga, K., et al (1999) Genetic dissection of “OLETF,” a rat model for non-insulin-dependent diabetes mellitus: quantitative trait locus analysis of (OLETF × BN) × OLETF. Genomics 58: 233239.
  • 672
    Wallis, R. H., Wallace, K. J., Collins, S. C., et al (2004) Enhanced insulin secretion and cholesterol metabolism in congenic strains of the spontaneously diabetic (Type 2) Goto Kakizaki rat are controlled by independent genetic loci in rat chromosome 8. Diabetologia 47: 10961106.
  • 673
    Kato, N., Hyne, G., Bihoreau, M. T., Gauguier, D., Lathrop, G. M., Rapp, JP. (1999) Complete genome searches for quantitative trait loci controlling blood pressure and related traits in four segregating populations derived from Dahl hypertensive rats. Mamm Genome. 10: 259265.
  • 674
    Ogino, T., Moralejo, D. H., Kose, H., Yamada, T., Matsumoto, K. (2003) Serum leptin concentration is linked to chromosomes 2 and 6 in the OLETF rat, an animal model of type 2 diabetes with mild obesity. Mamm Genome. 14: 839844.
  • 675
    Gauguier, D., Froguel, P., Parent, V., et al (1996) Chromosomal mapping of genetic loci associated with non-insulin dependent diabetes in the GK rat. Nat Genet. 12: 3843.
  • 676
    Galli, J., Li, L. S., Glaser, A., et al (1996) Genetic analysis of non-insulin dependent diabetes mellitus in the GK rat. Nat Genet. 12: 3137.
  • 677
    Chung, W. K., Zheng, M., Chua, M., et al (1997) Genetic modifiers of Leprfa associated with variability in insulin production and susceptibility to NIDDM. Genomics. 41: 332344.
  • 678
    Kanemoto, N., Hishigaki, H., Miyakita, A., et al (1998) Genetic dissection of “OLETF,” a rat model for non-insulin-dependent diabetes mellitus. Mamm Genome. 9: 419425.
  • 679
    Muramatsu, Y., Yamada, T., Taniguchi, Y., et al (2005) Pnlip encoding pancreatic lipase is possible candidate for obesity QTL in the OLETF rat. Biochem Biophys Res Commun. 331: 12701276.
  • 680
    Akhi, M., Kose, H., Matsumoto, K. (2005) Fine mapping of the hyperglycemic and obesity QTL by congenic strains suggests multiple loci on rat chromosome 14. J Med Invest. 52: 109113.
  • 681
    Kovacs, P., Kloting, I. (1998) Mapping of quantitative trait loci for body weight on chromosomes 1 and 4 in the rat. Biochem Mol Biol Int. 44: 399405.
  • 682
    Kloting, I., Kovacs, P., van den Brandt, J. (2001) Quantitative trait loci for body weight, blood pressure, blood glucose, and serum lipids: linkage analysis with wild rats (Rattus norvegicus). Biochem Biophys Res Commun. 284: 11261133.
  • 683
    Kloting, I., Kovacs, P., van den Brandt, J. (2001) Sex-specific and sex-independent quantitative trait loci for facets of the metabolic syndrome in WOKW rats. Biochem Biophys Res Commun. 284: 150156.
  • 684
    Malek, M., Dekkers, J. C., Lee, H. K., et al (2001) A molecular genome scan analysis to identify chromosomal regions influencing economic traits in the pig: II. Meat and muscle composition. Mamm Genome. 12: 637645.
  • 685
    Stearns, T. M., Beever, J. E., Southey, B. R., Ellis, M., McKeith, F. K., Rodriguez-Zas, SL. (2005) Evaluation of approaches to detect quantitative trait loci for growth, carcass, and meat quality on swine chromosomes 2, 6, 13, and 18: I. Univariate outbred F2 and sib-pair analyses. J Anim Sci. 83: 14811493.
  • 686
    Wang, L., Yu, T. P., Tuggle, C. K., Liu, H. C., Rothschild, MF. (1998) A directed search for quantitative trait loci on chromosomes 4 and 7 in pigs. J Anim Sci. 76: 25602567.
  • 687
    Rothschild, M. F., Liu, H. C., Tuggle, C. K., Yu, T. P., Wang, L. (1995) Analysis of pig chromosome 7 genetic markers for growth and carcass performance traits. J Animal Breed Genet. 112: 341348.
  • 688
    Marklund, L., Nystrom, P. E., Stern, S., Andersson-Eklund, L., Andersson, L. (1999) Confirmed quantitative trait loci for fatness and growth on pig chromosome 4. Heredity 82: 134141.
  • 689
    Knott, S. A., Marklund, L., Haley, C. S., et al (1998) Multiple marker mapping of quantitative trait loci in a cross between outbred wild boar and large white pigs. Genetics 149: 10691080.
  • 690
    Anderson, L., Haley, C. S., Ellegren, H., et al (1994) Genetic mapping of quantitative trait loci for growth and fatness in pigs. Science 263: 17711774.
  • 691
    Perez-Enciso, M., Clop, A., Noguera, J. L., et al (2000) A QTL on pig chromosome 4 affects fatty acid metabolism: evidence from an Iberian by Landrace intercross. J Anim Sci. 78: 25252531.
  • 692
    Mercade, A., Estelle, J., Noguera, J. L., et al (2005) On growth, fatness, and form: a further look at porcine chromosome 4 in an Iberian × Landrace cross. Mamm Genome. 16: 374382.
  • 693
    Ovilo, C., Fernandez, A., Noguera, J. L., et al (2005) Fine mapping of porcine chromosome 6 QTL and LEPR effects on body composition in multiple generations of an Iberian by Landrace intercross. Genet Res. 85: 5767.
  • 694
    Rattink, A. P., de Koning, D. J., Faivre, M., Harlizius, B., van Arendonk, J. A., Groenen, MA. (2000) Fine mapping and imprinting analysis for fatness trait QTLs in pigs. Mamm Genome. 11: 656661.
  • 695
    de Koning, D. J., Janss, L. L., Rattink, A. P., et al (1999) Detection of quantitative trait loci for backfat thickness and intramuscular fat content in pigs (Sus scrofa). Genetics 152: 16791690.
  • 696
    Sato, S., Oyamada, Y., Atsuji, K., et al (2003) Quantitative trait loci analysis for growth and carcass traits in a Meishan × Duroc F2 resource population. J Anim Sci. 81: 29382949.
  • 697
    Harlizius, B., Rattink, A., Faivre, M., et al (2000) The X Chromosome harbors quantitative trait loci for backfat thickness and intramuscular fat content in pigs. Mamm Genome. 11: 800802.
  • 698
    Wada, Y., Akita, T., Awata, T., et al (2000) Quantitative trait loci (QTL) analysis in a Meishan × Gottingen cross population. Anim Genet. 31: 376384.
  • 699
    Walling, G. A., Archibald, A. L., Cattermole, J. A., et al (1998) Mapping of quantitative trait loci on porcine chromosome 4. Anim Genet. 29: 415424.
  • 700
    Perez-Enciso, M., Mercade, A., Bidanel, J. P., et al (2005) Large-scale, multibreed, multitrait analyses of quantitative trait loci experiments: the case of porcine X chromosome. J Anim Sci. 83: 22892296.
  • 701
    Bidanel, J. P., Milan, D., Iannuccelli, N., et al (2001) Detection of quantitative trait loci for growth and fatness in pigs. Genet Sel Evol. 33: 289309.
  • 702
    Rohrer, GA. (2000) Identification of quantitative trait loci affecting birth characters and accumulation of backfat and weight in a Meishan-White Composite resource population. J Anim Sci. 78: 25472553.
  • 703
    Rohrer, G. A., Keele, JW. (1998) Identification of quantitative trait loci affecting carcass composition in swine: I. Fat deposition traits. J Anim Sci. 76: 22472254.
  • 704
    Yu, T-PW, Tuggle, C. K., Rothschild, MF. (1999) Mapping genes for fatness and growth on pig chromosome 13; a search in the region close to the pig PIT1 gene. J Am Breed Genet. 116: 269280.
  • 705
    Jeon, J. T., Carlborg, O., Tornsten, A., et al (1999) A paternally expressed QTL affecting skeletal and cardiac muscle mass in pigs maps to the IGF2 locus. Nat Genet. 21: 157158.
  • 706
    Dhar, M., Webb, L. S., Smith, L., Hauser, L., Johnson, D., West, DB. (2000) A novel ATPase on mouse chromosome 7 is a candidate gene for increased body fat. Physiol Genomics. 4: 93100.
  • 707
    Tuiskula-Haavisto, M., de Koning, D. J., Honkatukia, M., Schulman, N. F., Maki-Tanila, A., Vilkki, J. (2004) Quantitative trait loci with parent-of-origin effects in chicken. Genet Res. 84: 5766.
  • 708
    Hani, E. H., Clement, K., Velho, G., et al (1997) Genetic studies of the sulfonylurea receptor gene locus in NIDDM and in morbid obesity among French Caucasians. Diabetes 46: 688694.
  • 709
    Gylling, H., Hallikainen, M., Pihlajamaki, J., et al (2004) Polymorphisms in the ABCG5 and ABCG8 genes associate with cholesterol absorption and insulin sensitivity. J Lipid Res. 45: 16601665.
  • 710
    Katzov, H., Bennet, A. M., Kehoe, P., et al (2004) A cladistic model of ACE sequence variation with implications for myocardial infarction, Alzheimer disease and obesity. Hum Mol Genet. 13: 26472657.
  • 711
    Kramer, H., Wu, X., Kan, D., et al (2005) Angiotensin-converting enzyme gene polymorphisms and obesity: an examination of three black populations. Obes Res. 13: 823828.
  • 712
    Kritchevsky, S. B., Nicklas, B. J., Visser, M., et al (2005) Angiotensin-converting enzyme insertion/deletion genotype, exercise, and physical decline. JAMA 294: 691698.
  • 713
    Strazzullo, P., Iacone, R., Iacoviello, L., et al (2003) Genetic variation in the renin-angiotensin system and abdominal adiposity in men: the Olivetti Prospective Heart Study. Ann Intern Med. 138: 1723.
  • 714
    Wang, J. G., He, X., Wang, G. L., et al (2004) Family-based associations between the angiotensin- converting enzyme insertion/deletion polymorphism and multiple cardiovascular risk factors in Chinese. J Hypertens. 22: 487491.
  • 715
    Lucarini, N., Finocchi, G., Gloria-Bottini, F., et al (1990) A possible genetic component of obesity in childhood: observations on acid phosphatase polymorphism. Experientia. 46: 9091.
  • 716
    Lucarini, N., Antonacci, E., Bottini, N., Gloria-Bottini, F. (1997) Low-molecular-weight acid phosphatase (ACP1), obesity, and blood lipid levels in subjects with non-insulin-dependent diabetes mellitus. Hum Biol. 69: 509515.
  • 717
    Bottini, E., Gloria-Bottini, F. (1999) Adenosine deaminase and body mass index in non-insulin-dependent diabetes mellitus. Metabolism 48: 949951.
  • 718
    Nakatani, K., Noma, K., Nishioka, J., et al (2005) Adiponectin gene variation associates with the increasing risk of type 2 diabetes in non-diabetic Japanese subjects. Int J Mol Med. 15: 173177.
  • 719
    Sutton, B. S., Weinert, S., Langefeld, C. D., et al (2005) Genetic analysis of adiponectin and obesity in Hispanic families: the IRAS Family Study. Hum Genet. 117: 107118.
  • 720
    Xita, N., Georgiou, I., Chatzikyriakidou, A., et al (2005) Effect of adiponectin gene polymorphisms on circulating adiponectin and insulin resistance indexes in women with polycystic ovary syndrome. Clin Chem. 51: 416423.
  • 721
    Zacharova, J., Chiasson, J. L., Laakso, M. (2005) The common polymorphisms (single nucleotide polymorphism [SNP] +45 and SNP +276) of the adiponectin gene predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial. Diabetes 54: 893899.
  • 722
    Fumeron, F., Aubert, R., Siddiq, A., et al (2004) Adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period: the epidemiologic data on the insulin resistance syndrome prospective study. Diabetes 53: 11501157.
  • 723
    Gu, H. F., Abulaiti, A., Ostenson, C. G., et al (2004) Single nucleotide polymorphisms in the proximal promoter region of the adiponectin (APM1) gene are associated with type 2 diabetes in Swedish Caucasians. Diabetes 53(Suppl 1): S31S35.
  • 724
    Hu, F. B., Doria, A., Li, T., et al (2004) Genetic variation at the adiponectin locus and risk of type 2 diabetes in women. Diabetes 53: 209213.
  • 725
    Menzaghi, C., Ercolino, T., Di Paola, R., et al (2002) A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 51: 23062312.
  • 726
    Stumvoll, M., Tschritter, O., Fritsche, A., et al (2002) Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes. Diabetes 51: 3741.
  • 727
    Ukkola, O., Ravussin, E., Jacobson, P., Sjöström, L., Bouchard, C. (2003) Mutations in the adiponectin gene in lean and obese subjects from the Swedish obese subjects cohort. Metabolism 52: 881884.
  • 728
    Yang, W. S., Tsou, P. L., Lee, W. J., et al (2003) Allele-specific differential expression of a common adiponectin gene polymorphism related to obesity. J Mol Med. 81: 428434.
  • 729
    Garenc, C., Perusse, L., Chagnon, Y. C., et al (2002) The alpha 2-adrenergic receptor gene and body fat content and distribution: the HERITAGE Family Study. Mol Med. 8: 8894.
  • 730
    Oppert, J. M., Tourville, J., Chagnon, M., et al (1995) DNA polymorphisms in alpha 2- and beta 2-adrenoceptor genes and regional fat distribution in humans: association and linkage studies. Obes Res. 3: 249255.
  • 731
    Ukkola, O., Rankinen, T., Weisnagel, S. J., et al (2000) Interactions among the alpha2-, beta2-, and beta3-adrenergic receptor genes and obesity-related phenotypes in the Quebec Family Study. Metabolism 49: 10631070.
  • 732
    Wang, Y. C., Bai, Y. M., Chen, J. Y., Lin, C. C., Lai, I. C., Liou, YJ. (2005) Polymorphism of the adrenergic receptor alpha 2a −1291C>G genetic variation and clozapine-induced weight gain. J Neural Transm. 112: 14631468.
  • 733
    Heinonen, P., Koulu, M., Pesonen, U., et al (1999) Identification of a three-amino acid deletion in the alpha2B-adrenergic receptor that is associated with reduced basal metabolic rate in obese subjects. J Clin Endocrinol Metab. 84: 24292433.
  • 734
    Sivenius, K., Lindi, V., Niskanen, L., Laakso, M., Uusitupa, M. (2001) Effect of a three-amino acid deletion in the alpha2B-adrenergic receptor gene on long-term body weight change in Finnish non-diabetic and type 2 diabetic subjects. Int J Obes Relat Metab Disord. 25: 16091614.
  • 735
    Dionne, I. J., Garant, M. J., Nolan, A. A., et al (2002) Association between obesity and a polymorphism in the beta(1)-adrenoceptor gene (Gly389Arg ADRB1) in Caucasian women. Int J Obes Relat Metab Disord. 26: 633639.
  • 736
    Linne, Y., Dahlman, I., Hoffstedt, J. (2005) Beta1-Adrenoceptor gene polymorphism predicts long-term changes in body weight. Int J Obes (Lond). 29: 458462.
  • 737
    Corbalan, M. S., Marti, A., Forga, L., Martinez-Gonzalez, M. A., Martinez, JA. (2002) Beta(2)-adrenergic receptor mutation and abdominal obesity risk: effect modification by gender and HDL-cholesterol. Eur J Nutr. 41: 114118.
  • 738
    Ehrenborg, E., Skogsberg, J., Ruotolo, G., et al (2000) The Q/E27 polymorphism in the beta2-adrenoceptor gene is associated with increased body weight and dyslipoproteinaemia involving triglyceride-rich lipoproteins. J Intern Med. 247: 651656.
  • 739
    Ellsworth, D. L., Coady, S. A., Chen, W., et al (2002) Influence of the beta2-adrenergic receptor Arg16Gly polymorphism on longitudinal changes in obesity from childhood through young adulthood in a biracial cohort: the Bogalusa Heart Study. Int J Obes Relat Metab Disord. 26: 928937.
  • 740
    Eriksson, P., Dahlman, I., Ryden, M., Hoffstedt, J., Arner, P. (2004) Relationship between beta-2 adrenoceptor gene haplotypes and adipocyte lipolysis in women. Int J Obes Relat Metab Disord. 28: 185190.
  • 741
    Garenc, C., Perusse, L., Chagnon, Y. C., et al (2003) Effects of beta2-adrenergic receptor gene variants on adiposity: the HERITAGE Family Study. Obes Res. 11: 612618.
  • 742
    Hoffstedt, J., Iliadou, A., Pedersen, N. L., Schalling, M., Arner, P. (2001) The effect of the beta(2) adrenoceptor gene Thr164Ile polymorphism on human adipose tissue lipolytic function. Br J Pharmacol. 133: 708712.
  • 743
    Ishiyama-Shigemoto, S., Yamada, K., Yuan, X., Ichikawa, F., Nonaka, K. (1999) Association of polymorphisms in the beta 2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus. Diabetologia 42: 98101.
  • 744
    Lange, L. A., Norris, J. M., Langefeld, C. D., et al (2005) Association of adipose tissue deposition and beta-2 adrenergic receptor variants: the IRAS family study. Int J Obes (Lond). 29: 449457.
  • 745
    Large, V., Hellstrom, L., Reynisdottir, S., et al (1997) Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function. J Clin Invest. 100: 30053013.
  • 746
    Meirhaeghe, A., Helbecque, N., Cottel, D., Amouyel, P. (2000) Impact of polymorphisms of the human beta2-adrenoceptor gene on obesity in a French population. Int J Obes Relat Metab Disord. 24: 382387.
  • 747
    Meirhaeghe, A., Luan, J., Selberg-Franks, P., et al (2001) The effect of the Gly16Arg polymorphism of the beta(2)-adrenergic receptor gene on plasma free fatty acid levels is modulated by physical activity. J Clin Endocrinol Metab. 86: 58815887.
  • 748
    Meirhaeghe, A., Helbecque, N., Cottel, D., Amouyel, P. (1999) Beta2-adrenoceptor gene polymorphism, body weight, and physical activity. Lancet 353: 896
  • 749
    Moore, G. E., Shuldiner, A. R., Zmuda, J. M., Ferrell, R. E., McCole, S. D., Hagberg, JM. (2001) Obesity gene variant and elite endurance performance. Metabolism 50: 13911392.
  • 750
    Mori, Y., Kim-Motoyama, H., Ito, Y., et al (1999) The Gln27Glu beta2-adrenergic receptor variant is associated with obesity due to subcutaneous fat accumulation in Japanese men. Biochem Biophys Res Commun. 258: 138140.
  • 751
    Pereira, A. C., Floriano, M. S., Mota, G. F., et al (2003) Beta2 adrenoceptor functional gene variants, obesity, and blood pressure level interactions in the general population. Hypertension 42: 685692.
  • 752
    Rosmond, R., Ukkola, O., Chagnon, M., Bouchard, C., Björntorp, P. (2000) Polymorphisms of the beta2-adrenergic receptor gene (ADRB2) in relation to cardiovascular risk factors in men. J Intern Med. 248: 239244.
  • 753
    Ukkola, O., Tremblay, A., Bouchard, C. (2001) Beta-2 adrenergic receptor variants are associated with subcutaneous fat accumulation in response to long-term overfeeding. Int J Obes Relat Metab Disord. 25: 16041608.
  • 754
    van Rossum, C. T., Hoebee, B., Seidell, J. C., et al (2002) Genetic factors as predictors of weight gain in young adult Dutch men and women. Int J Obes Relat Metab Disord. 26: 517528.
  • 755
    Yamada, K., Ishiyama-Shigemoto, S., Ichikawa, F., et al (1999) Polymorphism in the 5′-leader cistron of the beta2-adrenergic receptor gene associated with obesity and type 2 diabetes. J Clin Endocrinol Metab. 84: 17541757.
  • 756
    Clement, K., Vaisse, C., Manning, B. S. J., et al (1995) Genetic variation in the B3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med. 333: 352354.
  • 757
    Corbalan, M. S., Marti, A., Forga, L., Martinez-Gonzalez, M. A., Martinez, JA. (2002) The risk of obesity and the Trp64Arg polymorphism of the beta(3)-adrenergic receptor: effect modification by age. Ann Nutr Metab. 46: 152158.
  • 758
    Corella, D., Guillen, M., Portoles, O., et al (2001) Gender specific associations of the Trp64Arg mutation in the beta3-adrenergic receptor gene with obesity-related phenotypes in a Mediterranean population: interaction with a common lipoprotein lipase gene variation. J Intern Med. 250: 348360.
  • 759
    Endo, K., Yanagi, H., Hirano, C., Hamaguchi, H., Tsuchiya, S., Tomura, S. (2000) Association of Trp64Arg polymorphism of the beta3-adrenergic receptor gene and no association of Gln223Arg polymorphism of the leptin receptor gene in Japanese schoolchildren with obesity. Int J Obes Relat Metab Disord. 24: 443449.
  • 760
    Festa, A., Krugluger, W., Shnawa, N., Hopmeier, P., Haffner, S. M., Schernthaner, G. (1999) Trp64Arg polymorphism of the beta3-adrenergic receptor gene in pregnancy: association with mild gestational diabetes mellitus. J Clin Endocrinol Metab. 84: 16951699.
  • 761
    Fujisawa, T., Ikegami, H., Yamato, E., et al (1996) Association of Trp64Arg mutation of the beta 3-adrenergic-receptor with NIDDM and body weight gain. Diabetologia 39: 349352.
  • 762
    Hao, K., Peng, S., Xing, H., et al (2004) beta(3) Adrenergic receptor polymorphism and obesity-related phenotypes in hypertensive patients. Obes Res. 12: 125130.
  • 763
    Higashi, K., Ishikawa, T., Ito, T., Yonemura, A., Shige, H., Nakamura, H. (1997) Association of a genetic variation in the beta 3-adrenergic receptor gene with coronary heart disease among Japanese. Biochem Biophys Res Commun. 232: 728730.
  • 764
    Hoffstedt, J., Poirier, O., Thorne, A., et al (1999) Polymorphism of the human beta(3)-adrenoceptor gene forms a well-conserved haplotype that is associated with moderate obesity and altered receptor function. Diabetes 48: 203205.
  • 765
    Jeyasingam, C., Bryson, J., Caterson, I., Yue, D., Donnelly, R. (1997) Expression of the beta3-adrenoceptor gene polymorphism (Trp64Arg) in obese diabetic and non-diabetic subjects. Clin Exp Pharmacol Physiol. 24: 733735.
  • 766
    Kadowaki, H., Yasuda, K., Iwamoto, K., et al (1995) A mutation in the beta 3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Biochem Biophys Res Commun. 215: 555560.
  • 767
    Kim-Motoyama, H., Yasuda, K., Yamaguchi, T., et al (1997) A mutation of the beta 3-adrenergic receptor is associated with visceral obesity but decreased serum triglyceride. Diabetologia 40: 469472.
  • 768
    Marti, A., Corbalan, M. S., Martinez-Gonzalez, M. A., Martinez, JA. (2002) TRP64ARG polymorphism of the beta3-adrenergic receptor gene and obesity risk: effect modification by a sedentary lifestyle. Diabetes Obes Metab. 4: 428430.
  • 769
    Matsuoka, H., Iwama, S., Miura, N., Ikezaki, A., Sugihara, S. (2004) Impact of polymorphisms of beta2- and beta3-adrenergic receptor genes on longitudinal changes in obesity in early childhood. Acta Paediatr. 93: 430
  • 770
    McFarlane-Anderson, N., Bennett, F., Wilks, R., et al (1998) The Trp64Arg mutation of the beta(3)-adrenergic receptor is associated with hyperglycemia and current body mass index in Jamaican women. Metabolism 47: 617621.
  • 771
    Mitchell, B., Blangero, J., Comuzzie, A., et al (1998) A paired sibling analysis of the beta-3 adrenergic receptor and obesity in Mexican Americans. J Clin Invest. 101: 584587.
  • 772
    Nagase, T., Aoki, A., Yamamoto, M., et al (1997) Lack of association between the Trp64 Arg mutation in the beta 3- adrenergic receptor gene and obesity in Japanese men: a longitudinal analysis. J Clin Endocrinol Metab. 82: 12841287.
  • 773
    Nozaki, Y., Saibara, T., Nemoto, Y., et al (2004) Polymorphisms of interleukin-1beta and beta3-adrenergic receptor in Japanese patients with nonalcoholic steatohepatitis. Alcohol Clin Exp Res. 28: 10610S.
  • 774
    Oizumi, T., Daimon, M., Saitoh, T., et al (2001) Genotype Arg/Arg, but not Trp/Arg, of the Trp64Arg polymorphism of the beta(3)-adrenergic receptor is associated with type 2 diabetes and obesity in a large Japanese sample. Diabetes Care 24: 15791583.
  • 775
    Oksanen, L., Mustajoki, P., Kaprio, J., et al (1996) Polymorphism of the beta 3-adrenergic receptor gene in morbid obesity. Int J Obes Relat Metab Disord. 20: 10551061.
  • 776
    Ongphiphadhanakul, B., Rajatanavin, R., Chanprasertyothin, S., et al (1999) Relation of beta3-adrenergic receptor gene mutation to total body fat but not percent body fat and insulin levels in Thais. Metabolism 48: 564567.
  • 777
    Sakane, N., Yoshida, T., Umekawa, T., Kondo, M., Sakai, Y., Takahashi, T. (1997) Beta 3-adrenergic-receptor polymorphism: a genetic marker for visceral fat obesity and the insulin resistance syndrome. Diabetologia 40: 200204.
  • 778
    Shima, Y., Tsukada, T., Nakanishi, K., Ohta, H. (1998) Association of the Trp64Arg mutation of the beta(3)-adrenergic receptor with fatty liver and mild glucose intolerance in Japanese subjects. Clin Chim Acta. 274: 167176.
  • 779
    Strazzullo, P., Iacone, R., Siani, A., et al (2001) Relationship of the Trp64Arg polymorphism of the beta3-adrenoceptor gene to central adiposity and high blood pressure: interaction with age. Cross-sectional and longitudinal findings of the Olivetti Prospective Heart Study. J Hypertens. 19: 399406.
  • 780
    Thomas, G. N., Tomlinson, B., Chan, J. C., Young, R. P., Critchley, JA. (2000) The Trp64Arg polymorphism of the beta3-adrenergic receptor gene and obesity in Chinese subjects with components of the metabolic syndrome. Int J Obes Relat Metab Disord. 24: 545551.
  • 781
    Urhammer, S. A., Clausen, J. O., Hansen, T., Pedersen, O. (1996) Insulin sensitivity and body weight changes in young white carriers of the codon 64 amino acid polymorphism of the Beta 3-adrenergic receptor gene. Diabetes 45: 11151120.
  • 782
    Widen, E., Lehto, M., Kannine, T., Walston, J., Shuldiner, A. R., Groop, LC. (1995) Association of a polymorphism in the beta 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med. 333: 348351.
  • 783
    Xinli, W., Xiaomei, T., Meihua, P., Song, L. (2001) Association of a mutation in the beta3-adrenergic receptor gene with obesity and response to dietary intervention in Chinese children. Acta Paediatr. 90: 12331237.
  • 784
    Argyropoulos, G., Rankinen, T., Neufeld, D. R., et al (2002) A polymorphism in the human agouti-related protein is associated with late-onset obesity. J Clin Endocrinol Metab. 87: 41984202.
  • 785
    Argyropoulos, G., Rankinen, T., Bai, F., et al (2003) The agouti-related protein and body fatness in humans. Int J Obes Relat Metab Disord. 27: 276280.
  • 786
    Marks, D. L., Boucher, N., Lanouette, C. M., et al (2004) Ala67Thr polymorphism in the Agouti-related peptide gene is associated with inherited leanness in humans. Am J Med Genet. 126A: 267271.
  • 787
    Chaves, F. J., Giner, V., Corella, D., et al (2002) Body weight changes and the A-6G polymorphism of the angiotensinogen gene. Int J Obes Relat Metab Disord. 26: 11731178.
  • 788
    Hegele, R. A., Brunt, J. H., Connelly, PW. (1995) Genetic variation on chromosome 1 associated with variation in body fat distribution in men. Circulation 92: 10891093.
  • 789
    Prat-Larquemin, L., Oppert, J. M., Clement, K., et al (2004) Adipose angiotensinogen secretion, blood pressure, and AGT M235T polymorphism in obese patients. Obes Res. 12: 556561.
  • 790
    Rankinen, T., Gagnon, J., Perusse, L., et al (1999) Body fat, resting and exercise blood pressure and the angiotensinogen M235T polymorphism: the HERITAGE family study. Obes Res. 7: 423430.
  • 791
    Ma, Y. Q., Thomas, G. N., Ng, M. C., et al (2003) Association of two apolipoprotein A-I gene MspI polymorphisms with high density lipoprotein (HDL)-cholesterol levels and indices of obesity in selected healthy Chinese subjects and in patients with early-onset type 2 diabetes. Clin Endocrinol (Oxf). 59: 442449.
  • 792
    Lara-Castro, C., Hunter, G. R., Lovejoy, J. C., Gower, B. A., Fernandez, J.R. (2005) Apolipoprotein A-II polymorphism and visceral adiposity in African-American and white women. Obes Res. 13: 507512.
  • 793
    van't Hooft, F. M., Ruotolo, G., Boquist, S., de Faire, U., Eggertsen, G., Hamsten, A. (2001) Human evidence that the apolipoprotein a-II gene is implicated in visceral fat accumulation and metabolism of triglyceride-rich lipoproteins. Circulation 104: 12231228.
  • 794
    Fiegenbaum, M., Hutz, MH. (2003) Further evidence for the association between obesity-related traits and the apolipoprotein A-IV gene. Int J Obes Relat Metab Disord. 27: 484490.
  • 795
    Fisher, R. M., Burke, H., Nicaud, V., Ehnholm, C., Humphries, SE. (1999) Effect of variation in the apo A-IV gene on body mass index and fasting and postprandial lipids in the European Atherosclerosis Research Study II. J Lipid Res. 40: 287294.
  • 796
    Lefevre, M., Lovejoy, J. C., DeFelice, S. M., et al (2000) Common apolipoprotein A-IV variants are associated with differences in body mass index levels and percentage body fat. Int J Obes Relat Metab Disord. 24: 945953.
  • 797
    Aberle, J., Evans, D., Beil, F. U., Seedorf, U. (2005) A polymorphism in the apolipoprotein A5 gene is associated with weight loss after short-term diet. Clin Genet. 68: 152154.
  • 798
    Pouliot, M. C., Despres, J. P., Dionne, F. T., et al (1994) Apo B-100 gene EcoR1 polymorphism: relations to plasma lipoprotein changes associated with abdominal visceral obesity. Arterioscler Thromb. 14: 527533.
  • 799
    Rajput-Williams, J., Wallis, S. C., Yarnell, J., et al (1988) Variation of apolipoprotein-B gene is associated with obesity, high blood cholesterol levels, and increased risk of coronary heart disease. Lancet 2: 14421446.
  • 800
    Saha, N., Tay, J. S. H., Heng, C. K., Humphries, SE. (1993) DNA polymorphisms of the apolipoprotein B gene are associated with obesity and serum lipids in healthy Indians in Singapore. Clin Genet. 44: 113120.
  • 801
    Olivieri, O., Bassi, A., Stranieri, C., et al (2003) Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease. J Lipid Res. 44: 23742381.
  • 802
    Vijayaraghavan, S., Hitman, G. A., Kopelman, PG. (1994) Apolipoprotein D polymorphism: a genetic marker of obesity and hyperinsulinemia. J Clin Endocrinol Metab. 79: 568570.
  • 803
    Gottlieb, D. J., DeStefano, A. L., Foley, D. J., et al (2004) APOE epsilon4 is associated with obstructive sleep apnea/hypopnea: the Sleep Heart Health Study. Neurology 63: 664668.
  • 804
    Long, J. R., Liu, P. Y., Liu, Y. J., et al (2003) APOE and TGF-beta1 genes are associated with obesity phenotypes. J Med Genet. 40: 918924.
  • 805
    Oh, J. Y., Barrett-Connor, E. (2001) Apolipoprotein E polymorphism and lipid levels differ by gender and family history of diabetes: the Rancho Bernardo Study. Clin Genet. 60: 132137.
  • 806
    Yanagisawa, Y., Hasegawa, K., Dever, G. J., et al (2001) Uncoupling protein 3 and peroxisome proliferator-activated receptor gamma2 contribute to obesity and diabetes in Palauans. Biochem Biophys Res Commun. 281: 772778.
  • 807
    Alevizaki, M., Cimponeriu, A. T., Garofallaki, M., et al (2003) The androgen receptor gene CAG polymorphism is associated with the severity of coronary artery disease in men. Clin Endocrinol (Oxf). 59: 749755.
  • 808
    Gustafson, D. R., Wen, M. J., Koppanati, BM. (2003) Androgen receptor gene repeats and indices of obesity in older adults. Int J Obes Relat Metab Disord. 27: 7581.
  • 809
    Walsh, S., Zmuda, J. M., Cauley, J. A., et al (2005) Androgen receptor CAG repeat polymorphism is associated with fat-free mass in men. J Appl Physiol. 98: 132137.
  • 810
    Zitzmann, M., Gromoll, J., von Eckardstein, A., Nieschlag, E. (2003) The CAG repeat polymorphism in the androgen receptor gene modulates body fat mass and serum concentrations of leptin and insulin in men. Diabetologia 46: 3139.
  • 811
    Deriaz, O., Dionne, F., Perusse, L., et al (1994) DNA variation in the genes of the Na,K-adenosine triphosphatase and its relation with resting metabolic rate, respiratory quotient, and body fat. J Clin Invest. 93: 838843.
  • 812
    Katzmarzyk, P. T., Rankinen, T., Perusse, L., et al (1999) Linkage and association of the sodium potassium-adenosine triphosphatase alpha2 and beta1 genes with respiratory quotient and resting metabolic rate in the Quebec Family Study. J Clin Endocrinol Metab. 84: 20932097.
  • 813
    Ukkola, O., Joanisse, D. R., Tremblay, A., Bouchard, C. (2003) Na+-K+-ATPase alpha 2-gene and skeletal muscle characteristics in response to long-term overfeeding. J Appl Physiol. 94: 18701874.
  • 814
    Ribases, M., Gratacos, M., Fernandez-Aranda, F., et al (2005) Association of BDNF with restricting anorexia nervosa and minimum body mass index: a family-based association study of eight European populations. Eur J Hum Genet. 13: 428434.
  • 815
    Hoffstedt, J., Naslund, E., Arner, P. (2002) Calpain-10 gene polymorphism is associated with reduced beta(3)-adrenoceptor function in human fat cells. J Clin Endocrinol Metab. 87: 33623367.
  • 816
    Shima, Y., Nakanishi, K., Odawara, M., Kobayashi, T., Ohta, H. (2003) Association of the SNP-19 genotype 22 in the calpain-10 gene with elevated body mass index and hemoglobin A1c levels in Japanese. Clin Chim Acta. 336: 8996.
  • 817
    Challis, B. G., Yeo, G. S., Farooqi, I. S., et al (2000) The CART gene and human obesity: mutational analysis and population genetics. Diabetes 49: 872875.
  • 818
    Yamada, K., Yuan, X., Otabe, S., Koyanagi, A., Koyama, W., Makita, Z. (2002) Sequencing of the putative promoter region of the cocaine- and amphetamine-regulated-transcript gene and identification of polymorphic sites associated with obesity. Int J Obes Relat Metab Disord. 26: 132136.
  • 819
    Wolford, J., Bogardus, C., Prochazka, M. (1998) Polymorphism in the 3′ untranslated region of MTG8 is associated with obesity in Pima Indian males. Biochem Biophys Res Commun. 246: 624626.
  • 820
    Funakoshi, A., Miyasaka, K., Matsumoto, H., et al (2000) Gene structure of human cholecystokinin (CCK) type-A receptor: body fat content is related to CCK type-A receptor gene promoter polymorphism. FEBS Lett. 466: 264266.
  • 821
    Roth, S. M., Metter, E. J., Lee, M. R., Hurley, B. F., Ferrell, RE. (2003) C174T polymorphism in the CNTF receptor gene is associated with fat-free mass in men and women. J Appl Physiol. 95: 14251430.
  • 822
    Eriksson, A. L., Suuriniemi, M., Mahonen, A., Cheng, S., Ohlsson, C. (2005) The COMT val158met polymorphism is associated with early pubertal development, height and cortical bone mass in girls. Pediatr Res. 58: 7177.
  • 823
    Tworoger, S. S., Chubak, J., Aiello, E. J., et al (2004) The effect of CYP19 and COMT polymorphisms on exercise-induced fat loss in postmenopausal women. Obes Res. 12: 972981.
  • 824
    Rajput, C., Makhijani, K., Norboo, T., et al (2005) CYP11B2 gene polymorphisms and hypertension in highlanders accustomed to high salt intake. J Hypertens. 23: 7986.
  • 825
    Baghaei, F., Rosmond, R., Westberg, L., et al (2003) The CYP19 gene and associations with androgens and abdominal obesity in premenopausal women. Obes Res. 11: 578585.
  • 826
    Gennari, L., Masi, L., Merlotti, D., et al (2004) A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism. J Clin Endocrinol Metab. 89: 28032810.
  • 827
    Ellingrod, V. L., Miller, D., Schultz, S. K., Wehring, H., Arndt, S. (2002) CYP2D6 polymorphisms and atypical antipsychotic weight gain. Psychiatr Genet. 12: 5558.
  • 828
    Han, Z., Heath, S. C., Shmulewitz, D., et al (2002) Candidate genes involved in cardiovascular risk factors by a family-based association study on the island of Kosrae, Federated States of Micronesia. Am J Med Genet. 110: 234242.
  • 829
    Ukkola, O., Chagnon, M., Tremblay, A., Bouchard, C. (2003) Genetic variation at the adipsin locus and response to long-term overfeeding. Eur J Clin Nutr. 57: 10731078.
  • 830
    Peeters, R. P., van den Beld, A. W., van Toor, H., et al (2005) A polymorphism in type I deiodinase is associated with circulating free insulin-like growth factor I levels and body composition in humans. J Clin Endocrinol Metab. 90: 256263.
  • 831
    Comings, D. E., Flanagan, S. D., Dietz, G., Muhleman, D., Knell, E., Gysin, R. (1993) The dopamine D2 receptor (DRD2) as a major gene in obesity and height. Biochem Med Metab Biol. 50: 176185.
  • 832
    Spitz, M. R., Detry, M. A., Pillow, P., et al (2000) Variant alleles of the D2 dopamine receptor gene and obesity. Nutr Res. 20: 371380.
  • 833
    Tataranni, P. A., Baier, L., Jenkinson, C., Harper, I., Del Parigi, A., Bogardus, C. (2001) A Ser311Cys mutation in the human dopamine receptor D2 gene is associated with reduced energy expenditure. Diabetes 50: 901904.
  • 834
    Thomas, G. N., Tomlinson, B., Critchley, JA. (2000) Modulation of blood pressure and obesity with the dopamine D2 receptor gene TaqI polymorphism. Hypertension 36: 177182.
  • 835
    Thomas, G. N., Critchley, J. A., Tomlinson, B., Cockram, C. S., Chan, JC. (2001) Relationships between the taqI polymorphism of the dopamine D2 receptor and blood pressure in hyperglycaemic and normoglycaemic Chinese subjects. Clin Endocrinol (Oxf). 55: 605611.
  • 836
    Levitan, R. D., Masellis, M., Basile, V. S., et al (2004) The dopamine-4 receptor gene associated with binge eating and weight gain in women with seasonal affective disorder: an evolutionary perspective. Biol Psychiatry. 56: 665669.
  • 837
    Levitan, R. D., Masellis, M., Lam, R. W., et al (2004) Childhood inattention and dysphoria and adult obesity associated with the dopamine D4 receptor gene in overeating women with seasonal affective disorder. Neuropsychopharmacology 29: 179186.
  • 838
    Gonzalez-Sanchez, J. L., Martinez-Larrad, M. T., Fernandez-Perez, C., Kubaszek, A., Laakso, M., Serrano-Rios, M. (2003) K121Q PC-1 Gene polymorphism is not associated with insulin resistance in a Spanish population. Obes Res. 11: 603605.
  • 839
    Meyre, D., Bouatia-Naji, N., Tounian, A., et al (2005) Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes. Nat Genet. 37: 863867.
  • 840
    Deng, H. W., Li, J., Li, J. L., et al (2000) Association of estrogen receptor-alpha genotypes with body mass index in normal healthy postmenopausal Caucasian women. J Clin Endocrinol Metab. 85: 27482751.
  • 841
    Mansur, Ade P, Nogueira, C. C., Strunz, C. M., Aldrighi, J. M., Ramires, JA. (2005) Genetic polymorphisms of estrogen receptors in patients with premature coronary artery disease. Arch Med Res. 36: 511517.
  • 842
    Okura, T., Koda, M., Ando, F., Niino, N., Ohta, S., Shimokata, H. (2003) Association of polymorphisms in the estrogen receptor alpha gene with body fat distribution. Int J Obes Relat Metab Disord. 27: 10201027.
  • 843
    Speer, G., Cseh, K., Winkler, G., et al (2001) Vitamin D and estrogen receptor gene polymorphisms in type 2 diabetes mellitus and in android type obesity. Eur J Endocrinol. 144: 385389.
  • 844
    Brouillette, C., Bosse, Y., Perusse, L., Gaudet, D., Vohl, MC. (2004) Effect of liver fatty acid binding protein (FABP) T94A missense mutation on plasma lipoprotein responsiveness to treatment with fenofibrate. J Hum Genet. 49: 424432.
  • 845
    Damcott, C. M., Feingold, E., Moffett, S. P., et al (2003) Variation in the FABP2 promoter alters transcriptional activity and is associated with body composition and plasma lipid levels. Hum Genet. 112: 610616.
  • 846
    Hegele, R. A., Harris, S. B., Hanley, A. J. G., Sadikian, S., Connelly, P. W., Zinman, B. (1996) Genetic variation of intestinal fatty acid binding protein associated with variation in body mass in Aboriginal Canadians. J Clin Endocrinol Metab. 81: 43344337.
  • 847
    Lara-Castro, C., Hunter, G. R., Lovejoy, J. C., Gower, B. A., Fernandez, J.R. (2005) Association of the intestinal fatty acid-binding protein Ala54Thr polymorphism and abdominal adipose tissue in African-American and Caucasian women. J Clin Endocrinol Metab. 90: 11961201.
  • 848
    Yamada, K., Yuan, X., Ishiyama, S., et al (1997) Association between Ala54Thr substitution of the fatty acid-binding protein 2 gene with insulin resistance and intra-abdominal fat thickness in Japanese men. Diabetologia 40: 706710.
  • 849
    Kovacs, P., Harper, I., Hanson, R. L., et al (2004) A novel missense substitution (Val1483Ile) in the fatty acid synthase gene (FAS) is associated with percentage of body fat and substrate oxidation rates in nondiabetic Pima Indians. Diabetes 53: 19151919.
  • 850
    Carlsson, E., Almgren, P., Hoffstedt, J., Groop, L., Ridderstrale, M. (2004) The FOXC2 C-512T polymorphism is associated with obesity and dyslipidemia. Obes Res. 12: 17381743.
  • 851
    Carlsson, E., Groop, L., Ridderstrale, M. (2005) Role of the FOXC2-512C>T polymorphism in type 2 diabetes: possible association with the dysmetabolic syndrome. Int J Obes (Lond). 29: 268274.
  • 852
    Kovacs, P., Lehn-Stefan, A., Stumvoll, M., Bogardus, C., Baier, LJ. (2003) Genetic variation in the human winged helix/forkhead transcription factor gene FOXC2 in Pima Indians. Diabetes 52: 12921295.
  • 853
    Yanagisawa, K., Hingstrup Larsen L., Andersen, G., et al (2003) The FOXC2-512C>T variant is associated with hypertriglyceridaemia and increased serum C-peptide in Danish Caucasian glucose-tolerant subjects. Diabetologia 46: 15761580.
  • 854
    Boutin, P., Dina, C., Vasseur, F., et al (2003) GAD2 on chromosome 10p12 is a candidate gene for human obesity. PLoS Biol. 1: E68
  • 855
    Meyre, D., Boutin, P., Tounian, A., et al (2005) Is glutamate decarboxylase 2 (GAD2) a genetic link between low birth weight and subsequent development of obesity in children? J Clin Endocrinol Metab. 90: 23842390.
  • 856
    Siani, A., Iacone, R., Russo, O., et al (2001) Gly40Ser polymorphism of the glucagon receptor gene is associated with central adiposity in men. Obes Res. 9: 722726.
  • 857
    Hattersley, A. T., Beards, F., Ballantyne, E., Appleton, M., Harvey, R., Ellard, S. (1998) Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nat Genet. 19: 268270.
  • 858
    Weigert, C., Thamer, C., Brodbeck, K., et al (2005) The −913 G/A glutamine:fructose-6-phosphate aminotransferase gene polymorphism is associated with measures of obesity and intramyocellular lipid content in nondiabetic subjects. J Clin Endocrinol Metab. 90: 16391643.
  • 859
    Baessler, A., Hasinoff, M. J., Fischer, M., et al (2005) Genetic linkage and association of the growth hormone secretagogue receptor (ghrelin receptor) gene in human obesity. Diabetes 54: 259267.
  • 860
    del Giudice, E. M., Cirillo, G., Santoro, N., et al (2001) Molecular screening of the proopiomelanocortin (POMC) gene in Italian obese children: report of three new mutations. Int J Obes Relat Metab Disord. 25: 6167.
  • 861
    Korbonits, M., Gueorguiev, M., O'Grady, E., et al (2002) A variation in the ghrelin gene increases weight and decreases insulin secretion in tall, obese children. J Clin Endocrinol Metab. 87: 40054008.
  • 862
    Ukkola, O., Ravussin, E., Jacobson, P., et al (2001) Mutations in the preproghrelin/ghrelin gene associated with obesity in humans. J Clin Endocrinol Metab. 86: 39963999.
  • 863
    Brand, E., Wang, J. G., Herrmann, S. M., Staessen, JA. (2003) An epidemiological study of blood pressure and metabolic phenotypes in relation to the Gbeta3 C825T polymorphism. J Hypertens. 21: 729737.
  • 864
    Dishy, V., Gupta, S., Landau, R., et al (2003) G-protein beta3 subunit 825 C/T polymorphism is associated with weight gain during pregnancy. Pharmacogenetics 13: 241242.
  • 865
    Gutersohn, A., Naber, C., Muller, N., Erbel, R., Siffert, W. (2000) G protein beta3 subunit 825 TT genotype and post-pregnancy weight retention. Lancet 355: 12401241.
  • 866
    Hauner, H., Rohrig, K., Siffert, W. (2002) Effects of the G-protein beta3 subunit 825T allele on adipogenesis and lipolysis in cultured human preadipocytes and adipocytes. Horm Metab Res. 34: 475480.
  • 867
    Hauner, H., Meier, M., Jockel, K. H., Frey, U. H., Siffert, W. (2003) Prediction of successful weight reduction under sibutramine therapy through genotyping of the G-protein beta3 subunit gene (GNB3) C825T polymorphism. Pharmacogenetics 13: 453459.
  • 868
    Hegele, R. A., Anderson, C., Young, T. K., Connelly, PW. (1999) G-protein beta3 subunit gene splice variant and body fat distribution in Nunavut Inuit. Genome Res. 9: 972977.
  • 869
    Hocher, B., Slowinski, T., Stolze, T., Pleschka, A., Neumayer, H. H., Halle, H. (2000) Association of maternal G protein beta3 subunit 825T allele with low birthweight. Lancet 355: 12411242.
  • 870
    Poch, E., Giner, V., Gonzalez-Nunez, D., Coll, E., Oriola, J., de la Sierra, A. (2002) Association of the G protein beta3 subunit T allele with insulin resistance in essential hypertension. Clin Exp Hypertens. 24: 345353.
  • 871
    Rankinen, T., Rice, T., Leon, A. S., et al (2002) G protein beta 3 polymorphism and hemodynamic and body composition phenotypes in the HERITAGE Family Study. Physiol Genomics 8: 151157.
  • 872
    Ryden, M., Faulds, G., Hoffstedt, J., Wennlund, A., Arner, P. (2002) Effect of the (C825T) Gbeta(3) polymorphism on adrenoceptor-mediated lipolysis in human fat cells. Diabetes 51: 16011608.
  • 873
    Siffert, W., Naber, C., Walla, M., Ritz, E. (1999) G protein beta 3 subunit 825T allele and its potential association with obesity in hypertensive individuals. J Hypertens. 17: 10951098.
  • 874
    Siffert, W., Forster, P., Jockel, K., et al (1999) Worldwide ethnic distribution of the G protein beta 3 subunit 825T allele and its association with obesity in Caucasian, Chinese, and Black African individuals. J Am Soc Nephrol. 10: 19211930.
  • 875
    Stefan, N., Stumvoll, M., Machicao, F., Koch, M., Haring, H. U., Fritsche, A. (2004) C825T polymorphism of the G protein beta3 subunit is associated with obesity but not with insulin sensitivity. Obes Res. 12: 679683.
  • 876
    Bell, C. G., Meyre, D., Samson, C., et al (2005) Association of melanin-concentrating hormone receptor 1 5′ polymorphism with early-onset extreme obesity. Diabetes 54: 30493055.
  • 877
    Wermter, A. K., Reichwald, K., Buch, T., et al (2005) Mutation analysis of the MCHR1 gene in human obesity. Eur J Endocrinol. 152: 851862.
  • 878
    Orho-Melander, M., Almgren, P., Kanninen, T., Forsblom, C., Groop, L. (1999) A paired-sibling analysis of the Xbal polymorphism in the muscle glycogen synthase gene. Diabetologia 42: 11381145.
  • 879
    Gelernter-Yaniv, L., Feng, N., Sebring, N. G., Hochberg, Z., Yanovski, JA. (2003) Associations between a polymorphism in the 11 beta hydroxysteroid dehydrogenase type I gene and body composition. Int J Obes Relat Metab Disord. 27: 983986.
  • 880
    Chouchane, L., Danguir, J., Beji, C., et al (2001) Genetic variation in the stress protein hsp70-2 gene is highly associated with obesity. Int J Obes Relat Metab Disord. 25: 462466.
  • 881
    Levitan, R. D., Kaplan, A. S., Masellis, M., et al (2001) Polymorphism of the serotonin 5-HT1B receptor gene (HTR1B) associated with minimum lifetime body mass index in women with bulimia nervosa. Biol Psychiatry 50: 640643.
  • 882
    Aubert, R., Betoulle, D., Herbeth, B., Siest, G., Fumeron, F. (2000) 5-HT2A receptor gene polymorphism is associated with food and alcohol intake in obese people. Int J Obes Relat Metab Disord. 24: 920924.
  • 883
    Rosmond, R., Bouchard, C., Björntorp, P. (2002) 5-HT(2A) Receptor gene promoter polymorphism in relation to abdominal obesity and cortisol. Obes Res. 10: 585589.
  • 884
    McCarthy, S., Mottagui-Tabar, S., Mizuno, Y., et al (2005) Complex HTR2C linkage disequilibrium and promoter associations with body mass index and serum leptin. Hum Genet. 117: 545557.
  • 885
    Pooley, E. C., Fairburn, C. G., Cooper, Z., Sodhi, M. S., Cowen, P. J., Harrison, PJ. (2004) A 5-HT2C receptor promoter polymorphism (HTR2C–759C/T) is associated with obesity in women, and with resistance to weight loss in heterozygotes. Am J Med Genet. 126B: 124127.
  • 886
    Reynolds, G. P., Zhang, Z. J., Zhang, XB. (2002) Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism. Lancet 359: 20862087.
  • 887
    Westberg, L., Bah, J., Rastam, M., et al (2002) Association between a polymorphism of the 5-HT2C receptor and weight loss in teenage girls. Neuropsychopharmacology 26: 789793.
  • 888
    Yuan, X., Yamada, K., Ishiyama-Shigemoto, S., Koyama, W., Nonaka, K. (2000) Identification of polymorphic loci in the promoter region of the serotonin 5-HT2C receptor gene and their association with obesity and type II diabetes. Diabetologia 43: 373376.
  • 889
    Basile, V. S., Masellis, M., De Luca, V., Meltzer, H. Y., Kennedy, JL. (2002) 759C/T genetic variation of 5HT(2C) receptor and clozapine-induced weight gain. Lancet 360: 17901791.
  • 890
    Ellingrod, V. L., Perry, P. J., Ringold, J. C., et al (2005) Weight gain associated with the −759C/T polymorphism of the 5HT2C receptor and olanzapine. Am J Med Genet B Neuropsychiatr Genet. 134: 7678.
  • 891
    del Miller D., Ellingrod, V. L., Holman, T. L., Buckley, P. F., Arndt, S. (2005) Clozapine-induced weight gain associated with the 5HT2C receptor −759C/T polymorphism. Am J Med Genet B Neuropsychiatr Genet. 133: 97100.
  • 892
    Templeman, L. A., Reynolds, G. P., Arranz, B., San, L. (2005) Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis. Pharmacogenet Genomics 15: 195200.
  • 893
    Reynolds, G. P., Zhang, Z., Zhang, X. (2003) Polymorphism of the promoter region of the serotonin 5-HT(2C) receptor gene and clozapine-induced weight gain. Am J Psychiatry 160: 677679.
  • 894
    Gu, H. F., Efendic, S., Nordman, S., et al (2004) Quantitative trait loci near the insulin-degrading enzyme (IDE) gene contribute to variation in plasma insulin levels. Diabetes 53: 21372142.
  • 895
    Sun, G., Gagnon, J., Chagnon, Y., et al (1999) Association and linkage between an insulin-like growth factor-1 gene polymorphism and fat free mass in the HERITAGE family study. Int J Obes Relat Metab Disord. 23: 929935.
  • 896
    Gu, D., O'Dell, S. D., Chen, X. H., Miller, G. J., Day, IN. (2002) Evidence of multiple causal sites affecting weight in the IGF2-INS-TH region of human chromosome 11. Hum Genet. 110: 173181.
  • 897
    O'Dell, S. D., Miller, G. J., Cooper, J. A., et al (1997) Apa1 polymorphism in insulin-like growth factor II (IGF2) gene and weight in middle-aged males. Int J Obes Relat Metab Disord. 21: 822825.
  • 898
    Roth, S. M., Schrager, M. A., Metter, E. J., et al (2002) IGF2 genotype and obesity in men and women across the adult age span. Int J Obes Relat Metab Disord. 26: 585587.
  • 899
    Schrager, M. A., Roth, S. M., Ferrell, R. E., et al (2004) Insulin-like growth factor-2 genotype, fat-free mass, and muscle performance across the adult life span. J Appl Physiol. 97: 21762183.
  • 900
    Berthier, M. T., Paradis, A. M., Tchernof, A., et al (2003) The interleukin 6-174G/C polymorphism is associated with indices of obesity in men. J Hum Genet. 48: 1419.
  • 901
    Kubaszek, A., Pihlajamaki, J., Punnonen, K., Karhapaa, P., Vauhkonen, I., Laakso, M. (2003) The C-174G promoter polymorphism of the IL-6 gene affects energy expenditure and insulin sensitivity. Diabetes 52: 558561.
  • 902
    Moffett, S. P., Zmuda, J. M., Cauley, J. A., et al (2004) Association of the G-174C variant in the interleukin-6 promoter region with bone loss and fracture risk in older women. J Bone Miner Res. 19: 16121618.
  • 903
    Roth, S. M., Schrager, M. A., Lee, M. R., Metter, E. J., Hurley, B. F., Ferrell, RE. (2003) Interleukin-6 (IL6) genotype is associated with fat-free mass in men but not women. J Gerontol A Biol Sci Med Sci. 58: B1085B1088.
  • 904
    Stephens, J. W., Hurel, S. J., Cooper, J. A., Acharya, J., Miller, G. J., Humphries, SE. (2004) A common functional variant in the interleukin-6 gene is associated with increased body mass index in subjects with type 2 diabetes mellitus. Mol Genet Metab. 82: 180186.
  • 905
    Wernstedt, I., Eriksson, A. L., Berndtsson, A., et al (2004) A common polymorphism in the interleukin-6 gene promoter is associated with overweight. Int J Obes Relat Metab Disord. 28: 12721279.
  • 906
    Escobar-Morreale, H. F., Calvo, R. M., Villuendas, G., Sancho, J., San Millan JL. (2003) Association of polymorphisms in the interleukin 6 receptor complex with obesity and hyperandrogenism. Obes Res. 11: 987996.
  • 907
    Wolford, J. K., Colligan, P. B., Gruber, J. D., Bogardus, C. (2003) Variants in the interleukin 6 receptor gene are associated with obesity in Pima Indians. Mol Genet Metab. 80: 338343.
  • 908
    Dunger, D. B., Ong, K. K. L., Huxtable, S. J., et al (1998) Association of the INS VNTR with size at birth. Nat Genet. 19: 98100.
  • 909
    Heude, B., Dubois, S., Charles, M. A., et al (2004) VNTR polymorphism of the insulin gene and childhood overweight in a general population. Obes Res. 12: 499504.
  • 910
    Le Stunff, C., Fallin, D., Bougneres, P. (2001) Paternal transmission of the very common class I INS VNTR alleles predisposes to childhood obesity. Nat Genet. 29: 9699.
  • 911
    O'Dell, S. D., Bujac, S. R., Miller, G. J., Day, IN. (1999) Associations of IGF2 ApaI RFLP and INS VNTR class I allele size with obesity. Eur J Hum Genet. 7: 821827.
  • 912
    Ong, K. K., Petry, C. J., Barratt, B. J., et al (2004) Maternal-fetal interactions and birth order influence insulin variable number of tandem repeats allele class associations with head size at birth and childhood weight gain. Diabetes 53: 11281133.
  • 913
    Weaver, J. U., Kopelman, P. G., Hitman, GA. (1992) Central obesity and hyperinsulinaemia in women are associated with polymorphism in the 5′ flanking region of the human insulin gene. Eur J Clin Invest. 22: 265270.
  • 914
    Zee, R. Y., Lou, Y. K., Morris, BJ. (1994) Insertion variant in intron 9, but not microsatellite in intron 2, of the insulin receptor gene is associated with essential hypertension. J Hypertens Suppl. 12: 1322.
  • 915
    Jellema, A., Mensink, R. P., Kromhout, D., Saris, W. H., Feskens, EJ. (2003) Metabolic risk markers in an overweight and normal weight population with oversampling of carriers of the IRS-1 972Arg-variant. Atherosclerosis 171: 7581.
  • 916
    Krempler, F., Hell, E., Winkler, C., Breban, D., Patsch, W. (1998) Plasma leptin levels: interaction of obesity with a common variant of insulin receptor substrate-1. Arterioscler Thromb Vasc Biol. 18: 16861690.
  • 917
    Lei, H., Coresh, J., Shuldiner, A., Boerwinkle, E., Brancati, F. (1999) Variants of the insulin receptor substrate-1 and fatty acid binding protein 2 genes and the risk of type 2 diabetes, obesity, and hyperinsulinemia in African-Americans: The Atherosclerosis Risk in Communities Study. Diabetes 48: 18681872.
  • 918
    Stefan, N., Kovacs, P., Stumvoll, M., et al (2003) Metabolic effects of the Gly1057Asp polymorphism in IRS-2 and interactions with obesity. Diabetes 52: 15441550.
  • 919
    Griffiths, L. R., Nyhold, D. R., Curtain, R. P., Gaffney, P. T., Morris, BJ. (1995) Cross-sectional study of a microsatellite marker in the low density lipoprotein receptor gene in obese normotensives. Clin Exp Pharmacol Physiol. 22: 496498.
  • 920
    Mattevi, V. S., Coimbra, C. E., Santos, R. V., Salzano, F. M., Hutz, MH. (2000) Association of the low-density lipoprotein receptor gene with obesity in Native American populations. Hum Genet. 106: 546552.
  • 921
    Rutherford, S., Nyholt, D., Curtain, R., et al (1997) Association of a low density lipoprotein receptor microsatellite variant with obesity. Int J Obes Relat Metab Disord. 21: 10321037.
  • 922
    Zee, R. Y. L., Griffiths, L. R., Morris, BJ. (1992) Marked association of a RFLP for the low density lipoprotein receptor gene with obesity in essential hypertensives. Biochem Biophys Res Commun. 189: 965971.
  • 923
    Zee, R. Y. L., Schrader, A. P., Robinson, B. G., Griffiths, L. R., Morris, BJ. (1995) Association of HincII RFLP of low density lipoprotein receptor gene with obesity in essential hypertensives. Clin Genet. 47: 118121.
  • 924
    Butler, M. G., Hedges, L., Hovis, C. L., Feurer, ID. (1998) Genetic variants of the human obesity (OB) gene in subjects with and without Prader-Willi syndrome: comparison with body mass index and weight. Clin Genet. 54: 385393.
  • 925
    Hager, J., Clement, K., Francke, S., et al (1998) A polymorphism in the 5′ untranslated region of the human ob gene is associated with low leptin levels. Int J Obes Relat Metab Disord. 22: 200205.
  • 926
    Hoffstedt, J., Eriksson, P., Mottagui-Tabar, S., Arner, P. (2002) A polymorphism in the leptin promoter region (−2548 g/a) influences gene expression and adipose tissue secretion of leptin. Horm Metab Res. 34: 355359.
  • 927
    Jiang, Y., Wilk, J. B., Borecki, I., et al (2004) Common variants in the 5′ region of the leptin gene are associated with body mass index in men from the National Heart, Lung, and Blood Institute Family Heart Study. Am J Hum Genet. 75: 220230.
  • 928
    Le Stunff, C., Le Bihan, C., Schork, N. J., Bougneres, P. (2000) A common promoter variant of the leptin gene is associated with changes in the relationship between serum leptin and fat mass in obese girls. Diabetes 49: 21962200.
  • 929
    Li, W. D., Reed, D. R., Lee, J. H., et al (1999) Sequence variants in the 5′ flanking region of the leptin gene are associated with obesity in women. Ann Hum Genet. 63: 227234.
  • 930
    Mammes, O., Betoulle, D., Aubert, R., et al (1998) Novel polymorphisms in the 5′ region of the LEP gene: association with leptin levels and response to low-calorie diet in human obesity. Diabetes. 47: 487489.
  • 931
    Oksanen, L., Ohman, M., Heiman, M., et al (1997) Markers for the gene ob and serum leptin levels in human morbid obesity. Hum Genet 99: 559564.
  • 932
    Shintani, M., Ikegami, H., Yamato, E., et al (1996) A novel microsatellite polymorphism in the human OB gene: a highly polymorphic marker for linkage analysis. Diabetologia 39: 13981401.
  • 933
    Zhang, Z. J., Yao, Z. J., Mou, X. D., et al (2003) Association of −2548G/A functional polymorphism in the promoter region of leptin gene with antipsychotic agent-induced weight gain. Zhonghua Yi Xue Za Zhi. 83: 21192123.
  • 934
    Chagnon, Y. C., Wilmore, J. H., Borecki, I. B., et al (2000) Associations between the leptin receptor gene and adiposity in middle-aged Caucasian males from the HERITAGE family study. J Clin Endocrinol Metab. 85: 2934.
  • 935
    Chagnon, Y. C., Chung, W. K., Perusse, L., Chagnon, M., Leibel, R. L., Bouchard, C. (1999) Linkages and associations between the leptin receptor (LEPR) gene and human body composition in the Quebec Family Study. Int J Obes Relat Metab Disord. 23: 278286.
  • 936
    de Silva, A. M., Walder, K. R., Boyko, E. J., et al (2001) Genetic variation and obesity in Australian women: a prospective study. Obes Res. 9: 733740.
  • 937
    Guizar-Mendoza, J. M., Amador-Licona, N., Flores-Martinez, S. E., Lopez-Cardona, M. G., Ahuatzin-Tremary, R., Sanchez-Corona, J. (2005) Association analysis of the Gln223Arg polymorphism in the human leptin receptor gene, and traits related to obesity in Mexican adolescents. J Hum Hypertens. 19: 341346.
  • 938
    Liu, Y. J., Rocha-Sanchez, S. M., Liu, P. Y., et al (2004) Tests of linkage and/or association of the LEPR gene polymorphisms with obesity phenotypes in Caucasian nuclear families. Physiol Genomics 17: 101106.
  • 939
    Mammes, O., Aubert, R., Betoulle, D., et al (2001) LEPR gene polymorphisms: associations with overweight, fat mass and response to diet in women. Eur J Clin Invest. 31: 398404.
  • 940
    Mattevi, V. S., Zembrzuski, V. M., Hutz, MH. (2002) Association analysis of genes involved in the leptin-signaling pathway with obesity in Brazil. Int J Obes Relat Metab Disord. 26: 11791185.
  • 941
    Quinton, N. D., Lee, A. J., Ross, R. J., Eastell, R., Blakemore, AI. (2001) A single nucleotide polymorphism (SNP) in the leptin receptor is associated with BMI, fat mass and leptin levels in postmenopausal Caucasian women. Hum Genet. 108: 233236.
  • 942
    Rosmond, R., Chagnon, Y. C., Holm, G., et al (2000) Hypertension in obesity and the leptin receptor gene locus. J Clin Endocrinol Metab. 85: 31263131.
  • 943
    Ross, J. A., Oeffinger, K. C., Davies, S. M., et al (2004) Genetic variation in the leptin receptor gene and obesity in survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 22: 35583562.
  • 944
    Roth, H., Korn, T., Rosenkranz, K., et al (1998) Transmission disequilibrium and sequence variants at the leptin receptor gene in extremely obese German children and adolescents. Hum Genet. 103: 540546.
  • 945
    Stefan, N., Vozarova, B., Del Parigi, A., et al (2002) The Gln223Arg polymorphism of the leptin receptor in Pima Indians: influence on energy expenditure, physical activity and lipid metabolism. Int J Obes Relat Metab Disord. 26: 16291632.
  • 946
    Thompson, D. B., Ravussin, E., Bennett, P. H., Bogardus, C. (1997) Structure and sequence variation at the human leptin receptor gene in lean and obese Pima Indians. Hum Mol Genet. 6: 675679.
  • 947
    Wauters, M., Mertens, I., Chagnon, M., et al (2001) Polymorphisms in the leptin receptor gene, body composition and fat distribution in overweight and obese women. Int J Obes Relat Metab Disord. 25: 714720.
  • 948
    Yiannakouris, N., Yannakoulia, M., Melistas, L., Chan, J. L., Klimis-Zacas, D., Mantzoros, CS. (2001) The Q223R polymorphism of the leptin receptor gene is significantly associated with obesity and predicts a small percentage of body weight and body composition variability. J Clin Endocrinol Metab. 86: 44344439.
  • 949
    Zacharova, J., Chiasson, J. L., Laakso, M. (2005) Leptin receptor gene variation predicts weight change in subjects with impaired glucose tolerance. Obes Res. 13: 501506.
  • 950
    St-Pierre, J., Miller-Felix, I., Paradis, M. E., et al (2003) Visceral obesity attenuates the effect of the hepatic lipase −514C>T polymorphism on plasma HDL-cholesterol levels in French-Canadian men. Mol Genet Metab. 78: 3136.
  • 951
    Stefan, N., Schafer, S., Machicao, F., et al (2005) Liver fat and insulin resistance are independently associated with the −514C>T polymorphism of the hepatic lipase gene. J Clin Endocrinol Metab. 90: 42384243.
  • 952
    Garenc, C., Perusse, L., Chagnon, Y. C., et al (2002) The hormone-sensitive lipase gene and body composition: the HERITAGE Family Study. Int J Obes Relat Metab Disord. 26: 220227.
  • 953
    Hoffstedt, J., Arner, P., Schalling, M., et al (2001) A common hormone-sensitive lipase i6 gene polymorphism is associated with decreased human adipocyte lipolytic function. Diabetes 50: 24102413.
  • 954
    Lavebratt, C., Ryden, M., Schalling, M., Sengul, S., Ahlberg, S., Hoffstedt, J. (2002) The hormone-sensitive lipase i6 gene polymorphism and body fat accumulation. Eur J Clin Invest. 32: 938942.
  • 955
    Magre, J., Laurell, H., Fizames, C., et al (1998) Human hormone-sensitive lipase: genetic mapping, identification of a new dinucleotide repeat, and association with obesity and NIDDM. Diabetes 47: 284286.
  • 956
    Pihlajamaki, J., Valve, R., Karjalainen, L., Karhapaa, P., Vauhkonen, I., Laakso, M. (2001) The hormone sensitive lipase gene in familial combined hyperlipidemia and insulin resistance. Eur J Clin Invest. 31: 302308.
  • 957
    Hegele, R. A., Cao, H., Huff, M. W., Anderson, CM. (2000) LMNA R482Q mutation in partial lipodystrophy associated with reduced plasma leptin concentration. J Clin Endocrinol Metab. 85: 30893093.
  • 958
    Hegele, R. A., Cao, H., Harris, S. B., Zinman, B., Hanley, A. J., Anderson, CM. (2000) Genetic variation in LMNA modulates plasma leptin and indices of obesity in aboriginal Canadians. Physiol Genomics 3: 3944.
  • 959
    Hegele, R. A., Anderson, C. M., Wang, J., Jones, D. C., Cao, H. (2000) Association between nuclear lamin A/C R482Q mutation and partial lipodystrophy with hyperinsulinemia, dyslipidemia, hypertension, and diabetes. Genome Res. 10: 652658.
  • 960
    Hegele, R. A., Huff, M. W., Young, TK. (2001) Common genomic variation in LMNA modulates indexes of obesity in Inuit. J Clin Endocrinol Metab. 86: 27472751.
  • 961
    Garenc, C., Perusse, L., Bergeron, J., et al (2001) Evidence of LPL gene-exercise interaction for body fat and LPL activity: the HERITAGE Family Study. J Appl Physiol. 91: 13341340.
  • 962
    Jemaa, R., Tuzet, S., Portos, C., Betoulle, D., Apfelbaum, M., Fumeron, F. (1995) Lipoprotein lipase gene polymorphisms: associations with hypertriglyceridemia and body mass index in obese people. Int J Obes Relat Metab Disord. 19: 270274.
  • 963
    McCarthy, J. J., Meyer, J., Moliterno, D. J., Newby, L. K., Rogers, W. J., Topol, EJ. (2003) Evidence for substantial effect modification by gender in a large-scale genetic association study of the metabolic syndrome among coronary heart disease patients. Hum Genet. 114: 8798.
  • 964
    Hamid, Y. H., Urhammer, S. A., Glumer, C., et al (2005) The common T60N polymorphism of the lymphotoxin-alpha gene is associated with type 2 diabetes and other phenotypes of the metabolic syndrome. Diabetologia 48: 445451.
  • 965
    Iwai, N., Mannami, T., Tomoike, H., Ono, K., Iwanaga, Y. (2003) An acyl-CoA synthetase gene family in chromosome 16p12 may contribute to multiple risk factors. Hypertension 41: 10411046.
  • 966
    Camarena, B., Santiago, H., Aguilar, A., Ruvinskis, E., Gonzalez-Barranco, J., Nicolini, H. (2004) Family-based association study between the monoamine oxidase A gene and obesity: implications for psychopharmacogenetic studies. Neuropsychobiology 49: 126129.
  • 967
    Boucher, N., Lanouette, C. M., Larose, M., Perusse, L., Bouchard, C., Chagnon, YC. (2002) A +2138InsCAGACC polymorphism of the melanocortin receptor 3 gene is associated in human with fat level and partitioning in interaction with body corpulence. Mol Med. 8: 158165.
  • 968
    Schalin-Jantti, C., Valli-Jaakola, K., Oksanen, L., et al (2003) Melanocortin-3-receptor gene variants in morbid obesity. Int J Obes Relat Metab Disord. 27: 7074.
  • 969
    Chagnon, Y. C., Chen, W. J., Perusse, L., et al (1997) Linkage and association studies between the melanocortin receptors 4 and 5 genes and obesity-related phenotypes in the Quebec Family Study. Mol Med. 3: 663673.
  • 970
    Geller, F., Reichwald, K., Dempfle, A., et al (2004) Melanocortin-4 receptor gene variant I103 is negatively associated with obesity. Am J Hum Genet. 74: 572581.
  • 971
    Loos, R. J., Rankinen, T., Tremblay, A., Perusse, L., Chagnon, Y., Bouchard, C. (2005) Melanocortin-4 receptor gene and physical activity in the Quebec Family Study. Int J Obes (Lond). 29: 420428.
  • 972
    Potoczna, N., Branson, R., Kral, J. G., et al (2004) Gene variants and binge eating as predictors of comorbidity and outcome of treatment in severe obesity. J Gastrointest Surg. 8: 971981; discussion. 81–2.
  • 973
    Rosmond, R., Chagnon, M., Bouchard, C., Björntorp, P. (2001) A missense mutation in the human melanocortin-4 receptor gene in relation to abdominal obesity and salivary cortisol. Diabetologia 44: 13351338.
  • 974
    Rutanen, J., Pihlajamaki, J., Karhapaa, P., et al (2004) The Val103Ile polymorphism of melanocortin-4 receptor regulates energy expenditure and weight gain. Obes Res. 12: 10601066.
  • 975
    Philibert, R., Caspers, K., Langbehn, D., et al (2002) The association of a HOPA polymorphism with major depression and phobia. Compr Psychiatry 43: 404410.
  • 976
    Berthier, M. T., Houde, A., Paradis, A. M., et al (2004) Molecular screening of the microsomal triglyceride transfer protein: association between polymorphisms and both abdominal obesity and plasma apolipoprotein B concentration. J Hum Genet. 49: 684690.
  • 977
    Wasserman, L., Flatt, S. W., Natarajan, L., et al (2003) Correlates of obesity in postmenopausal women with breast cancer: comparison of genetic, demographic, disease-related, life history and dietary factors. Int J Obes Relat Metab Disord. 14: 14
  • 978
    Bouchard, L., Drapeau, V., Provencher, V., et al (2004) Neuromedin beta: a strong candidate gene linking eating behaviors and susceptibility to obesity. Am J Clin Nutr. 80: 14781486.
  • 979
    Sarzani, R., Strazzullo, P., Salvi, F., et al (2004) Natriuretic peptide clearance receptor alleles and susceptibility to abdominal adiposity. Obes Res. 12: 351356.
  • 980
    Bray, M. S., Boerwinkle, E., Hanis, CL. (2000) Sequence variation within the neuropeptide Y gene and obesity in Mexican Americans. Obes Res. 8: 219226.
  • 981
    Ding, B., Kull, B., Liu, Z., et al (2005) Human neuropeptide Y signal peptide gain-of-function polymorphism is associated with increased body mass index: possible mode of function. Regul Pept. 127: 4553.
  • 982
    Karvonen, M. K., Koulu, M., Pesonen, U., et al (2000) Leucine 7 to proline 7 polymorphism in the preproneuropeptide Y is associated with birth weight and serum triglyceride concentration in preschool aged children. J Clin Endocrinol Metab. 85: 14551460.
  • 983
    Hung, C. C., Pirie, F., Luan, J., et al (2004) Studies of the peptide YY and neuropeptide Y2 receptor genes in relation to human obesity and obesity-related traits. Diabetes 53: 24612466.
  • 984
    Ma, L., Tataranni, P. A., Hanson, R. L., et al (2005) Variations in peptide YY and Y2 receptor genes are associated with severe obesity in Pima Indian men. Diabetes 54: 15981602.
  • 985
    Jenkinson, C. P., Cray, K., Walder, K., Herzog, H., Ravussin, E., Hanson, R. (2000) Novel polymorphisms in the neuropeptide-Y Y5 receptor associated with obesity in Pima Indians. Int J Obes Relat Metab Disord. 24: 580584.
  • 986
    Hung, C. C., Farooqi, I. S., Ong, K., et al (2003) Contribution of variants in the small heterodimer partner gene to birthweight, adiposity, and insulin levels: mutational analysis and association studies in multiple populations. Diabetes 52: 12881291.
  • 987
    Nishigori, H., Tomura, H., Tonooka, N., et al (2001) Mutations in the small heterodimer partner gene are associated with mild obesity in Japanese subjects. Proc Natl Acad Sci USA. 98: 575580.
  • 988
    Buemann, B., Vohl, M. C., Chagnon, M., et al (1997) Abdominal visceral fat is associated with a BclI restriction fragment length polymorphism at the glucocorticoid receptor gene locus. Obes Res. 5: 186192.
  • 989
    Di Blasio, A. M., van Rossum, E. F., Maestrini, S., et al (2003) The relation between two polymorphisms in the glucocorticoid receptor gene and body mass index, blood pressure and cholesterol in obese patients. Clin Endocrinol (Oxf). 59: 6874.
  • 990
    Dobson, M. G., Redfern, C. P., Unwin, N., Weaver, JU. (2001) The N363S polymorphism of the glucocorticoid receptor: potential contribution to central obesity in men and lack of association with other risk factors for coronary heart disease and diabetes mellitus. J Clin Endocrinol Metab. 86: 22702274.
  • 991
    Rosmond, R., Chagnon, Y. C., Holm, G., et al (2000) A glucocorticoid receptor gene marker is associated with abdominal obesity, leptin, and dysregulation of the hypothalamic-pituitary-adrenal axis. Obes Res. 8: 211218.
  • 992
    Roussel, R., Reis, A. F., Dubois-Laforgue, D., Bellanne-Chantelot, C., Timsit, J., Velho, G.